id	sid	tid	token	lemma	pos
ctmj-57	1	1	chinese	chinese	ADJ
ctmj-57	1	2	traditional	traditional	ADJ
ctmj-57	1	3	medicine	medicine	NOUN
ctmj-57	1	4	journal	journal	NOUN
ctmj-57	1	5	|	|	ADV
ctmj-57	1	6	2020	2020	NUM
ctmj-57	2	1	|	|	ADV
ctmj-57	2	2	vol	vol	NOUN
ctmj-57	2	3	3	3	NUM
ctmj-57	2	4	|	|	ADV
ctmj-57	2	5	issue	issue	VERB
ctmj-57	2	6	6	6	NUM
ctmj-57	2	7	issn	issn	NOUN
ctmj-57	2	8	:	:	PUNCT
ctmj-57	2	9	2693	2693	NUM
ctmj-57	2	10	6356	6356	NUM
ctmj-57	2	11	2020	2020	NUM
ctmj-57	2	12	|	|	ADV
ctmj-57	2	13	vol	vol	NOUN
ctmj-57	2	14	3	3	NUM
ctmj-57	3	1	|	|	ADV
ctmj-57	3	2	issue	issue	VERB
ctmj-57	3	3	6	6	NUM
ctmj-57	3	4	ctmj	ctmj	NOUN
ctmj-57	3	5	|	|	ADV
ctmj-57	3	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	3	7	for	for	ADP
ctmj-57	3	8	the	the	DET
ctmj-57	3	9	treatment	treatment	NOUN
ctmj-57	3	10	of	of	ADP
ctmj-57	3	11	dry	dry	ADJ
ctmj-57	3	12	eyes	eye	NOUN
ctmj-57	3	13	caused	cause	VERB
ctmj-57	3	14	by	by	ADP
ctmj-57	3	15	the	the	DET
ctmj-57	3	16	suppression	suppression	NOUN
ctmj-57	3	17	of	of	ADP
ctmj-57	3	18	the	the	DET
ctmj-57	3	19	jak2	jak2	PROPN
ctmj-57	3	20	/	/	SYM
ctmj-57	3	21	stat3	stat3	NOUN
ctmj-57	3	22	pathway	pathway	NOUN
ctmj-57	3	23	,	,	PUNCT
ctmj-57	3	24	a	a	DET
ctmj-57	3	25	combination	combination	NOUN
ctmj-57	3	26	of	of	ADP
ctmj-57	3	27	runmu	runmu	PROPN
ctmj-57	3	28	fengye	fengye	PROPN
ctmj-57	3	29	tang	tang	PROPN
ctmj-57	3	30	preparation	preparation	NOUN
ctmj-57	3	31	and	and	CCONJ
ctmj-57	3	32	hydroxysugar	hydroxysugar	PROPN
ctmj-57	3	33	glycolic	glycolic	NOUN
ctmj-57	3	34	acid	acid	PROPN
ctmj-57	3	35	eye	eye	NOUN
ctmj-57	3	36	drops	drop	NOUN
ctmj-57	3	37	is	be	AUX
ctmj-57	3	38	recommended	recommend	VERB
ctmj-57	3	39	.	.	PUNCT
ctmj-57	4	1	dr.p.aravinda	dr.p.aravinda	PROPN
ctmj-57	4	2	reddy	reddy	PROPN
ctmj-57	4	3	1	1	NUM
ctmj-57	4	4	,	,	PUNCT
ctmj-57	4	5	dr.v.ravikumar	dr.v.ravikumar	PROPN
ctmj-57	4	6	2,dr.rafia	2,dr.rafia	PROPN
ctmj-57	4	7	3,aashish	3,aashish	NUM
ctmj-57	4	8	r	r	NOUN
ctmj-57	4	9	hajare	hajare	NOUN
ctmj-57	4	10	4	4	NUM
ctmj-57	4	11	,	,	PUNCT
ctmj-57	4	12	assistant	assistant	NOUN
ctmj-57	4	13	professor	professor	NOUN
ctmj-57	4	14	1,2,3,4	1,2,3,4	NUM
ctmj-57	4	15	,	,	PUNCT
ctmj-57	4	16	department	department	NOUN
ctmj-57	4	17	of	of	ADP
ctmj-57	4	18	pharmacy	pharmacy	NOUN
ctmj-57	4	19	,	,	PUNCT
ctmj-57	4	20	samskruti	samskruti	PROPN
ctmj-57	4	21	college	college	PROPN
ctmj-57	4	22	of	of	ADP
ctmj-57	4	23	pharmacy	pharmacy	NOUN
ctmj-57	4	24	,	,	PUNCT
ctmj-57	4	25	kondapur	kondapur	NOUN
ctmj-57	4	26	(	(	PUNCT
ctmj-57	4	27	v	v	NOUN
ctmj-57	4	28	)	)	PUNCT
ctmj-57	4	29	,	,	PUNCT
ctmj-57	4	30	ghatkesar	ghatkesar	VERB
ctmj-57	4	31	(	(	PUNCT
ctmj-57	4	32	m	m	NOUN
ctmj-57	4	33	)	)	PUNCT
ctmj-57	4	34	medchal	medchal	ADJ
ctmj-57	4	35	dist	dist	NOUN
ctmj-57	4	36	,	,	PUNCT
ctmj-57	4	37	telangana	telangana	PROPN
ctmj-57	4	38	,	,	PUNCT
ctmj-57	4	39	india	india	PROPN
ctmj-57	4	40	.	.	PUNCT
ctmj-57	5	1	abstract	abstract	ADJ
ctmj-57	5	2	the	the	DET
ctmj-57	5	3	goal	goal	NOUN
ctmj-57	5	4	of	of	ADP
ctmj-57	5	5	this	this	DET
ctmj-57	5	6	study	study	NOUN
ctmj-57	5	7	is	be	AUX
ctmj-57	5	8	to	to	PART
ctmj-57	5	9	identify	identify	VERB
ctmj-57	5	10	therapeutic	therapeutic	ADJ
ctmj-57	5	11	approaches	approach	NOUN
ctmj-57	5	12	that	that	PRON
ctmj-57	5	13	successfully	successfully	ADV
ctmj-57	5	14	address	address	VERB
ctmj-57	5	15	dry	dry	ADJ
ctmj-57	5	16	eye	eye	NOUN
ctmj-57	5	17	in	in	ADP
ctmj-57	5	18	clinical	clinical	ADJ
ctmj-57	5	19	settings	setting	NOUN
ctmj-57	5	20	.	.	PUNCT
ctmj-57	6	1	methods	method	NOUN
ctmj-57	6	2	:	:	PUNCT
ctmj-57	6	3	eye	eye	NOUN
ctmj-57	6	4	drops	drop	VERB
ctmj-57	6	5	containing	contain	VERB
ctmj-57	6	6	glycerol	glycerol	NOUN
ctmj-57	6	7	,	,	PUNCT
ctmj-57	6	8	dextran	dextran	NOUN
ctmj-57	6	9	70	70	NUM
ctmj-57	6	10	,	,	PUNCT
ctmj-57	6	11	and	and	CCONJ
ctmj-57	6	12	runmu	runmu	PROPN
ctmj-57	6	13	fengliang	fengliang	PROPN
ctmj-57	6	14	tang	tang	PROPN
ctmj-57	6	15	(	(	PUNCT
ctmj-57	6	16	rmfs	rmfs	NOUN
ctmj-57	6	17	)	)	PUNCT
ctmj-57	6	18	were	be	AUX
ctmj-57	6	19	given	give	VERB
ctmj-57	6	20	to	to	ADP
ctmj-57	6	21	rabbits	rabbit	NOUN
ctmj-57	6	22	in	in	ADP
ctmj-57	6	23	a	a	DET
ctmj-57	6	24	model	model	NOUN
ctmj-57	6	25	of	of	ADP
ctmj-57	6	26	scopolamine	scopolamine	NOUN
ctmj-57	6	27	-	-	PUNCT
ctmj-57	6	28	induced	induce	VERB
ctmj-57	6	29	dry	dry	ADJ
ctmj-57	6	30	eye	eye	NOUN
ctmj-57	6	31	(	(	PUNCT
ctmj-57	6	32	hga	hga	PROPN
ctmj-57	6	33	)	)	PUNCT
ctmj-57	6	34	.	.	PUNCT
ctmj-57	7	1	dry	dry	ADJ
ctmj-57	7	2	eye	eye	NOUN
ctmj-57	7	3	symptoms	symptom	NOUN
ctmj-57	7	4	and	and	CCONJ
ctmj-57	7	5	lacrimal	lacrimal	ADJ
ctmj-57	7	6	gland	gland	NOUN
ctmj-57	7	7	damage	damage	NOUN
ctmj-57	7	8	were	be	AUX
ctmj-57	7	9	assessed	assess	VERB
ctmj-57	7	10	using	use	VERB
ctmj-57	7	11	schirmer	schirmer	PROPN
ctmj-57	7	12	's	's	PART
ctmj-57	7	13	i	i	PRON
ctmj-57	7	14	test	test	NOUN
ctmj-57	7	15	(	(	PUNCT
ctmj-57	7	16	sit	sit	VERB
ctmj-57	7	17	)	)	PUNCT
ctmj-57	7	18	,	,	PUNCT
ctmj-57	7	19	break	break	NOUN
ctmj-57	7	20	-	-	PUNCT
ctmj-57	7	21	up	up	ADP
ctmj-57	7	22	time	time	NOUN
ctmj-57	7	23	(	(	PUNCT
ctmj-57	7	24	but	but	CCONJ
ctmj-57	7	25	)	)	PUNCT
ctmj-57	7	26	,	,	PUNCT
ctmj-57	7	27	and	and	CCONJ
ctmj-57	7	28	histopathologic	histopathologic	NOUN
ctmj-57	7	29	exams	exam	NOUN
ctmj-57	7	30	(	(	PUNCT
ctmj-57	7	31	h&e	h&e	PROPN
ctmj-57	7	32	)	)	PUNCT
ctmj-57	7	33	.	.	PUNCT
ctmj-57	8	1	apoptotic	apoptotic	ADJ
ctmj-57	8	2	cell	cell	NOUN
ctmj-57	8	3	count	count	NOUN
ctmj-57	8	4	and	and	CCONJ
ctmj-57	8	5	th17	th17	PROPN
ctmj-57	8	6	/	/	SYM
ctmj-57	8	7	treg	treg	PROPN
ctmj-57	8	8	percentages	percentage	NOUN
ctmj-57	8	9	were	be	AUX
ctmj-57	8	10	determined	determine	VERB
ctmj-57	8	11	by	by	ADP
ctmj-57	8	12	flow	flow	NOUN
ctmj-57	8	13	cytometry	cytometry	NOUN
ctmj-57	8	14	,	,	PUNCT
ctmj-57	8	15	and	and	CCONJ
ctmj-57	8	16	jak2	jak2	PROPN
ctmj-57	8	17	/	/	SYM
ctmj-57	8	18	stat3	stat3	NOUN
ctmj-57	8	19	pathway	pathway	NOUN
ctmj-57	8	20	protein	protein	NOUN
ctmj-57	8	21	expression	expression	NOUN
ctmj-57	8	22	was	be	AUX
ctmj-57	8	23	assessed	assess	VERB
ctmj-57	8	24	by	by	ADP
ctmj-57	8	25	western	western	ADJ
ctmj-57	8	26	blot	blot	NOUN
ctmj-57	8	27	test	test	NOUN
ctmj-57	8	28	.	.	PUNCT
ctmj-57	9	1	findings	finding	NOUN
ctmj-57	9	2	:	:	PUNCT
ctmj-57	9	3	in	in	ADP
ctmj-57	9	4	the	the	DET
ctmj-57	9	5	rabbit	rabbit	NOUN
ctmj-57	9	6	scopolamine	scopolamine	NOUN
ctmj-57	9	7	-	-	PUNCT
ctmj-57	9	8	induced	induce	VERB
ctmj-57	9	9	dry	dry	ADJ
ctmj-57	9	10	eye	eye	NOUN
ctmj-57	9	11	model	model	NOUN
ctmj-57	9	12	,	,	PUNCT
ctmj-57	9	13	the	the	DET
ctmj-57	9	14	combination	combination	NOUN
ctmj-57	9	15	of	of	ADP
ctmj-57	9	16	rmfs	rmfs	NOUN
ctmj-57	9	17	with	with	ADP
ctmj-57	9	18	hga	hga	PROPN
ctmj-57	9	19	considerably	considerably	ADV
ctmj-57	9	20	enhanced	enhance	VERB
ctmj-57	9	21	tear	tear	ADJ
ctmj-57	9	22	production	production	NOUN
ctmj-57	9	23	(	(	PUNCT
ctmj-57	9	24	p	p	X
ctmj-57	9	25	<	<	X
ctmj-57	9	26	0.001	0.001	NUM
ctmj-57	9	27	)	)	PUNCT
ctmj-57	9	28	,	,	PUNCT
ctmj-57	9	29	decreased	decrease	VERB
ctmj-57	9	30	tear	tear	ADJ
ctmj-57	9	31	break	break	NOUN
ctmj-57	9	32	-	-	PUNCT
ctmj-57	9	33	up	up	ADP
ctmj-57	9	34	time	time	NOUN
ctmj-57	9	35	(	(	PUNCT
ctmj-57	9	36	p	p	X
ctmj-57	9	37	<	<	X
ctmj-57	9	38	0.001	0.001	NUM
ctmj-57	9	39	)	)	PUNCT
ctmj-57	9	40	,	,	PUNCT
ctmj-57	9	41	restored	restore	VERB
ctmj-57	9	42	ocular	ocular	ADJ
ctmj-57	9	43	surface	surface	NOUN
ctmj-57	9	44	damage	damage	NOUN
ctmj-57	9	45	,	,	PUNCT
ctmj-57	9	46	and	and	CCONJ
ctmj-57	9	47	decreased	decrease	VERB
ctmj-57	9	48	apoptosis	apoptosis	NOUN
ctmj-57	9	49	(	(	PUNCT
ctmj-57	9	50	p	p	X
ctmj-57	9	51	<	<	X
ctmj-57	9	52	0.05	0.05	NUM
ctmj-57	9	53	)	)	PUNCT
ctmj-57	9	54	as	as	SCONJ
ctmj-57	9	55	compared	compare	VERB
ctmj-57	9	56	to	to	ADP
ctmj-57	9	57	the	the	DET
ctmj-57	9	58	group	group	NOUN
ctmj-57	9	59	that	that	PRON
ctmj-57	9	60	received	receive	VERB
ctmj-57	9	61	just	just	ADV
ctmj-57	9	62	one	one	NUM
ctmj-57	9	63	injection	injection	NOUN
ctmj-57	9	64	of	of	ADP
ctmj-57	9	65	the	the	DET
ctmj-57	9	66	medication	medication	NOUN
ctmj-57	9	67	.	.	PUNCT
ctmj-57	10	1	furthermore	furthermore	ADV
ctmj-57	10	2	,	,	PUNCT
ctmj-57	10	3	it	it	PRON
ctmj-57	10	4	suppressed	suppress	VERB
ctmj-57	10	5	the	the	DET
ctmj-57	10	6	jak2	jak2	PROPN
ctmj-57	10	7	/	/	SYM
ctmj-57	10	8	sata3	sata3	PROPN
ctmj-57	10	9	pathway	pathway	NOUN
ctmj-57	10	10	and	and	CCONJ
ctmj-57	10	11	controlled	control	VERB
ctmj-57	10	12	the	the	DET
ctmj-57	10	13	balance	balance	NOUN
ctmj-57	10	14	of	of	ADP
ctmj-57	10	15	cytokines	cytokine	NOUN
ctmj-57	10	16	associated	associate	VERB
ctmj-57	10	17	to	to	ADP
ctmj-57	10	18	th17	th17	PROPN
ctmj-57	10	19	and	and	CCONJ
ctmj-57	10	20	tregs	treg	NOUN
ctmj-57	10	21	.	.	PUNCT
ctmj-57	11	1	in	in	ADP
ctmj-57	11	2	conclusion	conclusion	NOUN
ctmj-57	11	3	,	,	PUNCT
ctmj-57	11	4	scopolamine	scopolamine	NOUN
ctmj-57	11	5	-	-	PUNCT
ctmj-57	11	6	induced	induce	VERB
ctmj-57	11	7	dry	dry	ADJ
ctmj-57	11	8	eye	eye	NOUN
ctmj-57	11	9	symptoms	symptom	NOUN
ctmj-57	11	10	are	be	AUX
ctmj-57	11	11	alleviated	alleviate	VERB
ctmj-57	11	12	in	in	ADP
ctmj-57	11	13	rabbit	rabbit	NOUN
ctmj-57	11	14	models	model	NOUN
ctmj-57	11	15	when	when	SCONJ
ctmj-57	11	16	rmfs	rmfs	NOUN
ctmj-57	11	17	and	and	CCONJ
ctmj-57	11	18	hga	hga	NOUN
ctmj-57	11	19	are	be	AUX
ctmj-57	11	20	administered	administer	VERB
ctmj-57	11	21	together	together	ADV
ctmj-57	11	22	,	,	PUNCT
ctmj-57	11	23	suggesting	suggest	VERB
ctmj-57	11	24	that	that	SCONJ
ctmj-57	11	25	this	this	DET
ctmj-57	11	26	medication	medication	NOUN
ctmj-57	11	27	may	may	AUX
ctmj-57	11	28	be	be	AUX
ctmj-57	11	29	useful	useful	ADJ
ctmj-57	11	30	in	in	ADP
ctmj-57	11	31	the	the	DET
ctmj-57	11	32	treatment	treatment	NOUN
ctmj-57	11	33	of	of	ADP
ctmj-57	11	34	dry	dry	ADJ
ctmj-57	11	35	eye	eye	NOUN
ctmj-57	11	36	illness	illness	NOUN
ctmj-57	11	37	.	.	PUNCT
ctmj-57	12	1	collecting	collect	VERB
ctmj-57	12	2	clinical	clinical	ADJ
ctmj-57	12	3	data	datum	NOUN
ctmj-57	12	4	to	to	PART
ctmj-57	12	5	examine	examine	VERB
ctmj-57	12	6	the	the	DET
ctmj-57	12	7	combination	combination	NOUN
ctmj-57	12	8	's	's	PART
ctmj-57	12	9	effectiveness	effectiveness	NOUN
ctmj-57	12	10	and	and	CCONJ
ctmj-57	12	11	safety	safety	NOUN
ctmj-57	12	12	should	should	AUX
ctmj-57	12	13	be	be	AUX
ctmj-57	12	14	the	the	DET
ctmj-57	12	15	focus	focus	NOUN
ctmj-57	12	16	of	of	ADP
ctmj-57	12	17	future	future	ADJ
ctmj-57	12	18	investigations	investigation	NOUN
ctmj-57	12	19	.	.	PUNCT
ctmj-57	13	1	topics	topic	NOUN
ctmj-57	13	2	covered	cover	VERB
ctmj-57	13	3	include	include	VERB
ctmj-57	13	4	:	:	PUNCT
ctmj-57	13	5	hypromellose	hypromellose	NOUN
ctmj-57	13	6	2910	2910	NUM
ctmj-57	13	7	,	,	PUNCT
ctmj-57	13	8	runmu	runmu	PROPN
ctmj-57	13	9	fengliang	fengliang	PROPN
ctmj-57	13	10	tang	tang	PROPN
ctmj-57	13	11	,	,	PUNCT
ctmj-57	13	12	glycerol	glycerol	NOUN
ctmj-57	13	13	eye	eye	NOUN
ctmj-57	13	14	drops	drop	NOUN
ctmj-57	13	15	,	,	PUNCT
ctmj-57	13	16	the	the	DET
ctmj-57	13	17	th17	th17	PROPN
ctmj-57	13	18	/	/	SYM
ctmj-57	13	19	treg	treg	PROPN
ctmj-57	13	20	and	and	CCONJ
ctmj-57	13	21	jak2	jak2	PROPN
ctmj-57	13	22	/	/	SYM
ctmj-57	13	23	sata3	sata3	PROPN
ctmj-57	13	24	pathways	pathway	NOUN
ctmj-57	13	25	,	,	PUNCT
ctmj-57	13	26	and	and	CCONJ
ctmj-57	13	27	dry	dry	ADJ
ctmj-57	13	28	eye	eye	NOUN
ctmj-57	13	29	syndrome	syndrome	NOUN
ctmj-57	13	30	.	.	PUNCT
ctmj-57	14	1	introduction	introduction	NOUN
ctmj-57	14	2	dry	dry	ADJ
ctmj-57	14	3	eye	eye	NOUN
ctmj-57	14	4	disease	disease	NOUN
ctmj-57	14	5	(	(	PUNCT
ctmj-57	14	6	ded	de	VERB
ctmj-57	14	7	)	)	PUNCT
ctmj-57	14	8	is	be	AUX
ctmj-57	14	9	a	a	DET
ctmj-57	14	10	multifactorial	multifactorial	ADJ
ctmj-57	14	11	ocular	ocular	ADJ
ctmj-57	14	12	surface	surface	NOUN
ctmj-57	14	13	disease	disease	NOUN
ctmj-57	14	14	characterized	characterize	VERB
ctmj-57	14	15	by	by	ADP
ctmj-57	14	16	tear	tear	ADJ
ctmj-57	14	17	film	film	NOUN
ctmj-57	14	18	homeostasis	homeostasis	NOUN
ctmj-57	14	19	,	,	PUNCT
ctmj-57	14	20	ocular	ocular	ADJ
ctmj-57	14	21	surface	surface	NOUN
ctmj-57	14	22	inflammatory	inflammatory	ADJ
ctmj-57	14	23	response	response	NOUN
ctmj-57	14	24	and	and	CCONJ
ctmj-57	14	25	damage	damage	NOUN
ctmj-57	14	26	,	,	PUNCT
ctmj-57	14	27	and	and	CCONJ
ctmj-57	14	28	ocular	ocular	ADJ
ctmj-57	14	29	discomfort	discomfort	NOUN
ctmj-57	14	30	[	[	X
ctmj-57	14	31	1	1	NUM
ctmj-57	14	32	]	]	PUNCT
ctmj-57	14	33	.	.	PUNCT
ctmj-57	15	1	the	the	DET
ctmj-57	15	2	reported	report	VERB
ctmj-57	15	3	prevalence	prevalence	NOUN
ctmj-57	15	4	of	of	ADP
ctmj-57	15	5	ded	ded	ADJ
ctmj-57	15	6	ranges	range	NOUN
ctmj-57	15	7	from	from	ADP
ctmj-57	15	8	5	5	NUM
ctmj-57	15	9	to	to	PART
ctmj-57	15	10	34	34	NUM
ctmj-57	15	11	%	%	NOUN
ctmj-57	15	12	,	,	PUNCT
ctmj-57	15	13	with	with	ADP
ctmj-57	15	14	a	a	DET
ctmj-57	15	15	higher	high	ADJ
ctmj-57	15	16	prevalence	prevalence	NOUN
ctmj-57	15	17	in	in	ADP
ctmj-57	15	18	women	woman	NOUN
ctmj-57	15	19	and	and	CCONJ
ctmj-57	15	20	older	old	ADJ
ctmj-57	15	21	adults	adult	NOUN
ctmj-57	15	22	[	[	X
ctmj-57	15	23	2,3	2,3	NUM
ctmj-57	15	24	]	]	PUNCT
ctmj-57	15	25	.	.	PUNCT
ctmj-57	16	1	in	in	ADP
ctmj-57	16	2	recent	recent	ADJ
ctmj-57	16	3	years	year	NOUN
ctmj-57	16	4	,	,	PUNCT
ctmj-57	16	5	with	with	ADP
ctmj-57	16	6	the	the	DET
ctmj-57	16	7	changes	change	NOUN
ctmj-57	16	8	in	in	ADP
ctmj-57	16	9	the	the	DET
ctmj-57	16	10	living	live	VERB
ctmj-57	16	11	environment	environment	NOUN
ctmj-57	16	12	and	and	CCONJ
ctmj-57	16	13	the	the	DET
ctmj-57	16	14	extensive	extensive	ADJ
ctmj-57	16	15	use	use	NOUN
ctmj-57	16	16	of	of	ADP
ctmj-57	16	17	video	video	NOUN
ctmj-57	16	18	terminals	terminal	NOUN
ctmj-57	16	19	,	,	PUNCT
ctmj-57	16	20	the	the	DET
ctmj-57	16	21	incidence	incidence	NOUN
ctmj-57	16	22	of	of	ADP
ctmj-57	16	23	dry	dry	ADJ
ctmj-57	16	24	eye	eye	NOUN
ctmj-57	16	25	disease	disease	NOUN
ctmj-57	16	26	is	be	AUX
ctmj-57	16	27	increasing	increase	VERB
ctmj-57	16	28	year	year	NOUN
ctmj-57	16	29	by	by	ADP
ctmj-57	16	30	year	year	NOUN
ctmj-57	16	31	and	and	CCONJ
ctmj-57	16	32	there	there	PRON
ctmj-57	16	33	is	be	VERB
ctmj-57	16	34	a	a	DET
ctmj-57	16	35	trend	trend	NOUN
ctmj-57	16	36	of	of	ADP
ctmj-57	16	37	rejuvenation	rejuvenation	NOUN
ctmj-57	16	38	[	[	X
ctmj-57	16	39	4	4	NUM
ctmj-57	16	40	]	]	PUNCT
ctmj-57	16	41	.	.	PUNCT
ctmj-57	17	1	the	the	DET
ctmj-57	17	2	ded	ded	PROPN
ctmj-57	17	3	is	be	AUX
ctmj-57	17	4	often	often	ADV
ctmj-57	17	5	associated	associate	VERB
ctmj-57	17	6	with	with	ADP
ctmj-57	17	7	symptoms	symptom	NOUN
ctmj-57	17	8	such	such	ADJ
ctmj-57	17	9	as	as	ADP
ctmj-57	17	10	itching	itch	VERB
ctmj-57	17	11	,	,	PUNCT
ctmj-57	17	12	foreign	foreign	ADJ
ctmj-57	17	13	body	body	NOUN
ctmj-57	17	14	sensation	sensation	NOUN
ctmj-57	17	15	and	and	CCONJ
ctmj-57	17	16	burning	burn	VERB
ctmj-57	17	17	sensation	sensation	NOUN
ctmj-57	17	18	in	in	ADP
ctmj-57	17	19	both	both	DET
ctmj-57	17	20	eyes	eye	NOUN
ctmj-57	17	21	,	,	PUNCT
ctmj-57	17	22	which	which	PRON
ctmj-57	17	23	reduce	reduce	VERB
ctmj-57	17	24	the	the	DET
ctmj-57	17	25	quality	quality	NOUN
ctmj-57	17	26	of	of	ADP
ctmj-57	17	27	life	life	NOUN
ctmj-57	17	28	of	of	ADP
ctmj-57	17	29	affected	affected	ADJ
ctmj-57	17	30	individuals	individual	NOUN
ctmj-57	17	31	.	.	PUNCT
ctmj-57	18	1	the	the	DET
ctmj-57	18	2	chronic	chronic	ADJ
ctmj-57	18	3	inflammatory	inflammatory	ADJ
ctmj-57	18	4	state	state	NOUN
ctmj-57	18	5	involved	involve	VERB
ctmj-57	18	6	in	in	ADP
ctmj-57	18	7	de	de	X
ctmj-57	18	8	lead	lead	NOUN
ctmj-57	18	9	to	to	ADP
ctmj-57	18	10	vision	vision	NOUN
ctmj-57	18	11	loss	loss	NOUN
ctmj-57	18	12	or	or	CCONJ
ctmj-57	18	13	blindness	blindness	NOUN
ctmj-57	18	14	if	if	SCONJ
ctmj-57	18	15	not	not	PART
ctmj-57	18	16	treated	treat	VERB
ctmj-57	18	17	promptly	promptly	ADV
ctmj-57	18	18	with	with	ADP
ctmj-57	18	19	appropriate	appropriate	ADJ
ctmj-57	18	20	therapies	therapy	NOUN
ctmj-57	18	21	.	.	PUNCT
ctmj-57	19	1	however	however	ADV
ctmj-57	19	2	,	,	PUNCT
ctmj-57	19	3	treatment	treatment	NOUN
ctmj-57	19	4	of	of	ADP
ctmj-57	19	5	ded	ded	PROPN
ctmj-57	19	6	is	be	AUX
ctmj-57	19	7	difficult	difficult	ADJ
ctmj-57	19	8	and	and	CCONJ
ctmj-57	19	9	effective	effective	ADJ
ctmj-57	19	10	treatments	treatment	NOUN
ctmj-57	19	11	are	be	AUX
ctmj-57	19	12	still	still	ADV
ctmj-57	19	13	lacking	lack	VERB
ctmj-57	19	14	.	.	PUNCT
ctmj-57	20	1	thus	thus	ADV
ctmj-57	20	2	,	,	PUNCT
ctmj-57	20	3	an	an	DET
ctmj-57	20	4	investigation	investigation	NOUN
ctmj-57	20	5	into	into	ADP
ctmj-57	20	6	effective	effective	ADJ
ctmj-57	20	7	drugs	drug	NOUN
ctmj-57	20	8	required	require	VERB
ctmj-57	20	9	for	for	ADP
ctmj-57	20	10	the	the	DET
ctmj-57	20	11	prevention	prevention	NOUN
ctmj-57	20	12	and	and	CCONJ
ctmj-57	20	13	treatment	treatment	NOUN
ctmj-57	20	14	of	of	ADP
ctmj-57	20	15	dry	dry	ADJ
ctmj-57	20	16	eye	eye	NOUN
ctmj-57	20	17	is	be	AUX
ctmj-57	20	18	a	a	DET
ctmj-57	20	19	key	key	ADJ
ctmj-57	20	20	scientific	scientific	ADJ
ctmj-57	20	21	task	task	NOUN
ctmj-57	20	22	that	that	PRON
ctmj-57	20	23	needs	need	VERB
ctmj-57	20	24	to	to	PART
ctmj-57	20	25	be	be	AUX
ctmj-57	20	26	done	do	VERB
ctmj-57	20	27	,	,	PUNCT
ctmj-57	20	28	as	as	SCONJ
ctmj-57	20	29	it	it	PRON
ctmj-57	20	30	will	will	AUX
ctmj-57	20	31	have	have	VERB
ctmj-57	20	32	practical	practical	ADJ
ctmj-57	20	33	and	and	CCONJ
ctmj-57	20	34	effective	effective	ADJ
ctmj-57	20	35	implications	implication	NOUN
ctmj-57	20	36	on	on	ADP
ctmj-57	20	37	the	the	DET
ctmj-57	20	38	patients	patient	NOUN
ctmj-57	20	39	and	and	CCONJ
ctmj-57	20	40	therapeutics	therapeutic	NOUN
ctmj-57	20	41	in	in	ADP
ctmj-57	20	42	general	general	ADJ
ctmj-57	20	43	.	.	PUNCT
ctmj-57	21	1	in	in	ADP
ctmj-57	21	2	recent	recent	ADJ
ctmj-57	21	3	years	year	NOUN
ctmj-57	21	4	,	,	PUNCT
ctmj-57	21	5	the	the	DET
ctmj-57	21	6	study	study	NOUN
ctmj-57	21	7	of	of	ADP
ctmj-57	21	8	immunomodulation	immunomodulation	NOUN
ctmj-57	21	9	has	have	AUX
ctmj-57	21	10	gained	gain	VERB
ctmj-57	21	11	increasing	increase	VERB
ctmj-57	21	12	attention	attention	NOUN
ctmj-57	21	13	and	and	CCONJ
ctmj-57	21	14	researchers	researcher	NOUN
ctmj-57	21	15	have	have	AUX
ctmj-57	21	16	found	find	VERB
ctmj-57	21	17	that	that	SCONJ
ctmj-57	21	18	regulatory	regulatory	ADJ
ctmj-57	21	19	t	t	NOUN
ctmj-57	21	20	cells	cell	NOUN
ctmj-57	21	21	(	(	PUNCT
ctmj-57	21	22	treg	treg	PROPN
ctmj-57	21	23	)	)	PUNCT
ctmj-57	21	24	and	and	CCONJ
ctmj-57	21	25	the	the	DET
ctmj-57	21	26	helper	helper	NOUN
ctmj-57	21	27	t	t	PROPN
ctmj-57	21	28	cell	cell	NOUN
ctmj-57	21	29	subset	subset	VERB
ctmj-57	21	30	17	17	NUM
ctmj-57	21	31	cells	cell	NOUN
ctmj-57	21	32	(	(	PUNCT
ctmj-57	21	33	th17	th17	PROPN
ctmj-57	21	34	)	)	PUNCT
ctmj-57	21	35	play	play	VERB
ctmj-57	21	36	a	a	DET
ctmj-57	21	37	very	very	ADV
ctmj-57	21	38	important	important	ADJ
ctmj-57	21	39	role	role	NOUN
ctmj-57	21	40	in	in	ADP
ctmj-57	21	41	immune	immune	NOUN
ctmj-57	21	42	-	-	PUNCT
ctmj-57	21	43	inflammatory	inflammatory	ADJ
ctmj-57	21	44	diseases	disease	NOUN
ctmj-57	21	45	[	[	X
ctmj-57	21	46	5	5	NUM
ctmj-57	21	47	]	]	PUNCT
ctmj-57	21	48	.	.	PUNCT
ctmj-57	22	1	it	it	PRON
ctmj-57	22	2	has	have	AUX
ctmj-57	22	3	been	be	AUX
ctmj-57	22	4	shown	show	VERB
ctmj-57	22	5	that	that	SCONJ
ctmj-57	22	6	the	the	DET
ctmj-57	22	7	development	development	NOUN
ctmj-57	22	8	of	of	ADP
ctmj-57	22	9	dry	dry	ADJ
ctmj-57	22	10	eye	eye	NOUN
ctmj-57	22	11	disease	disease	NOUN
ctmj-57	22	12	is	be	AUX
ctmj-57	22	13	significantly	significantly	ADV
ctmj-57	22	14	associated	associate	VERB
ctmj-57	22	15	with	with	ADP
ctmj-57	22	16	disturbed	disturbed	ADJ
ctmj-57	22	17	treg	treg	PROPN
ctmj-57	22	18	/	/	SYM
ctmj-57	22	19	th17	th17	PROPN
ctmj-57	22	20	cell	cell	NOUN
ctmj-57	22	21	homeostasis	homeostasis	NOUN
ctmj-57	22	22	and	and	CCONJ
ctmj-57	22	23	that	that	SCONJ
ctmj-57	22	24	blocking	block	VERB
ctmj-57	22	25	il-17	il-17	NUM
ctmj-57	22	26	in	in	ADP
ctmj-57	22	27	vivo	vivo	NOUN
ctmj-57	22	28	significantly	significantly	ADV
ctmj-57	22	29	reduces	reduce	VERB
ctmj-57	22	30	the	the	DET
ctmj-57	22	31	severity	severity	NOUN
ctmj-57	22	32	and	and	CCONJ
ctmj-57	22	33	progression	progression	NOUN
ctmj-57	22	34	of	of	ADP
ctmj-57	22	35	the	the	DET
ctmj-57	22	36	disease	disease	NOUN
ctmj-57	22	37	by	by	ADP
ctmj-57	22	38	restoring	restore	VERB
ctmj-57	22	39	the	the	DET
ctmj-57	22	40	treg	treg	PROPN
ctmj-57	22	41	/	/	SYM
ctmj-57	22	42	th17	th17	PROPN
ctmj-57	22	43	cell	cell	NOUN
ctmj-57	22	44	ratio	ratio	NOUN
ctmj-57	23	1	[	[	X
ctmj-57	23	2	6	6	NUM
ctmj-57	23	3	]	]	PUNCT
ctmj-57	23	4	.	.	PUNCT
ctmj-57	24	1	therefore	therefore	ADV
ctmj-57	24	2	,	,	PUNCT
ctmj-57	24	3	protection	protection	NOUN
ctmj-57	24	4	of	of	ADP
ctmj-57	24	5	chinese	chinese	ADJ
ctmj-57	24	6	traditional	traditional	ADJ
ctmj-57	24	7	medicine	medicine	NOUN
ctmj-57	24	8	journal	journal	NOUN
ctmj-57	24	9	|	|	ADV
ctmj-57	24	10	2020	2020	NUM
ctmj-57	24	11	|	|	ADV
ctmj-57	24	12	vol	vol	NOUN
ctmj-57	24	13	3	3	NUM
ctmj-57	24	14	|	|	ADV
ctmj-57	24	15	issue	issue	VERB
ctmj-57	24	16	6	6	NUM
ctmj-57	24	17	issn	issn	NOUN
ctmj-57	24	18	:	:	PUNCT
ctmj-57	24	19	2693	2693	NUM
ctmj-57	24	20	6356	6356	NUM
ctmj-57	24	21	2020	2020	NUM
ctmj-57	24	22	|	|	ADV
ctmj-57	24	23	vol	vol	NOUN
ctmj-57	24	24	3	3	NUM
ctmj-57	25	1	|	|	ADV
ctmj-57	25	2	issue	issue	VERB
ctmj-57	25	3	6	6	NUM
ctmj-57	25	4	ctmj	ctmj	NOUN
ctmj-57	25	5	|	|	ADV
ctmj-57	25	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	25	7	the	the	DET
ctmj-57	25	8	homeostatic	homeostatic	ADJ
ctmj-57	25	9	balance	balance	NOUN
ctmj-57	25	10	of	of	ADP
ctmj-57	25	11	th17	th17	PROPN
ctmj-57	25	12	/	/	SYM
ctmj-57	25	13	treg	treg	PROPN
ctmj-57	25	14	cells	cell	NOUN
ctmj-57	25	15	may	may	AUX
ctmj-57	25	16	contribute	contribute	VERB
ctmj-57	25	17	to	to	ADP
ctmj-57	25	18	the	the	DET
ctmj-57	25	19	treatment	treatment	NOUN
ctmj-57	25	20	of	of	ADP
ctmj-57	25	21	dry	dry	ADJ
ctmj-57	25	22	eye	eye	NOUN
ctmj-57	25	23	.	.	PUNCT
ctmj-57	26	1	traditional	traditional	ADJ
ctmj-57	26	2	chinese	chinese	ADJ
ctmj-57	26	3	medicine	medicine	NOUN
ctmj-57	26	4	may	may	AUX
ctmj-57	26	5	also	also	ADV
ctmj-57	26	6	play	play	VERB
ctmj-57	26	7	an	an	DET
ctmj-57	26	8	important	important	ADJ
ctmj-57	26	9	role	role	NOUN
ctmj-57	26	10	in	in	ADP
ctmj-57	26	11	the	the	DET
ctmj-57	26	12	treatment	treatment	NOUN
ctmj-57	26	13	of	of	ADP
ctmj-57	26	14	dry	dry	ADJ
ctmj-57	26	15	eye	eye	NOUN
ctmj-57	26	16	disease	disease	NOUN
ctmj-57	26	17	.	.	PUNCT
ctmj-57	27	1	therefore	therefore	ADV
ctmj-57	27	2	,	,	PUNCT
ctmj-57	27	3	the	the	DET
ctmj-57	27	4	aim	aim	NOUN
ctmj-57	27	5	of	of	ADP
ctmj-57	27	6	this	this	DET
ctmj-57	27	7	study	study	NOUN
ctmj-57	27	8	was	be	AUX
ctmj-57	27	9	investigate	investigate	VERB
ctmj-57	27	10	the	the	DET
ctmj-57	27	11	efficacy	efficacy	NOUN
ctmj-57	27	12	of	of	ADP
ctmj-57	27	13	a	a	DET
ctmj-57	27	14	combined	combined	ADJ
ctmj-57	27	15	remedy	remedy	NOUN
ctmj-57	27	16	using	use	VERB
ctmj-57	27	17	rmfs	rmfs	NOUN
ctmj-57	27	18	and	and	CCONJ
ctmj-57	27	19	hga	hga	NOUN
ctmj-57	27	20	in	in	ADP
ctmj-57	27	21	the	the	DET
ctmj-57	27	22	treatment	treatment	NOUN
ctmj-57	27	23	of	of	ADP
ctmj-57	27	24	dry	dry	ADJ
ctmj-57	27	25	eye	eye	NOUN
ctmj-57	27	26	symptoms	symptom	NOUN
ctmj-57	27	27	in	in	ADP
ctmj-57	27	28	model	model	NOUN
ctmj-57	27	29	rabbits	rabbit	NOUN
ctmj-57	27	30	.	.	PUNCT
ctmj-57	28	1	experimental	experimental	ADJ
ctmj-57	28	2	animals	animal	NOUN
ctmj-57	28	3	and	and	CCONJ
ctmj-57	28	4	design	design	VERB
ctmj-57	28	5	a	a	DET
ctmj-57	28	6	total	total	NOUN
ctmj-57	28	7	of	of	ADP
ctmj-57	28	8	30	30	NUM
ctmj-57	28	9	healthy	healthy	ADJ
ctmj-57	28	10	new	new	PROPN
ctmj-57	28	11	zealand	zealand	PROPN
ctmj-57	28	12	rabbits	rabbit	NOUN
ctmj-57	28	13	(	(	PUNCT
ctmj-57	28	14	2	2	NUM
ctmj-57	28	15	3	3	NUM
ctmj-57	28	16	months	month	NOUN
ctmj-57	28	17	old	old	ADJ
ctmj-57	28	18	,	,	PUNCT
ctmj-57	28	19	males	male	NOUN
ctmj-57	28	20	=	=	SYM
ctmj-57	28	21	females	female	NOUN
ctmj-57	28	22	=	=	SYM
ctmj-57	28	23	15	15	NUM
ctmj-57	28	24	,	,	PUNCT
ctmj-57	28	25	1.5	1.5	NUM
ctmj-57	28	26	kg	kg	NOUN
ctmj-57	28	27	±	±	NUM
ctmj-57	28	28	0.45	0.45	NUM
ctmj-57	28	29	kg	kg	NOUN
ctmj-57	28	30	)	)	PUNCT
ctmj-57	28	31	were	be	AUX
ctmj-57	28	32	obtained	obtain	VERB
ctmj-57	28	33	from	from	ADP
ctmj-57	28	34	key	key	ADJ
ctmj-57	28	35	laboratory	laboratory	NOUN
ctmj-57	28	36	of	of	ADP
ctmj-57	28	37	medical	medical	ADJ
ctmj-57	28	38	biotechnology	biotechnology	NOUN
ctmj-57	28	39	and	and	CCONJ
ctmj-57	28	40	translational	translational	ADJ
ctmj-57	28	41	medicine	medicine	NOUN
ctmj-57	28	42	,	,	PUNCT
ctmj-57	28	43	embryo	embryo	NOUN
ctmj-57	28	44	engineering	engineering	NOUN
ctmj-57	28	45	laboratory	laboratory	NOUN
ctmj-57	28	46	,	,	PUNCT
ctmj-57	28	47	guilin	guilin	PROPN
ctmj-57	28	48	medical	medical	PROPN
ctmj-57	28	49	university	university	PROPN
ctmj-57	28	50	(	(	PUNCT
ctmj-57	28	51	guilin	guilin	PROPN
ctmj-57	28	52	,	,	PUNCT
ctmj-57	28	53	china	china	PROPN
ctmj-57	28	54	)	)	PUNCT
ctmj-57	28	55	.	.	PUNCT
ctmj-57	29	1	all	all	DET
ctmj-57	29	2	animal	animal	NOUN
ctmj-57	29	3	experiments	experiment	NOUN
ctmj-57	29	4	were	be	AUX
ctmj-57	29	5	approved	approve	VERB
ctmj-57	29	6	by	by	ADP
ctmj-57	29	7	the	the	DET
ctmj-57	29	8	ethics	ethic	NOUN
ctmj-57	29	9	committee	committee	PROPN
ctmj-57	29	10	of	of	ADP
ctmj-57	29	11	affiliated	affiliated	ADJ
ctmj-57	29	12	hospital	hospital	NOUN
ctmj-57	29	13	of	of	ADP
ctmj-57	29	14	guilin	guilin	PROPN
ctmj-57	29	15	medical	medical	PROPN
ctmj-57	29	16	university	university	PROPN
ctmj-57	29	17	for	for	ADP
ctmj-57	29	18	the	the	DET
ctmj-57	29	19	use	use	NOUN
ctmj-57	29	20	of	of	ADP
ctmj-57	29	21	animals	animal	NOUN
ctmj-57	29	22	(	(	PUNCT
ctmj-57	29	23	grant	grant	VERB
ctmj-57	29	24	no	no	INTJ
ctmj-57	29	25	.	.	PUNCT
ctmj-57	30	1	gxzyc20220296	gxzyc20220296	PROPN
ctmj-57	30	2	)	)	PUNCT
ctmj-57	31	1	and	and	CCONJ
ctmj-57	31	2	conducted	conduct	VERB
ctmj-57	31	3	in	in	ADP
ctmj-57	31	4	accordance	accordance	NOUN
ctmj-57	31	5	with	with	ADP
ctmj-57	31	6	the	the	DET
ctmj-57	31	7	national	national	PROPN
ctmj-57	31	8	institutes	institutes	PROPN
ctmj-57	31	9	of	of	ADP
ctmj-57	31	10	health	health	PROPN
ctmj-57	31	11	laboratory	laboratory	NOUN
ctmj-57	31	12	animal	animal	NOUN
ctmj-57	31	13	care	care	NOUN
ctmj-57	31	14	and	and	CCONJ
ctmj-57	31	15	use	use	VERB
ctmj-57	31	16	guidelines	guideline	NOUN
ctmj-57	31	17	[	[	X
ctmj-57	31	18	7	7	NUM
ctmj-57	31	19	]	]	PUNCT
ctmj-57	31	20	.	.	PUNCT
ctmj-57	32	1	all	all	DET
ctmj-57	32	2	rabbits	rabbit	NOUN
ctmj-57	32	3	were	be	AUX
ctmj-57	32	4	housed	house	VERB
ctmj-57	32	5	in	in	ADP
ctmj-57	32	6	a	a	DET
ctmj-57	32	7	single	single	ADJ
ctmj-57	32	8	standard	standard	ADJ
ctmj-57	32	9	rabbit	rabbit	NOUN
ctmj-57	32	10	cage	cage	NOUN
ctmj-57	32	11	(	(	PUNCT
ctmj-57	32	12	2	2	NUM
ctmj-57	32	13	rabbits	rabbit	NOUN
ctmj-57	32	14	/	/	SYM
ctmj-57	32	15	cage	cage	NOUN
ctmj-57	32	16	)	)	PUNCT
ctmj-57	32	17	at	at	ADP
ctmj-57	32	18	21	21	NUM
ctmj-57	32	19	±	±	NUM
ctmj-57	32	20	2	2	NUM
ctmj-57	32	21	°	°	ADP
ctmj-57	32	22	c	c	NOUN
ctmj-57	32	23	,	,	PUNCT
ctmj-57	32	24	58	58	NUM
ctmj-57	32	25	±	±	NUM
ctmj-57	32	26	9	9	NUM
ctmj-57	32	27	%	%	NOUN
ctmj-57	32	28	relative	relative	ADJ
ctmj-57	32	29	humidity	humidity	NOUN
ctmj-57	32	30	and	and	CCONJ
ctmj-57	32	31	12	12	NUM
ctmj-57	32	32	h	h	NOUN
ctmj-57	32	33	light	light	ADJ
ctmj-57	32	34	/	/	SYM
ctmj-57	32	35	dark	dark	ADJ
ctmj-57	32	36	cycle	cycle	NOUN
ctmj-57	32	37	.	.	PUNCT
ctmj-57	33	1	water	water	NOUN
ctmj-57	33	2	and	and	CCONJ
ctmj-57	33	3	standard	standard	ADJ
ctmj-57	33	4	feed	feed	NOUN
ctmj-57	33	5	were	be	AUX
ctmj-57	33	6	provided	provide	VERB
ctmj-57	33	7	ad	ad	NOUN
ctmj-57	33	8	libitum	libitum	NOUN
ctmj-57	33	9	and	and	CCONJ
ctmj-57	33	10	they	they	PRON
ctmj-57	33	11	were	be	AUX
ctmj-57	33	12	allowed	allow	VERB
ctmj-57	33	13	to	to	PART
ctmj-57	33	14	acclimatize	acclimatize	VERB
ctmj-57	33	15	for	for	ADP
ctmj-57	33	16	5	5	NUM
ctmj-57	33	17	days	day	NOUN
ctmj-57	33	18	.	.	PUNCT
ctmj-57	34	1	prior	prior	ADV
ctmj-57	34	2	to	to	ADP
ctmj-57	34	3	the	the	DET
ctmj-57	34	4	experiments	experiment	NOUN
ctmj-57	34	5	,	,	PUNCT
ctmj-57	34	6	the	the	DET
ctmj-57	34	7	animals	animal	NOUN
ctmj-57	34	8	were	be	AUX
ctmj-57	34	9	carefully	carefully	ADV
ctmj-57	34	10	examined	examine	VERB
ctmj-57	34	11	and	and	CCONJ
ctmj-57	34	12	found	find	VERB
ctmj-57	34	13	to	to	PART
ctmj-57	34	14	be	be	AUX
ctmj-57	34	15	free	free	ADJ
ctmj-57	34	16	of	of	ADP
ctmj-57	34	17	ocular	ocular	ADJ
ctmj-57	34	18	inflammation	inflammation	NOUN
ctmj-57	34	19	or	or	CCONJ
ctmj-57	34	20	obvious	obvious	ADJ
ctmj-57	34	21	signs	sign	NOUN
ctmj-57	34	22	of	of	ADP
ctmj-57	34	23	abnormality	abnormality	NOUN
ctmj-57	34	24	.	.	PUNCT
ctmj-57	35	1	the	the	DET
ctmj-57	35	2	rabbits	rabbit	NOUN
ctmj-57	35	3	were	be	AUX
ctmj-57	35	4	randomly	randomly	ADV
ctmj-57	35	5	divided	divide	VERB
ctmj-57	35	6	into	into	ADP
ctmj-57	35	7	5	5	NUM
ctmj-57	35	8	groups	group	NOUN
ctmj-57	35	9	,	,	PUNCT
ctmj-57	35	10	with	with	ADP
ctmj-57	35	11	6	6	NUM
ctmj-57	35	12	rabbits	rabbit	NOUN
ctmj-57	35	13	in	in	ADP
ctmj-57	35	14	each	each	DET
ctmj-57	35	15	group	group	NOUN
ctmj-57	35	16	.	.	PUNCT
ctmj-57	36	1	the	the	DET
ctmj-57	36	2	five	five	NUM
ctmj-57	36	3	groups	group	NOUN
ctmj-57	36	4	were	be	AUX
ctmj-57	36	5	control	control	NOUN
ctmj-57	36	6	group	group	NOUN
ctmj-57	36	7	,	,	PUNCT
ctmj-57	36	8	model	model	NOUN
ctmj-57	36	9	group	group	NOUN
ctmj-57	36	10	,	,	PUNCT
ctmj-57	36	11	model	model	NOUN
ctmj-57	36	12	+	+	CCONJ
ctmj-57	36	13	rmfs	rmfs	NOUN
ctmj-57	36	14	group	group	NOUN
ctmj-57	36	15	,	,	PUNCT
ctmj-57	36	16	model	model	NOUN
ctmj-57	36	17	+	+	CCONJ
ctmj-57	36	18	hga	hga	PROPN
ctmj-57	36	19	group	group	NOUN
ctmj-57	36	20	and	and	CCONJ
ctmj-57	36	21	model	model	NOUN
ctmj-57	36	22	+	+	CCONJ
ctmj-57	36	23	rmfs	rmfs	NOUN
ctmj-57	36	24	+	+	CCONJ
ctmj-57	36	25	hga	hga	NOUN
ctmj-57	36	26	group	group	NOUN
ctmj-57	36	27	.	.	PUNCT
ctmj-57	37	1	control	control	PROPN
ctmj-57	37	2	group	group	PROPN
ctmj-57	37	3	did	do	AUX
ctmj-57	37	4	not	not	PART
ctmj-57	37	5	receive	receive	VERB
ctmj-57	37	6	any	any	DET
ctmj-57	37	7	treatment	treatment	NOUN
ctmj-57	37	8	while	while	SCONJ
ctmj-57	37	9	the	the	DET
ctmj-57	37	10	remaining	remain	VERB
ctmj-57	37	11	four	four	NUM
ctmj-57	37	12	model	model	NOUN
ctmj-57	37	13	groups	group	NOUN
ctmj-57	37	14	were	be	AUX
ctmj-57	37	15	treated	treat	VERB
ctmj-57	37	16	by	by	ADP
ctmj-57	37	17	subcutaneous	subcutaneous	ADJ
ctmj-57	37	18	injection	injection	NOUN
ctmj-57	37	19	of	of	ADP
ctmj-57	37	20	0.2	0.2	NUM
ctmj-57	37	21	mg	mg	NUM
ctmj-57	37	22	/	/	SYM
ctmj-57	37	23	kg	kg	NOUN
ctmj-57	37	24	scopolamine	scopolamine	NOUN
ctmj-57	37	25	(	(	PUNCT
ctmj-57	37	26	sigma	sigma	PROPN
ctmj-57	37	27	-	-	PUNCT
ctmj-57	37	28	aldrich	aldrich	PROPN
ctmj-57	37	29	,	,	PUNCT
ctmj-57	37	30	st	st	PROPN
ctmj-57	37	31	.	.	PROPN
ctmj-57	37	32	louis	louis	PROPN
ctmj-57	37	33	,	,	PUNCT
ctmj-57	37	34	mo	mo	PROPN
ctmj-57	37	35	,	,	PUNCT
ctmj-57	37	36	usa	usa	PROPN
ctmj-57	37	37	)	)	PUNCT
ctmj-57	37	38	four	four	NUM
ctmj-57	37	39	times	time	NOUN
ctmj-57	37	40	a	a	DET
ctmj-57	37	41	day	day	NOUN
ctmj-57	37	42	(	(	PUNCT
ctmj-57	37	43	injected	inject	VERB
ctmj-57	37	44	at	at	ADP
ctmj-57	37	45	8:00	8:00	NUM
ctmj-57	37	46	,	,	PUNCT
ctmj-57	37	47	11:00	11:00	NUM
ctmj-57	37	48	,	,	PUNCT
ctmj-57	37	49	14:00	14:00	NUM
ctmj-57	37	50	and	and	CCONJ
ctmj-57	37	51	17:00	17:00	NUM
ctmj-57	37	52	hours	hour	NOUN
ctmj-57	37	53	,	,	PUNCT
ctmj-57	37	54	respectively	respectively	ADV
ctmj-57	37	55	)	)	PUNCT
ctmj-57	37	56	for	for	ADP
ctmj-57	37	57	28	28	NUM
ctmj-57	37	58	consecutive	consecutive	ADJ
ctmj-57	37	59	days	day	NOUN
ctmj-57	37	60	to	to	PART
ctmj-57	37	61	induce	induce	VERB
ctmj-57	37	62	dry	dry	ADJ
ctmj-57	37	63	eye	eye	NOUN
ctmj-57	37	64	.	.	PUNCT
ctmj-57	38	1	for	for	ADP
ctmj-57	38	2	the	the	DET
ctmj-57	38	3	model	model	NOUN
ctmj-57	38	4	+	+	CCONJ
ctmj-57	38	5	rmfs	rmfs	NOUN
ctmj-57	38	6	group	group	NOUN
ctmj-57	38	7	,	,	PUNCT
ctmj-57	38	8	51.85	51.85	NUM
ctmj-57	38	9	g	g	NOUN
ctmj-57	38	10	/	/	SYM
ctmj-57	38	11	kg	kg	PROPN
ctmj-57	38	12	of	of	ADP
ctmj-57	38	13	runmu	runmu	PROPN
ctmj-57	38	14	fengliang	fengliang	PROPN
ctmj-57	38	15	tang	tang	PROPN
ctmj-57	38	16	(	(	PUNCT
ctmj-57	38	17	rmfs	rmfs	NOUN
ctmj-57	38	18	)	)	PUNCT
ctmj-57	38	19	was	be	AUX
ctmj-57	38	20	administered	administer	VERB
ctmj-57	38	21	by	by	ADP
ctmj-57	38	22	gavage	gavage	NOUN
ctmj-57	38	23	,	,	PUNCT
ctmj-57	38	24	twice	twice	ADV
ctmj-57	38	25	daily	daily	ADV
ctmj-57	38	26	for	for	ADP
ctmj-57	38	27	28	28	NUM
ctmj-57	38	28	days	day	NOUN
ctmj-57	38	29	.	.	PUNCT
ctmj-57	39	1	in	in	ADP
ctmj-57	39	2	the	the	DET
ctmj-57	39	3	model	model	NOUN
ctmj-57	39	4	+	+	CCONJ
ctmj-57	39	5	hga	hga	PROPN
ctmj-57	39	6	group	group	NOUN
ctmj-57	39	7	,	,	PUNCT
ctmj-57	39	8	hypromellose	hypromellose	NOUN
ctmj-57	39	9	2910	2910	NUM
ctmj-57	39	10	,	,	PUNCT
ctmj-57	39	11	dextran	dextran	NOUN
ctmj-57	39	12	70	70	NUM
ctmj-57	39	13	and	and	CCONJ
ctmj-57	39	14	glycerol	glycerol	NOUN
ctmj-57	39	15	eye	eye	NOUN
ctmj-57	39	16	drops	drop	NOUN
ctmj-57	39	17	(	(	PUNCT
ctmj-57	39	18	hga	hga	NOUN
ctmj-57	39	19	,	,	PUNCT
ctmj-57	39	20	alcon	alcon	NOUN
ctmj-57	39	21	laboratories	laboratory	NOUN
ctmj-57	39	22	.	.	PUNCT
ctmj-57	40	1	inc	inc	PROPN
ctmj-57	40	2	,	,	PUNCT
ctmj-57	40	3	tx	tx	PROPN
ctmj-57	40	4	,	,	PUNCT
ctmj-57	40	5	usa	usa	PROPN
ctmj-57	40	6	)	)	PUNCT
ctmj-57	40	7	was	be	AUX
ctmj-57	40	8	administered	administer	VERB
ctmj-57	40	9	into	into	ADP
ctmj-57	40	10	the	the	DET
ctmj-57	40	11	eyes	eye	NOUN
ctmj-57	40	12	of	of	ADP
ctmj-57	40	13	the	the	DET
ctmj-57	40	14	rabbits	rabbit	NOUN
ctmj-57	40	15	at	at	ADP
ctmj-57	40	16	1	1	NUM
ctmj-57	40	17	to	to	PART
ctmj-57	40	18	2	2	NUM
ctmj-57	40	19	drops	drop	NOUN
ctmj-57	40	20	(	(	PUNCT
ctmj-57	40	21	approximately	approximately	ADV
ctmj-57	40	22	0.025	0.025	NUM
ctmj-57	40	23	0.05	0.05	NUM
ctmj-57	40	24	ml	ml	NOUN
ctmj-57	40	25	)	)	PUNCT
ctmj-57	40	26	4	4	NUM
ctmj-57	40	27	times	time	NOUN
ctmj-57	40	28	daily	daily	ADV
ctmj-57	40	29	,	,	PUNCT
ctmj-57	40	30	for	for	ADP
ctmj-57	40	31	28	28	NUM
ctmj-57	40	32	days	day	NOUN
ctmj-57	40	33	.	.	PUNCT
ctmj-57	41	1	rabbits	rabbit	NOUN
ctmj-57	41	2	in	in	ADP
ctmj-57	41	3	model	model	NOUN
ctmj-57	41	4	+	+	CCONJ
ctmj-57	41	5	rmfs	rmfs	NOUN
ctmj-57	41	6	+	+	CCONJ
ctmj-57	41	7	hga	hga	NOUN
ctmj-57	41	8	group	group	NOUN
ctmj-57	41	9	were	be	AUX
ctmj-57	41	10	treated	treat	VERB
ctmj-57	41	11	with	with	ADP
ctmj-57	41	12	a	a	DET
ctmj-57	41	13	combination	combination	NOUN
ctmj-57	41	14	of	of	ADP
ctmj-57	41	15	rmfs	rmfs	NOUN
ctmj-57	41	16	and	and	CCONJ
ctmj-57	41	17	hga	hga	NOUN
ctmj-57	41	18	for	for	ADP
ctmj-57	41	19	28	28	NUM
ctmj-57	41	20	days	day	NOUN
ctmj-57	41	21	.	.	PUNCT
ctmj-57	42	1	tear	tear	ADJ
ctmj-57	42	2	volume	volume	NOUN
ctmj-57	42	3	(	(	PUNCT
ctmj-57	42	4	schirmer	schirmer	PROPN
ctmj-57	42	5	’s	’s	PROPN
ctmj-57	42	6	i	i	PRON
ctmj-57	42	7	test	test	NOUN
ctmj-57	42	8	(	(	PUNCT
ctmj-57	42	9	sit	sit	VERB
ctmj-57	42	10	)	)	PUNCT
ctmj-57	42	11	)	)	PUNCT
ctmj-57	42	12	and	and	CCONJ
ctmj-57	42	13	tear	tear	ADJ
ctmj-57	42	14	film	film	NOUN
ctmj-57	42	15	rupture	rupture	NOUN
ctmj-57	42	16	break	break	NOUN
ctmj-57	42	17	-	-	PUNCT
ctmj-57	42	18	up	up	ADP
ctmj-57	42	19	time	time	NOUN
ctmj-57	42	20	(	(	PUNCT
ctmj-57	42	21	but	but	CCONJ
ctmj-57	42	22	)	)	PUNCT
ctmj-57	42	23	were	be	AUX
ctmj-57	42	24	measured	measure	VERB
ctmj-57	42	25	on	on	ADP
ctmj-57	42	26	day	day	NOUN
ctmj-57	42	27	0	0	NUM
ctmj-57	42	28	,	,	PUNCT
ctmj-57	42	29	7	7	NUM
ctmj-57	42	30	,	,	PUNCT
ctmj-57	42	31	14	14	NUM
ctmj-57	42	32	,	,	PUNCT
ctmj-57	42	33	17	17	NUM
ctmj-57	42	34	,	,	PUNCT
ctmj-57	42	35	21	21	NUM
ctmj-57	42	36	and	and	CCONJ
ctmj-57	42	37	28	28	NUM
ctmj-57	42	38	for	for	SCONJ
ctmj-57	42	39	each	each	DET
ctmj-57	42	40	group	group	NOUN
ctmj-57	42	41	of	of	ADP
ctmj-57	42	42	rabbits	rabbit	NOUN
ctmj-57	42	43	and	and	CCONJ
ctmj-57	42	44	the	the	DET
ctmj-57	42	45	experimental	experimental	ADJ
ctmj-57	42	46	animals	animal	NOUN
ctmj-57	42	47	were	be	AUX
ctmj-57	42	48	euthanized	euthanize	VERB
ctmj-57	42	49	on	on	ADP
ctmj-57	42	50	the	the	DET
ctmj-57	42	51	28th	28th	ADJ
ctmj-57	42	52	day	day	NOUN
ctmj-57	42	53	.	.	PUNCT
ctmj-57	43	1	schirmer	schirmer	PROPN
ctmj-57	43	2	’s	’s	PROPN
ctmj-57	43	3	i	i	PRON
ctmj-57	43	4	test	test	NOUN
ctmj-57	43	5	(	(	PUNCT
ctmj-57	43	6	sit	sit	VERB
ctmj-57	43	7	)	)	PUNCT
ctmj-57	43	8	as	as	SCONJ
ctmj-57	43	9	previously	previously	ADV
ctmj-57	43	10	reported	report	VERB
ctmj-57	43	11	,	,	PUNCT
ctmj-57	43	12	one	one	NUM
ctmj-57	43	13	end	end	NOUN
ctmj-57	43	14	of	of	ADP
ctmj-57	43	15	the	the	DET
ctmj-57	43	16	color	color	NOUN
ctmj-57	43	17	bar	bar	NOUN
ctmj-57	43	18	schirmer	schirmer	NOUN
ctmj-57	43	19	strips	strip	NOUN
ctmj-57	43	20	(	(	PUNCT
ctmj-57	43	21	eaglevision	eaglevision	NOUN
ctmj-57	43	22	,	,	PUNCT
ctmj-57	43	23	memphis	memphis	PROPN
ctmj-57	43	24	tn	tn	PROPN
ctmj-57	43	25	)	)	PUNCT
ctmj-57	43	26	was	be	AUX
ctmj-57	43	27	folded	fold	VERB
ctmj-57	43	28	and	and	CCONJ
ctmj-57	43	29	placed	place	VERB
ctmj-57	43	30	into	into	ADP
ctmj-57	43	31	the	the	DET
ctmj-57	43	32	conjunctival	conjunctival	NOUN
ctmj-57	43	33	sac	sac	NOUN
ctmj-57	43	34	in	in	ADP
ctmj-57	43	35	the	the	DET
ctmj-57	43	36	outer	outer	ADJ
ctmj-57	43	37	1/3	1/3	NUM
ctmj-57	43	38	of	of	ADP
ctmj-57	43	39	the	the	DET
ctmj-57	43	40	rabbit	rabbit	NOUN
ctmj-57	43	41	's	's	PART
ctmj-57	43	42	lower	low	ADJ
ctmj-57	43	43	eyelid	eyelid	NOUN
ctmj-57	43	44	.	.	PUNCT
ctmj-57	44	1	after	after	ADP
ctmj-57	44	2	5	5	NUM
ctmj-57	44	3	minutes	minute	NOUN
ctmj-57	44	4	,	,	PUNCT
ctmj-57	44	5	the	the	DET
ctmj-57	44	6	filter	filter	NOUN
ctmj-57	44	7	paper	paper	NOUN
ctmj-57	44	8	was	be	AUX
ctmj-57	44	9	collected	collect	VERB
ctmj-57	44	10	and	and	CCONJ
ctmj-57	44	11	the	the	DET
ctmj-57	44	12	length	length	NOUN
ctmj-57	44	13	of	of	ADP
ctmj-57	44	14	wetting	wetting	NOUN
ctmj-57	44	15	was	be	AUX
ctmj-57	44	16	measured	measure	VERB
ctmj-57	44	17	from	from	ADP
ctmj-57	44	18	the	the	DET
ctmj-57	44	19	point	point	NOUN
ctmj-57	44	20	of	of	ADP
ctmj-57	44	21	folding	fold	VERB
ctmj-57	44	22	[	[	X
ctmj-57	44	23	8	8	NUM
ctmj-57	44	24	]	]	PUNCT
ctmj-57	44	25	.	.	PUNCT
ctmj-57	45	1	tear	tear	PROPN
ctmj-57	45	2	break	break	VERB
ctmj-57	45	3	up	up	ADP
ctmj-57	45	4	time	time	NOUN
ctmj-57	45	5	(	(	PUNCT
ctmj-57	45	6	but	but	CCONJ
ctmj-57	45	7	)	)	PUNCT
ctmj-57	45	8	placing	place	VERB
ctmj-57	45	9	1	1	NUM
ctmj-57	45	10	μl	μl	ADP
ctmj-57	45	11	of	of	ADP
ctmj-57	45	12	0.1	0.1	NUM
ctmj-57	45	13	%	%	NOUN
ctmj-57	45	14	liquid	liquid	ADJ
ctmj-57	45	15	sodium	sodium	NOUN
ctmj-57	45	16	fluorescein	fluorescein	NOUN
ctmj-57	45	17	into	into	ADP
ctmj-57	45	18	the	the	DET
ctmj-57	45	19	conjunctival	conjunctival	NOUN
ctmj-57	45	20	sac	sac	NOUN
ctmj-57	45	21	caused	cause	VERB
ctmj-57	45	22	3	3	NUM
ctmj-57	45	23	blinks	blink	NOUN
ctmj-57	45	24	,	,	PUNCT
ctmj-57	45	25	which	which	PRON
ctmj-57	45	26	were	be	AUX
ctmj-57	45	27	recorded	record	VERB
ctmj-57	45	28	over	over	ADP
ctmj-57	45	29	several	several	ADJ
ctmj-57	45	30	seconds	second	NOUN
ctmj-57	45	31	and	and	CCONJ
ctmj-57	45	32	this	this	PRON
ctmj-57	45	33	was	be	AUX
ctmj-57	45	34	observed	observe	VERB
ctmj-57	45	35	under	under	ADP
ctmj-57	45	36	a	a	DET
ctmj-57	45	37	slit	slit	ADJ
ctmj-57	45	38	-	-	PUNCT
ctmj-57	45	39	lamp	lamp	NOUN
ctmj-57	45	40	microscope	microscope	NOUN
ctmj-57	45	41	with	with	ADP
ctmj-57	45	42	cobalt	cobalt	NOUN
ctmj-57	45	43	blue	blue	ADJ
ctmj-57	45	44	light	light	NOUN
ctmj-57	45	45	(	(	PUNCT
ctmj-57	45	46	ckx41	ckx41	ADJ
ctmj-57	45	47	,	,	PUNCT
ctmj-57	45	48	olympus	olympus	PROPN
ctmj-57	45	49	,	,	PUNCT
ctmj-57	45	50	tokyo	tokyo	PROPN
ctmj-57	45	51	,	,	PUNCT
ctmj-57	45	52	japan	japan	PROPN
ctmj-57	45	53	)	)	PUNCT
ctmj-57	45	54	until	until	SCONJ
ctmj-57	45	55	the	the	DET
ctmj-57	45	56	first	first	ADJ
ctmj-57	45	57	dryness	dryness	NOUN
ctmj-57	45	58	of	of	ADP
ctmj-57	45	59	the	the	DET
ctmj-57	45	60	tear	tear	ADJ
ctmj-57	45	61	film	film	NOUN
ctmj-57	45	62	spot	spot	NOUN
ctmj-57	45	63	appeared	appear	VERB
ctmj-57	45	64	.	.	PUNCT
ctmj-57	46	1	the	the	DET
ctmj-57	46	2	time	time	NOUN
ctmj-57	46	3	from	from	ADP
ctmj-57	46	4	eyelid	eyelid	NOUN
ctmj-57	46	5	opening	opening	NOUN
ctmj-57	46	6	to	to	ADP
ctmj-57	46	7	the	the	DET
ctmj-57	46	8	appearance	appearance	NOUN
ctmj-57	46	9	of	of	ADP
ctmj-57	46	10	the	the	DET
ctmj-57	46	11	first	first	ADJ
ctmj-57	46	12	dry	dry	ADJ
ctmj-57	46	13	spot	spot	NOUN
ctmj-57	46	14	was	be	AUX
ctmj-57	46	15	recorded	record	VERB
ctmj-57	46	16	and	and	CCONJ
ctmj-57	46	17	measured	measure	VERB
ctmj-57	46	18	.	.	PUNCT
ctmj-57	47	1	the	the	DET
ctmj-57	47	2	experiment	experiment	NOUN
ctmj-57	47	3	was	be	AUX
ctmj-57	47	4	repeated	repeat	VERB
ctmj-57	47	5	three	three	NUM
ctmj-57	47	6	times	time	NOUN
ctmj-57	47	7	and	and	CCONJ
ctmj-57	47	8	the	the	DET
ctmj-57	47	9	average	average	NOUN
ctmj-57	47	10	calculated	calculate	VERB
ctmj-57	47	11	.	.	PUNCT
ctmj-57	48	1	hematoxylin	hematoxylin	NOUN
ctmj-57	48	2	and	and	CCONJ
ctmj-57	48	3	eosin	eosin	PROPN
ctmj-57	48	4	(	(	PUNCT
ctmj-57	48	5	h&e	h&e	PROPN
ctmj-57	48	6	)	)	PUNCT
ctmj-57	48	7	the	the	DET
ctmj-57	48	8	lacrimal	lacrimal	ADJ
ctmj-57	48	9	glands	gland	NOUN
ctmj-57	48	10	of	of	ADP
ctmj-57	48	11	rabbits	rabbit	NOUN
ctmj-57	48	12	in	in	ADP
ctmj-57	48	13	each	each	DET
ctmj-57	48	14	group	group	NOUN
ctmj-57	48	15	were	be	AUX
ctmj-57	48	16	removed	remove	VERB
ctmj-57	48	17	and	and	CCONJ
ctmj-57	48	18	treated	treat	VERB
ctmj-57	48	19	with	with	ADP
ctmj-57	48	20	4	4	NUM
ctmj-57	48	21	%	%	NOUN
ctmj-57	48	22	paraformaldehyde	paraformaldehyde	NOUN
ctmj-57	48	23	immediately	immediately	ADV
ctmj-57	48	24	and	and	CCONJ
ctmj-57	48	25	embedded	embed	VERB
ctmj-57	48	26	in	in	ADP
ctmj-57	48	27	paraffin	paraffin	NOUN
ctmj-57	48	28	.	.	PUNCT
ctmj-57	49	1	then	then	ADV
ctmj-57	49	2	,	,	PUNCT
ctmj-57	49	3	tissues	tissue	NOUN
ctmj-57	49	4	were	be	AUX
ctmj-57	49	5	cut	cut	VERB
ctmj-57	49	6	into	into	ADP
ctmj-57	49	7	4	4	NUM
ctmj-57	49	8	μm	μm	NOUN
ctmj-57	49	9	slices	slice	NOUN
ctmj-57	49	10	and	and	CCONJ
ctmj-57	49	11	subsequently	subsequently	ADV
ctmj-57	49	12	deparaffinized	deparaffinize	VERB
ctmj-57	49	13	.	.	PUNCT
ctmj-57	50	1	thereafter	thereafter	ADV
ctmj-57	50	2	,	,	PUNCT
ctmj-57	50	3	the	the	DET
ctmj-57	50	4	samples	sample	NOUN
ctmj-57	50	5	were	be	AUX
ctmj-57	50	6	rehydrated	rehydrate	VERB
ctmj-57	50	7	and	and	CCONJ
ctmj-57	50	8	stained	stain	VERB
ctmj-57	50	9	with	with	ADP
ctmj-57	50	10	hematoxylin	hematoxylin	NOUN
ctmj-57	50	11	and	and	CCONJ
ctmj-57	50	12	eosin	eosin	NOUN
ctmj-57	50	13	(	(	PUNCT
ctmj-57	50	14	h&e	h&e	PROPN
ctmj-57	50	15	)	)	PUNCT
ctmj-57	50	16	.	.	PUNCT
ctmj-57	51	1	the	the	DET
ctmj-57	51	2	images	image	NOUN
ctmj-57	51	3	were	be	AUX
ctmj-57	51	4	examined	examine	VERB
ctmj-57	51	5	under	under	ADP
ctmj-57	51	6	a	a	DET
ctmj-57	51	7	light	light	ADJ
ctmj-57	51	8	microscope	microscope	NOUN
ctmj-57	51	9	and	and	CCONJ
ctmj-57	51	10	three	three	NUM
ctmj-57	51	11	pathologists	pathologist	NOUN
ctmj-57	51	12	who	who	PRON
ctmj-57	51	13	were	be	AUX
ctmj-57	51	14	unaware	unaware	ADJ
ctmj-57	51	15	of	of	ADP
ctmj-57	51	16	the	the	DET
ctmj-57	51	17	grouping	grouping	NOUN
ctmj-57	51	18	of	of	ADP
ctmj-57	51	19	the	the	DET
ctmj-57	51	20	animals	animal	NOUN
ctmj-57	51	21	were	be	AUX
ctmj-57	51	22	asked	ask	VERB
ctmj-57	51	23	to	to	PART
ctmj-57	51	24	evaluate	evaluate	VERB
ctmj-57	51	25	each	each	DET
ctmj-57	51	26	group	group	NOUN
ctmj-57	51	27	of	of	ADP
ctmj-57	51	28	sections	section	NOUN
ctmj-57	51	29	.	.	PUNCT
ctmj-57	52	1	flow	flow	NOUN
ctmj-57	52	2	cytometry	cytometry	NOUN
ctmj-57	52	3	for	for	ADP
ctmj-57	52	4	apoptosis	apoptosis	NOUN
ctmj-57	52	5	detection	detection	NOUN
ctmj-57	52	6	experiments	experiment	NOUN
ctmj-57	52	7	,	,	PUNCT
ctmj-57	52	8	rabbit	rabbit	NOUN
ctmj-57	52	9	corneal	corneal	ADJ
ctmj-57	52	10	tissues	tissue	NOUN
ctmj-57	52	11	from	from	ADP
ctmj-57	52	12	each	each	DET
ctmj-57	52	13	group	group	NOUN
ctmj-57	52	14	were	be	AUX
ctmj-57	52	15	removed	remove	VERB
ctmj-57	52	16	and	and	CCONJ
ctmj-57	52	17	homogenates	homogenate	NOUN
ctmj-57	52	18	were	be	AUX
ctmj-57	52	19	prepared	prepare	VERB
ctmj-57	52	20	(	(	PUNCT
ctmj-57	52	21	one	one	NUM
ctmj-57	52	22	homogenate	homogenate	NOUN
ctmj-57	52	23	was	be	AUX
ctmj-57	52	24	made	make	VERB
ctmj-57	52	25	from	from	ADP
ctmj-57	52	26	each	each	DET
ctmj-57	52	27	group	group	NOUN
ctmj-57	52	28	of	of	ADP
ctmj-57	52	29	collected	collect	VERB
ctmj-57	52	30	tissues	tissue	NOUN
ctmj-57	52	31	)	)	PUNCT
ctmj-57	52	32	.	.	PUNCT
ctmj-57	53	1	then	then	ADV
ctmj-57	53	2	they	they	PRON
ctmj-57	53	3	were	be	AUX
ctmj-57	53	4	digested	digest	VERB
ctmj-57	53	5	with	with	ADP
ctmj-57	53	6	enzymes	enzyme	NOUN
ctmj-57	53	7	and	and	CCONJ
ctmj-57	53	8	undigested	undigested	ADJ
ctmj-57	53	9	sections	section	NOUN
ctmj-57	53	10	were	be	AUX
ctmj-57	53	11	filtered	filter	VERB
ctmj-57	53	12	out	out	ADP
ctmj-57	53	13	using	use	VERB
ctmj-57	53	14	strainers	strainer	NOUN
ctmj-57	53	15	to	to	PART
ctmj-57	53	16	form	form	VERB
ctmj-57	53	17	single	single	ADJ
ctmj-57	53	18	cell	cell	NOUN
ctmj-57	53	19	suspensions	suspension	NOUN
ctmj-57	53	20	.	.	PUNCT
ctmj-57	54	1	next	next	ADV
ctmj-57	54	2	,	,	PUNCT
ctmj-57	54	3	the	the	DET
ctmj-57	54	4	cells	cell	NOUN
ctmj-57	54	5	were	be	AUX
ctmj-57	54	6	stained	stain	VERB
ctmj-57	54	7	with	with	ADP
ctmj-57	54	8	annexin	annexin	NOUN
ctmj-57	54	9	v	v	NOUN
ctmj-57	54	10	-	-	PUNCT
ctmj-57	54	11	fluorescein	fluorescein	ADJ
ctmj-57	54	12	isothiocyanate	isothiocyanate	NOUN
ctmj-57	54	13	(	(	PUNCT
ctmj-57	54	14	fitc)/propidium	fitc)/propidium	NOUN
ctmj-57	54	15	iodide	iodide	NOUN
ctmj-57	54	16	(	(	PUNCT
ctmj-57	54	17	pi	pi	NOUN
ctmj-57	54	18	)	)	PUNCT
ctmj-57	54	19	reagent	reagent	NOUN
ctmj-57	54	20	(	(	PUNCT
ctmj-57	54	21	vazyme	vazyme	NOUN
ctmj-57	54	22	,	,	PUNCT
ctmj-57	54	23	nanjing	nanjing	PROPN
ctmj-57	54	24	,	,	PUNCT
ctmj-57	54	25	china	china	PROPN
ctmj-57	54	26	)	)	PUNCT
ctmj-57	54	27	under	under	ADP
ctmj-57	54	28	dark	dark	ADJ
ctmj-57	54	29	conditions	condition	NOUN
ctmj-57	54	30	for	for	ADP
ctmj-57	54	31	15	15	NUM
ctmj-57	54	32	minutes	minute	NOUN
ctmj-57	54	33	.	.	PUNCT
ctmj-57	55	1	subsequently	subsequently	ADV
ctmj-57	55	2	,	,	PUNCT
ctmj-57	55	3	flow	flow	NOUN
ctmj-57	55	4	cytometry	cytometry	NOUN
ctmj-57	55	5	(	(	PUNCT
ctmj-57	55	6	bd	bd	PROPN
ctmj-57	55	7	,	,	PUNCT
ctmj-57	55	8	facscalibur	facscalibur	PROPN
ctmj-57	55	9	,	,	PUNCT
ctmj-57	55	10	usa	usa	PROPN
ctmj-57	55	11	)	)	PUNCT
ctmj-57	55	12	was	be	AUX
ctmj-57	55	13	used	use	VERB
ctmj-57	55	14	to	to	PART
ctmj-57	55	15	analyze	analyze	VERB
ctmj-57	55	16	the	the	DET
ctmj-57	55	17	percentage	percentage	NOUN
ctmj-57	55	18	of	of	ADP
ctmj-57	55	19	apoptosis	apoptosis	NOUN
ctmj-57	55	20	.	.	PUNCT
ctmj-57	56	1	for	for	SCONJ
ctmj-57	56	2	experiments	experiment	NOUN
ctmj-57	56	3	to	to	PART
ctmj-57	56	4	measure	measure	VERB
ctmj-57	56	5	th17	th17	PROPN
ctmj-57	56	6	and	and	CCONJ
ctmj-57	56	7	treg	treg	PROPN
ctmj-57	56	8	cells	cell	NOUN
ctmj-57	56	9	,	,	PUNCT
ctmj-57	56	10	lacrimal	lacrimal	ADJ
ctmj-57	56	11	glands	gland	NOUN
ctmj-57	56	12	of	of	ADP
ctmj-57	56	13	rabbits	rabbit	NOUN
ctmj-57	56	14	in	in	ADP
ctmj-57	56	15	each	each	DET
ctmj-57	56	16	group	group	NOUN
ctmj-57	56	17	were	be	AUX
ctmj-57	56	18	taken	take	VERB
ctmj-57	56	19	and	and	CCONJ
ctmj-57	56	20	dried	dry	VERB
ctmj-57	56	21	for	for	ADP
ctmj-57	56	22	5	5	NUM
ctmj-57	56	23	days	day	NOUN
ctmj-57	56	24	and	and	CCONJ
ctmj-57	56	25	then	then	ADV
ctmj-57	56	26	homogenized	homogenize	VERB
ctmj-57	56	27	(	(	PUNCT
ctmj-57	56	28	one	one	NUM
ctmj-57	56	29	homogenate	homogenate	NOUN
ctmj-57	56	30	was	be	AUX
ctmj-57	56	31	made	make	VERB
ctmj-57	56	32	from	from	ADP
ctmj-57	56	33	each	each	DET
ctmj-57	56	34	group	group	NOUN
ctmj-57	56	35	of	of	ADP
ctmj-57	56	36	collected	collect	VERB
ctmj-57	56	37	chinese	chinese	ADJ
ctmj-57	56	38	traditional	traditional	ADJ
ctmj-57	56	39	medicine	medicine	NOUN
ctmj-57	56	40	journal	journal	NOUN
ctmj-57	56	41	|	|	ADV
ctmj-57	56	42	2020	2020	NUM
ctmj-57	57	1	|	|	ADV
ctmj-57	57	2	vol	vol	NOUN
ctmj-57	57	3	3	3	NUM
ctmj-57	57	4	|	|	ADV
ctmj-57	57	5	issue	issue	VERB
ctmj-57	57	6	6	6	NUM
ctmj-57	57	7	issn	issn	NOUN
ctmj-57	57	8	:	:	PUNCT
ctmj-57	57	9	2693	2693	NUM
ctmj-57	57	10	6356	6356	NUM
ctmj-57	57	11	2020	2020	NUM
ctmj-57	57	12	|	|	ADV
ctmj-57	57	13	vol	vol	NOUN
ctmj-57	57	14	3	3	NUM
ctmj-57	58	1	|	|	ADV
ctmj-57	58	2	issue	issue	VERB
ctmj-57	58	3	6	6	NUM
ctmj-57	58	4	ctmj	ctmj	NOUN
ctmj-57	58	5	|	|	ADV
ctmj-57	58	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	58	7	tissues	tissue	NOUN
ctmj-57	58	8	)	)	PUNCT
ctmj-57	58	9	.	.	PUNCT
ctmj-57	59	1	they	they	PRON
ctmj-57	59	2	were	be	AUX
ctmj-57	59	3	digested	digest	VERB
ctmj-57	59	4	with	with	ADP
ctmj-57	59	5	pancreatic	pancreatic	ADJ
ctmj-57	59	6	enzyme	enzyme	NOUN
ctmj-57	59	7	and	and	CCONJ
ctmj-57	59	8	undigested	undigested	ADJ
ctmj-57	59	9	sections	section	NOUN
ctmj-57	59	10	were	be	AUX
ctmj-57	59	11	filtered	filter	VERB
ctmj-57	59	12	out	out	ADP
ctmj-57	59	13	using	use	VERB
ctmj-57	59	14	strainers	strainer	NOUN
ctmj-57	59	15	to	to	PART
ctmj-57	59	16	form	form	VERB
ctmj-57	59	17	single	single	ADJ
ctmj-57	59	18	cell	cell	NOUN
ctmj-57	59	19	suspensions	suspension	NOUN
ctmj-57	59	20	.	.	PUNCT
ctmj-57	60	1	then	then	ADV
ctmj-57	60	2	,	,	PUNCT
ctmj-57	60	3	single	single	ADJ
ctmj-57	60	4	cell	cell	NOUN
ctmj-57	60	5	suspensions	suspension	NOUN
ctmj-57	60	6	of	of	ADP
ctmj-57	60	7	the	the	DET
ctmj-57	60	8	lacrimal	lacrimal	ADJ
ctmj-57	60	9	gland	gland	NOUN
ctmj-57	60	10	were	be	AUX
ctmj-57	60	11	subjected	subject	VERB
ctmj-57	60	12	to	to	PART
ctmj-57	60	13	flow	flow	VERB
ctmj-57	60	14	cytometry	cytometry	NOUN
ctmj-57	60	15	using	use	VERB
ctmj-57	60	16	the	the	DET
ctmj-57	60	17	following	follow	VERB
ctmj-57	60	18	specific	specific	ADJ
ctmj-57	60	19	antibodies	antibody	NOUN
ctmj-57	60	20	:	:	PUNCT
ctmj-57	60	21	anti	anti	ADJ
ctmj-57	60	22	-	-	ADJ
ctmj-57	60	23	cd4	cd4	ADJ
ctmj-57	60	24	antibody	antibody	NOUN
ctmj-57	60	25	,	,	PUNCT
ctmj-57	60	26	fluorophoreconjugated	fluorophoreconjugate	VERB
ctmj-57	60	27	anti	anti	ADJ
ctmj-57	60	28	-	-	ADJ
ctmj-57	60	29	il17	il17	ADJ
ctmj-57	60	30	antibody	antibody	NOUN
ctmj-57	60	31	and	and	CCONJ
ctmj-57	60	32	anti	anti	ADJ
ctmj-57	60	33	-	-	NOUN
ctmj-57	60	34	foxp3	foxp3	ADJ
ctmj-57	60	35	.	.	PUNCT
ctmj-57	61	1	the	the	DET
ctmj-57	61	2	negative	negative	ADJ
ctmj-57	61	3	control	control	NOUN
ctmj-57	61	4	samples	sample	NOUN
ctmj-57	61	5	were	be	AUX
ctmj-57	61	6	stained	stain	VERB
ctmj-57	61	7	with	with	ADP
ctmj-57	61	8	the	the	DET
ctmj-57	61	9	appropriate	appropriate	ADJ
ctmj-57	61	10	isotype	isotype	NOUN
ctmj-57	61	11	-	-	PUNCT
ctmj-57	61	12	matched	match	VERB
ctmj-57	61	13	antibodies	antibody	NOUN
ctmj-57	61	14	.	.	PUNCT
ctmj-57	62	1	data	datum	NOUN
ctmj-57	62	2	was	be	AUX
ctmj-57	62	3	analyzed	analyze	VERB
ctmj-57	62	4	using	use	VERB
ctmj-57	62	5	flowjo	flowjo	ADJ
ctmj-57	62	6	software	software	NOUN
ctmj-57	62	7	(	(	PUNCT
ctmj-57	62	8	tree	tree	NOUN
ctmj-57	62	9	star	star	NOUN
ctmj-57	62	10	,	,	PUNCT
ctmj-57	62	11	ashland	ashland	PROPN
ctmj-57	62	12	,	,	PUNCT
ctmj-57	62	13	or	or	CCONJ
ctmj-57	62	14	,	,	PUNCT
ctmj-57	62	15	usa	usa	PROPN
ctmj-57	62	16	)	)	PUNCT
ctmj-57	62	17	.	.	PUNCT
ctmj-57	63	1	western	western	ADJ
ctmj-57	63	2	blotting	blotting	NOUN
ctmj-57	63	3	(	(	PUNCT
ctmj-57	63	4	wb	wb	PROPN
ctmj-57	63	5	)	)	PUNCT
ctmj-57	63	6	the	the	DET
ctmj-57	63	7	lacrimal	lacrimal	ADJ
ctmj-57	63	8	gland	gland	NOUN
ctmj-57	63	9	tissues	tissue	NOUN
ctmj-57	63	10	isolated	isolate	VERB
ctmj-57	63	11	from	from	ADP
ctmj-57	63	12	the	the	DET
ctmj-57	63	13	rabbits	rabbit	NOUN
ctmj-57	63	14	were	be	AUX
ctmj-57	63	15	lysed	lyse	VERB
ctmj-57	63	16	using	use	VERB
ctmj-57	63	17	1x	1x	NUM
ctmj-57	63	18	radioimmunoprecipitation	radioimmunoprecipitation	NOUN
ctmj-57	63	19	(	(	PUNCT
ctmj-57	63	20	ripa	ripa	NOUN
ctmj-57	63	21	)	)	PUNCT
ctmj-57	63	22	lysis	lysis	NOUN
ctmj-57	63	23	buffer	buffer	NOUN
ctmj-57	63	24	(	(	PUNCT
ctmj-57	63	25	20	20	NUM
ctmj-57	63	26	-	-	SYM
ctmj-57	63	27	188	188	NUM
ctmj-57	63	28	,	,	PUNCT
ctmj-57	63	29	millipore	millipore	PROPN
ctmj-57	63	30	,	,	PUNCT
ctmj-57	63	31	usa	usa	PROPN
ctmj-57	63	32	)	)	PUNCT
ctmj-57	63	33	.	.	PUNCT
ctmj-57	64	1	the	the	DET
ctmj-57	64	2	concentration	concentration	NOUN
ctmj-57	64	3	of	of	ADP
ctmj-57	64	4	total	total	ADJ
ctmj-57	64	5	protein	protein	NOUN
ctmj-57	64	6	was	be	AUX
ctmj-57	64	7	determined	determine	VERB
ctmj-57	64	8	using	use	VERB
ctmj-57	64	9	a	a	DET
ctmj-57	64	10	bca	bca	NOUN
ctmj-57	64	11	protein	protein	NOUN
ctmj-57	64	12	assay	assay	NOUN
ctmj-57	64	13	kit	kit	NOUN
ctmj-57	64	14	(	(	PUNCT
ctmj-57	64	15	beyotime	beyotime	NOUN
ctmj-57	64	16	,	,	PUNCT
ctmj-57	64	17	shanghai	shanghai	PROPN
ctmj-57	64	18	,	,	PUNCT
ctmj-57	64	19	china	china	PROPN
ctmj-57	64	20	)	)	PUNCT
ctmj-57	64	21	.	.	PUNCT
ctmj-57	65	1	protein	protein	NOUN
ctmj-57	65	2	lysates	lysate	NOUN
ctmj-57	65	3	were	be	AUX
ctmj-57	65	4	separated	separate	VERB
ctmj-57	65	5	by	by	ADP
ctmj-57	65	6	electrophoresis	electrophoresis	NOUN
ctmj-57	65	7	on	on	ADP
ctmj-57	65	8	a	a	DET
ctmj-57	65	9	10	10	NUM
ctmj-57	65	10	%	%	NOUN
ctmj-57	65	11	sodium	sodium	NOUN
ctmj-57	65	12	sds	sds	PROPN
ctmj-57	65	13	-	-	PUNCT
ctmj-57	65	14	polyacrylamide	polyacrylamide	NOUN
ctmj-57	65	15	gel	gel	NOUN
ctmj-57	65	16	(	(	PUNCT
ctmj-57	65	17	sds	sds	NOUN
ctmj-57	65	18	-	-	PUNCT
ctmj-57	65	19	page	page	NOUN
ctmj-57	65	20	)	)	PUNCT
ctmj-57	65	21	,	,	PUNCT
ctmj-57	65	22	then	then	ADV
ctmj-57	65	23	transferred	transfer	VERB
ctmj-57	65	24	to	to	ADP
ctmj-57	65	25	pvdf	pvdf	PROPN
ctmj-57	65	26	membranes	membrane	NOUN
ctmj-57	65	27	(	(	PUNCT
ctmj-57	65	28	millipore	millipore	PROPN
ctmj-57	65	29	,	,	PUNCT
ctmj-57	65	30	china	china	PROPN
ctmj-57	65	31	)	)	PUNCT
ctmj-57	65	32	and	and	CCONJ
ctmj-57	65	33	treated	treat	VERB
ctmj-57	65	34	with	with	ADP
ctmj-57	65	35	5	5	NUM
ctmj-57	65	36	%	%	NOUN
ctmj-57	65	37	non	non	ADJ
ctmj-57	65	38	-	-	ADJ
ctmj-57	65	39	fat	fat	ADJ
ctmj-57	65	40	milk	milk	NOUN
ctmj-57	65	41	for	for	ADP
ctmj-57	65	42	1	1	NUM
ctmj-57	65	43	hour	hour	NOUN
ctmj-57	65	44	at	at	ADP
ctmj-57	65	45	room	room	NOUN
ctmj-57	65	46	temperature	temperature	NOUN
ctmj-57	65	47	.	.	PUNCT
ctmj-57	66	1	the	the	DET
ctmj-57	66	2	protein	protein	NOUN
ctmj-57	66	3	was	be	AUX
ctmj-57	66	4	identified	identify	VERB
ctmj-57	66	5	by	by	ADP
ctmj-57	66	6	incubating	incubate	VERB
ctmj-57	66	7	with	with	ADP
ctmj-57	66	8	specific	specific	ADJ
ctmj-57	66	9	primary	primary	ADJ
ctmj-57	66	10	antibodies	antibody	NOUN
ctmj-57	66	11	overnight	overnight	ADV
ctmj-57	66	12	at	at	ADP
ctmj-57	66	13	4	4	NUM
ctmj-57	66	14	°	°	NOUN
ctmj-57	66	15	c	c	NOUN
ctmj-57	66	16	.	.	PUNCT
ctmj-57	67	1	information	information	NOUN
ctmj-57	67	2	on	on	ADP
ctmj-57	67	3	the	the	DET
ctmj-57	67	4	specific	specific	ADJ
ctmj-57	67	5	primary	primary	ADJ
ctmj-57	67	6	antibodies	antibody	NOUN
ctmj-57	67	7	used	use	VERB
ctmj-57	67	8	in	in	ADP
ctmj-57	67	9	this	this	DET
ctmj-57	67	10	study	study	NOUN
ctmj-57	67	11	is	be	AUX
ctmj-57	67	12	as	as	SCONJ
ctmj-57	67	13	follows	follow	VERB
ctmj-57	67	14	:	:	PUNCT
ctmj-57	67	15	anti	anti	ADJ
ctmj-57	67	16	-	-	ADJ
ctmj-57	67	17	bcl2	bcl2	ADJ
ctmj-57	67	18	(	(	PUNCT
ctmj-57	67	19	ab196495	ab196495	PROPN
ctmj-57	67	20	,	,	PUNCT
ctmj-57	67	21	1:1000	1:1000	NUM
ctmj-57	67	22	,	,	PUNCT
ctmj-57	67	23	abcam	abcam	PROPN
ctmj-57	67	24	,	,	PUNCT
ctmj-57	67	25	cambridge	cambridge	PROPN
ctmj-57	67	26	,	,	PUNCT
ctmj-57	67	27	ma	ma	PROPN
ctmj-57	67	28	,	,	PUNCT
ctmj-57	67	29	usa	usa	PROPN
ctmj-57	67	30	)	)	PUNCT
ctmj-57	67	31	,	,	PUNCT
ctmj-57	67	32	anticleaved	anticleave	VERB
ctmj-57	67	33	caspase3	caspase3	NOUN
ctmj-57	67	34	(	(	PUNCT
ctmj-57	67	35	ab2302	ab2302	PROPN
ctmj-57	67	36	,	,	PUNCT
ctmj-57	67	37	1:1000	1:1000	NUM
ctmj-57	67	38	,	,	PUNCT
ctmj-57	67	39	abcam	abcam	PROPN
ctmj-57	67	40	,	,	PUNCT
ctmj-57	67	41	cambridge	cambridge	PROPN
ctmj-57	67	42	,	,	PUNCT
ctmj-57	67	43	ma	ma	PROPN
ctmj-57	67	44	,	,	PUNCT
ctmj-57	67	45	usa	usa	PROPN
ctmj-57	67	46	)	)	PUNCT
ctmj-57	67	47	,	,	PUNCT
ctmj-57	67	48	anti	anti	ADJ
ctmj-57	67	49	-	-	ADJ
ctmj-57	67	50	bax	bax	ADJ
ctmj-57	67	51	(	(	PUNCT
ctmj-57	67	52	ab104156	ab104156	PROPN
ctmj-57	67	53	,	,	PUNCT
ctmj-57	67	54	1:1000	1:1000	NUM
ctmj-57	67	55	,	,	PUNCT
ctmj-57	67	56	abcam	abcam	PROPN
ctmj-57	67	57	,	,	PUNCT
ctmj-57	67	58	cambridge	cambridge	PROPN
ctmj-57	67	59	,	,	PUNCT
ctmj-57	67	60	ma	ma	PROPN
ctmj-57	67	61	,	,	PUNCT
ctmj-57	67	62	usa	usa	PROPN
ctmj-57	67	63	)	)	PUNCT
ctmj-57	67	64	,	,	PUNCT
ctmj-57	67	65	anti	anti	ADJ
ctmj-57	67	66	-	-	ADJ
ctmj-57	67	67	rorγt	rorγt	ADJ
ctmj-57	67	68	(	(	PUNCT
ctmj-57	67	69	ab91187	ab91187	PROPN
ctmj-57	67	70	,	,	PUNCT
ctmj-57	67	71	1:1000	1:1000	NUM
ctmj-57	67	72	,	,	PUNCT
ctmj-57	67	73	abcam	abcam	PROPN
ctmj-57	67	74	,	,	PUNCT
ctmj-57	67	75	cambridge	cambridge	PROPN
ctmj-57	67	76	,	,	PUNCT
ctmj-57	67	77	ma	ma	PROPN
ctmj-57	67	78	,	,	PUNCT
ctmj-57	67	79	usa	usa	PROPN
ctmj-57	67	80	)	)	PUNCT
ctmj-57	67	81	,	,	PUNCT
ctmj-57	67	82	anti	anti	ADJ
ctmj-57	67	83	-	-	ADJ
ctmj-57	67	84	foxp3	foxp3	ADJ
ctmj-57	67	85	(	(	PUNCT
ctmj-57	67	86	ab75763	ab75763	PROPN
ctmj-57	67	87	,	,	PUNCT
ctmj-57	67	88	1:1000	1:1000	NUM
ctmj-57	67	89	,	,	PUNCT
ctmj-57	67	90	abcam	abcam	PROPN
ctmj-57	67	91	,	,	PUNCT
ctmj-57	67	92	cambridge	cambridge	PROPN
ctmj-57	67	93	,	,	PUNCT
ctmj-57	67	94	ma	ma	PROPN
ctmj-57	67	95	,	,	PUNCT
ctmj-57	67	96	usa	usa	PROPN
ctmj-57	67	97	)	)	PUNCT
ctmj-57	67	98	,	,	PUNCT
ctmj-57	67	99	anti	anti	ADJ
ctmj-57	67	100	-	-	ADJ
ctmj-57	67	101	p	p	ADJ
ctmj-57	67	102	-	-	PUNCT
ctmj-57	67	103	stat3	stat3	NOUN
ctmj-57	67	104	(	(	PUNCT
ctmj-57	67	105	ab30647	ab30647	PROPN
ctmj-57	67	106	,	,	PUNCT
ctmj-57	67	107	1:1000	1:1000	NUM
ctmj-57	67	108	,	,	PUNCT
ctmj-57	67	109	abcam	abcam	PROPN
ctmj-57	67	110	,	,	PUNCT
ctmj-57	67	111	cambridge	cambridge	PROPN
ctmj-57	67	112	,	,	PUNCT
ctmj-57	67	113	ma	ma	PROPN
ctmj-57	67	114	,	,	PUNCT
ctmj-57	67	115	usa	usa	PROPN
ctmj-57	67	116	)	)	PUNCT
ctmj-57	67	117	,	,	PUNCT
ctmj-57	67	118	anti	anti	ADJ
ctmj-57	67	119	-	-	ADJ
ctmj-57	67	120	stat3	stat3	ADJ
ctmj-57	67	121	(	(	PUNCT
ctmj-57	67	122	ab31370	ab31370	PROPN
ctmj-57	67	123	,	,	PUNCT
ctmj-57	67	124	1:1000	1:1000	NUM
ctmj-57	67	125	,	,	PUNCT
ctmj-57	67	126	abcam	abcam	PROPN
ctmj-57	67	127	,	,	PUNCT
ctmj-57	67	128	cambridge	cambridge	PROPN
ctmj-57	67	129	,	,	PUNCT
ctmj-57	67	130	ma	ma	PROPN
ctmj-57	67	131	,	,	PUNCT
ctmj-57	67	132	usa	usa	PROPN
ctmj-57	67	133	)	)	PUNCT
ctmj-57	67	134	,	,	PUNCT
ctmj-57	67	135	anti	anti	ADJ
ctmj-57	67	136	-	-	ADJ
ctmj-57	67	137	p	p	ADJ
ctmj-57	67	138	-	-	PUNCT
ctmj-57	67	139	jak2	jak2	NOUN
ctmj-57	67	140	(	(	PUNCT
ctmj-57	67	141	ab195055	ab195055	PROPN
ctmj-57	67	142	,	,	PUNCT
ctmj-57	67	143	1:1000	1:1000	NUM
ctmj-57	67	144	,	,	PUNCT
ctmj-57	67	145	abcam	abcam	PROPN
ctmj-57	67	146	,	,	PUNCT
ctmj-57	67	147	cambridge	cambridge	PROPN
ctmj-57	67	148	,	,	PUNCT
ctmj-57	67	149	ma	ma	PROPN
ctmj-57	67	150	,	,	PUNCT
ctmj-57	67	151	usa	usa	PROPN
ctmj-57	67	152	)	)	PUNCT
ctmj-57	67	153	,	,	PUNCT
ctmj-57	67	154	anti	anti	ADJ
ctmj-57	67	155	-	-	NOUN
ctmj-57	67	156	jak2	jak2	ADJ
ctmj-57	67	157	(	(	PUNCT
ctmj-57	67	158	ab245303	ab245303	PROPN
ctmj-57	67	159	,	,	PUNCT
ctmj-57	67	160	1:1000	1:1000	NUM
ctmj-57	67	161	,	,	PUNCT
ctmj-57	67	162	abcam	abcam	PROPN
ctmj-57	67	163	,	,	PUNCT
ctmj-57	67	164	cambridge	cambridge	PROPN
ctmj-57	67	165	,	,	PUNCT
ctmj-57	67	166	ma	ma	PROPN
ctmj-57	67	167	,	,	PUNCT
ctmj-57	67	168	usa	usa	PROPN
ctmj-57	67	169	)	)	PUNCT
ctmj-57	67	170	and	and	CCONJ
ctmj-57	67	171	anti	anti	ADJ
ctmj-57	67	172	-	-	ADJ
ctmj-57	67	173	β	β	NOUN
ctmj-57	67	174	-	-	NOUN
ctmj-57	67	175	actin	actin	NOUN
ctmj-57	67	176	(	(	PUNCT
ctmj-57	67	177	ab8227	ab8227	PROPN
ctmj-57	67	178	,	,	PUNCT
ctmj-57	67	179	1:1000	1:1000	NUM
ctmj-57	67	180	dilution	dilution	NOUN
ctmj-57	67	181	,	,	PUNCT
ctmj-57	67	182	abcam	abcam	PROPN
ctmj-57	67	183	,	,	PUNCT
ctmj-57	67	184	cambridge	cambridge	PROPN
ctmj-57	67	185	,	,	PUNCT
ctmj-57	67	186	ma	ma	PROPN
ctmj-57	67	187	,	,	PUNCT
ctmj-57	67	188	usa	usa	PROPN
ctmj-57	67	189	)	)	PUNCT
ctmj-57	67	190	.	.	PUNCT
ctmj-57	68	1	the	the	DET
ctmj-57	68	2	following	following	ADJ
ctmj-57	68	3	day	day	NOUN
ctmj-57	68	4	,	,	PUNCT
ctmj-57	68	5	pvdf	pvdf	PROPN
ctmj-57	68	6	membrane	membrane	NOUN
ctmj-57	68	7	were	be	AUX
ctmj-57	68	8	washed	wash	VERB
ctmj-57	68	9	3	3	NUM
ctmj-57	68	10	times	time	NOUN
ctmj-57	68	11	in	in	ADP
ctmj-57	68	12	tbst	tbst	NOUN
ctmj-57	68	13	and	and	CCONJ
ctmj-57	68	14	incubated	incubate	VERB
ctmj-57	68	15	with	with	ADP
ctmj-57	68	16	hrp	hrp	PROPN
ctmj-57	68	17	-	-	PUNCT
ctmj-57	68	18	conjugated	conjugate	VERB
ctmj-57	68	19	secondary	secondary	ADJ
ctmj-57	68	20	igg	igg	NOUN
ctmj-57	68	21	antibody	antibody	NOUN
ctmj-57	68	22	(	(	PUNCT
ctmj-57	68	23	(	(	PUNCT
ctmj-57	68	24	ab6734	ab6734	ADJ
ctmj-57	68	25	,	,	PUNCT
ctmj-57	68	26	1:2000	1:2000	NUM
ctmj-57	68	27	dilution	dilution	NOUN
ctmj-57	68	28	,	,	PUNCT
ctmj-57	68	29	abcam	abcam	PROPN
ctmj-57	68	30	,	,	PUNCT
ctmj-57	68	31	cambridge	cambridge	PROPN
ctmj-57	68	32	,	,	PUNCT
ctmj-57	68	33	ma	ma	PROPN
ctmj-57	68	34	,	,	PUNCT
ctmj-57	68	35	usa	usa	PROPN
ctmj-57	68	36	)	)	PUNCT
ctmj-57	68	37	for	for	ADP
ctmj-57	68	38	1	1	NUM
ctmj-57	68	39	hour	hour	NOUN
ctmj-57	68	40	at	at	ADP
ctmj-57	68	41	room	room	NOUN
ctmj-57	68	42	temperature	temperature	NOUN
ctmj-57	68	43	.	.	PUNCT
ctmj-57	69	1	image	image	NOUN
ctmj-57	69	2	j	j	PROPN
ctmj-57	69	3	was	be	AUX
ctmj-57	69	4	used	use	VERB
ctmj-57	69	5	for	for	ADP
ctmj-57	69	6	quantification	quantification	NOUN
ctmj-57	69	7	.	.	PUNCT
ctmj-57	70	1	statistical	statistical	ADJ
ctmj-57	70	2	analysis	analysis	NOUN
ctmj-57	70	3	mean	mean	VERB
ctmj-57	70	4	±	±	NUM
ctmj-57	70	5	standard	standard	ADJ
ctmj-57	70	6	deviation	deviation	NOUN
ctmj-57	70	7	(	(	PUNCT
ctmj-57	70	8	sd	sd	NOUN
ctmj-57	70	9	)	)	PUNCT
ctmj-57	70	10	are	be	AUX
ctmj-57	70	11	used	use	VERB
ctmj-57	70	12	to	to	PART
ctmj-57	70	13	express	express	VERB
ctmj-57	70	14	all	all	DET
ctmj-57	70	15	the	the	DET
ctmj-57	70	16	data	datum	NOUN
ctmj-57	70	17	.	.	PUNCT
ctmj-57	71	1	each	each	DET
ctmj-57	71	2	set	set	NOUN
ctmj-57	71	3	of	of	ADP
ctmj-57	71	4	experiments	experiment	NOUN
ctmj-57	71	5	were	be	AUX
ctmj-57	71	6	repeated	repeat	VERB
ctmj-57	71	7	three	three	NUM
ctmj-57	71	8	times	time	NOUN
ctmj-57	71	9	.	.	PUNCT
ctmj-57	72	1	graphpad	graphpad	NOUN
ctmj-57	72	2	prism	prism	NOUN
ctmj-57	72	3	(	(	PUNCT
ctmj-57	72	4	version	version	NOUN
ctmj-57	72	5	7.04	7.04	NUM
ctmj-57	72	6	)	)	PUNCT
ctmj-57	72	7	was	be	AUX
ctmj-57	72	8	used	use	VERB
ctmj-57	72	9	for	for	ADP
ctmj-57	72	10	statistical	statistical	ADJ
ctmj-57	72	11	analysis	analysis	NOUN
ctmj-57	72	12	.	.	PUNCT
ctmj-57	73	1	student	student	NOUN
ctmj-57	73	2	's	's	PART
ctmj-57	73	3	t	t	PROPN
ctmj-57	73	4	-	-	PUNCT
ctmj-57	73	5	test	test	NOUN
ctmj-57	73	6	was	be	AUX
ctmj-57	73	7	used	use	VERB
ctmj-57	73	8	for	for	ADP
ctmj-57	73	9	comparison	comparison	NOUN
ctmj-57	73	10	between	between	ADP
ctmj-57	73	11	two	two	NUM
ctmj-57	73	12	groups	group	NOUN
ctmj-57	73	13	,	,	PUNCT
ctmj-57	73	14	while	while	SCONJ
ctmj-57	73	15	one	one	NUM
ctmj-57	73	16	-	-	PUNCT
ctmj-57	73	17	way	way	NOUN
ctmj-57	73	18	anova	anova	PROPN
ctmj-57	73	19	was	be	AUX
ctmj-57	73	20	used	use	VERB
ctmj-57	73	21	for	for	ADP
ctmj-57	73	22	comparisons	comparison	NOUN
ctmj-57	73	23	between	between	ADP
ctmj-57	73	24	multiple	multiple	ADJ
ctmj-57	73	25	groups	group	NOUN
ctmj-57	73	26	.	.	PUNCT
ctmj-57	74	1	p	p	X
ctmj-57	74	2	<	<	X
ctmj-57	74	3	0.05	0.05	NUM
ctmj-57	74	4	was	be	AUX
ctmj-57	74	5	considered	consider	VERB
ctmj-57	74	6	statistically	statistically	ADV
ctmj-57	74	7	significant	significant	ADJ
ctmj-57	74	8	.	.	PUNCT
ctmj-57	75	1	results	result	VERB
ctmj-57	75	2	treatment	treatment	NOUN
ctmj-57	75	3	with	with	ADP
ctmj-57	75	4	rmfs	rmfs	NOUN
ctmj-57	75	5	and	and	CCONJ
ctmj-57	75	6	hga	hga	PROPN
ctmj-57	75	7	repairs	repair	NOUN
ctmj-57	75	8	ocular	ocular	ADJ
ctmj-57	75	9	surface	surface	NOUN
ctmj-57	75	10	damage	damage	NOUN
ctmj-57	75	11	in	in	ADP
ctmj-57	75	12	the	the	DET
ctmj-57	75	13	model	model	NOUN
ctmj-57	75	14	group	group	NOUN
ctmj-57	75	15	,	,	PUNCT
ctmj-57	75	16	the	the	DET
ctmj-57	75	17	sit	sit	NOUN
ctmj-57	75	18	value	value	NOUN
ctmj-57	75	19	decreased	decrease	VERB
ctmj-57	75	20	significantly	significantly	ADV
ctmj-57	75	21	with	with	ADP
ctmj-57	75	22	time	time	NOUN
ctmj-57	75	23	compared	compare	VERB
ctmj-57	75	24	to	to	ADP
ctmj-57	75	25	control	control	NOUN
ctmj-57	75	26	group	group	NOUN
ctmj-57	75	27	(	(	PUNCT
ctmj-57	75	28	p	p	X
ctmj-57	75	29	<	<	X
ctmj-57	75	30	0.001	0.001	NUM
ctmj-57	75	31	)	)	PUNCT
ctmj-57	75	32	,	,	PUNCT
ctmj-57	75	33	whereas	whereas	SCONJ
ctmj-57	75	34	treatment	treatment	NOUN
ctmj-57	75	35	with	with	ADP
ctmj-57	75	36	rmfs	rmfs	NOUN
ctmj-57	75	37	or	or	CCONJ
ctmj-57	75	38	hga	hga	PROPN
ctmj-57	75	39	alone	alone	ADV
ctmj-57	75	40	restored	restore	VERB
ctmj-57	75	41	the	the	DET
ctmj-57	75	42	sit	sit	NOUN
ctmj-57	75	43	value	value	NOUN
ctmj-57	75	44	.	.	PUNCT
ctmj-57	76	1	interestingly	interestingly	ADV
ctmj-57	76	2	,	,	PUNCT
ctmj-57	76	3	the	the	DET
ctmj-57	76	4	increase	increase	NOUN
ctmj-57	76	5	in	in	ADP
ctmj-57	76	6	sit	sit	NOUN
ctmj-57	76	7	was	be	AUX
ctmj-57	76	8	more	more	ADV
ctmj-57	76	9	when	when	SCONJ
ctmj-57	76	10	combined	combined	ADJ
ctmj-57	76	11	treatment	treatment	NOUN
ctmj-57	76	12	of	of	ADP
ctmj-57	76	13	rmfs	rmfs	NOUN
ctmj-57	76	14	and	and	CCONJ
ctmj-57	76	15	hga	hga	PROPN
ctmj-57	76	16	was	be	AUX
ctmj-57	76	17	used	use	VERB
ctmj-57	76	18	(	(	PUNCT
ctmj-57	76	19	figure	figure	NOUN
ctmj-57	76	20	1	1	NUM
ctmj-57	76	21	a	a	NOUN
ctmj-57	76	22	)	)	PUNCT
ctmj-57	76	23	.	.	PUNCT
ctmj-57	77	1	furthermore	furthermore	ADV
ctmj-57	77	2	,	,	PUNCT
ctmj-57	77	3	as	as	SCONJ
ctmj-57	77	4	demonstrated	demonstrate	VERB
ctmj-57	77	5	in	in	ADP
ctmj-57	77	6	figure	figure	NOUN
ctmj-57	77	7	1	1	NUM
ctmj-57	77	8	b	b	PROPN
ctmj-57	77	9	,	,	PUNCT
ctmj-57	77	10	the	the	DET
ctmj-57	77	11	but	but	CCONJ
ctmj-57	77	12	of	of	ADP
ctmj-57	77	13	the	the	DET
ctmj-57	77	14	model	model	NOUN
ctmj-57	77	15	group	group	NOUN
ctmj-57	77	16	was	be	AUX
ctmj-57	77	17	significantly	significantly	ADV
ctmj-57	77	18	shorter	short	ADJ
ctmj-57	77	19	than	than	ADP
ctmj-57	77	20	that	that	PRON
ctmj-57	77	21	of	of	ADP
ctmj-57	77	22	control	control	NOUN
ctmj-57	77	23	group	group	NOUN
ctmj-57	77	24	and	and	CCONJ
ctmj-57	77	25	the	the	DET
ctmj-57	77	26	decrease	decrease	NOUN
ctmj-57	77	27	was	be	AUX
ctmj-57	77	28	inversely	inversely	ADV
ctmj-57	77	29	proportional	proportional	ADJ
ctmj-57	77	30	to	to	ADP
ctmj-57	77	31	incubation	incubation	NOUN
ctmj-57	77	32	time	time	NOUN
ctmj-57	77	33	,	,	PUNCT
ctmj-57	77	34	while	while	SCONJ
ctmj-57	77	35	treatment	treatment	NOUN
ctmj-57	77	36	with	with	ADP
ctmj-57	77	37	rmfs	rmfs	NOUN
ctmj-57	77	38	or	or	CCONJ
ctmj-57	77	39	hga	hga	PROPN
ctmj-57	77	40	alone	alone	ADV
ctmj-57	77	41	enhanced	enhance	VERB
ctmj-57	77	42	the	the	DET
ctmj-57	77	43	but	but	CCONJ
ctmj-57	77	44	of	of	ADP
ctmj-57	77	45	the	the	DET
ctmj-57	77	46	model	model	NOUN
ctmj-57	77	47	group	group	NOUN
ctmj-57	77	48	.	.	PUNCT
ctmj-57	78	1	the	the	DET
ctmj-57	78	2	but	but	CCONJ
ctmj-57	78	3	of	of	ADP
ctmj-57	78	4	the	the	DET
ctmj-57	78	5	model	model	NOUN
ctmj-57	78	6	group	group	NOUN
ctmj-57	78	7	treated	treat	VERB
ctmj-57	78	8	with	with	ADP
ctmj-57	78	9	a	a	DET
ctmj-57	78	10	combination	combination	NOUN
ctmj-57	78	11	of	of	ADP
ctmj-57	78	12	rmfs	rmfs	NOUN
ctmj-57	78	13	and	and	CCONJ
ctmj-57	78	14	hga	hga	NOUN
ctmj-57	78	15	was	be	AUX
ctmj-57	78	16	longer	long	ADJ
ctmj-57	78	17	than	than	ADP
ctmj-57	78	18	the	the	DET
ctmj-57	78	19	single	single	ADJ
ctmj-57	78	20	-	-	PUNCT
ctmj-57	78	21	administration	administration	NOUN
ctmj-57	78	22	group	group	NOUN
ctmj-57	78	23	.	.	PUNCT
ctmj-57	79	1	next	next	ADJ
ctmj-57	79	2	,	,	PUNCT
ctmj-57	79	3	pathological	pathological	ADJ
ctmj-57	79	4	sections	section	NOUN
ctmj-57	79	5	of	of	ADP
ctmj-57	79	6	the	the	DET
ctmj-57	79	7	lacrimal	lacrimal	ADJ
ctmj-57	79	8	gland	gland	NOUN
ctmj-57	79	9	tissues	tissue	NOUN
ctmj-57	79	10	were	be	AUX
ctmj-57	79	11	made	make	VERB
ctmj-57	79	12	on	on	ADP
ctmj-57	79	13	each	each	DET
ctmj-57	79	14	group	group	NOUN
ctmj-57	79	15	of	of	ADP
ctmj-57	79	16	animals	animal	NOUN
ctmj-57	79	17	.	.	PUNCT
ctmj-57	80	1	the	the	DET
ctmj-57	80	2	results	result	NOUN
ctmj-57	80	3	showed	show	VERB
ctmj-57	80	4	that	that	SCONJ
ctmj-57	80	5	,	,	PUNCT
ctmj-57	80	6	compared	compare	VERB
ctmj-57	80	7	to	to	ADP
ctmj-57	80	8	control	control	PROPN
ctmj-57	80	9	group	group	NOUN
ctmj-57	80	10	,	,	PUNCT
ctmj-57	80	11	the	the	DET
ctmj-57	80	12	lacrimal	lacrimal	ADJ
ctmj-57	80	13	gland	gland	NOUN
ctmj-57	80	14	structure	structure	NOUN
ctmj-57	80	15	was	be	AUX
ctmj-57	80	16	unclear	unclear	ADJ
ctmj-57	80	17	,	,	PUNCT
ctmj-57	80	18	and	and	CCONJ
ctmj-57	80	19	the	the	DET
ctmj-57	80	20	vesicles	vesicle	NOUN
ctmj-57	80	21	and	and	CCONJ
ctmj-57	80	22	lacrimal	lacrimal	ADJ
ctmj-57	80	23	epithelium	epithelium	NOUN
ctmj-57	80	24	were	be	AUX
ctmj-57	80	25	of	of	ADP
ctmj-57	80	26	different	different	ADJ
ctmj-57	80	27	sizes	size	NOUN
ctmj-57	80	28	and	and	CCONJ
ctmj-57	80	29	disorganized	disorganized	ADJ
ctmj-57	80	30	in	in	ADP
ctmj-57	80	31	the	the	DET
ctmj-57	80	32	model	model	NOUN
ctmj-57	80	33	group	group	NOUN
ctmj-57	80	34	.	.	PUNCT
ctmj-57	81	1	this	this	DET
ctmj-57	81	2	observation	observation	NOUN
ctmj-57	81	3	was	be	AUX
ctmj-57	81	4	better	well	ADV
ctmj-57	81	5	modified	modify	VERB
ctmj-57	81	6	when	when	SCONJ
ctmj-57	81	7	combined	combined	ADJ
ctmj-57	81	8	rmfs	rmfs	NOUN
ctmj-57	81	9	and	and	CCONJ
ctmj-57	81	10	hga	hga	NOUN
ctmj-57	81	11	treatment	treatment	NOUN
ctmj-57	81	12	was	be	AUX
ctmj-57	81	13	used	use	VERB
ctmj-57	81	14	(	(	PUNCT
ctmj-57	81	15	figure	figure	NOUN
ctmj-57	81	16	1	1	NUM
ctmj-57	81	17	c	c	NOUN
ctmj-57	81	18	)	)	PUNCT
ctmj-57	81	19	.	.	PUNCT
ctmj-57	82	1	the	the	DET
ctmj-57	82	2	combination	combination	NOUN
ctmj-57	82	3	of	of	ADP
ctmj-57	82	4	runmufengye	runmufengye	NOUN
ctmj-57	82	5	soup	soup	PROPN
ctmj-57	82	6	and	and	CCONJ
ctmj-57	82	7	hydroxysugar	hydroxysugar	PROPN
ctmj-57	82	8	glycolic	glycolic	NOUN
ctmj-57	82	9	acid	acid	PROPN
ctmj-57	82	10	eye	eye	NOUN
ctmj-57	82	11	drops	drop	NOUN
ctmj-57	82	12	could	could	AUX
ctmj-57	82	13	improve	improve	VERB
ctmj-57	82	14	dry	dry	ADJ
ctmj-57	82	15	eye	eye	NOUN
ctmj-57	82	16	symptoms	symptom	NOUN
ctmj-57	82	17	and	and	CCONJ
ctmj-57	82	18	repair	repair	VERB
ctmj-57	82	19	ocular	ocular	ADJ
ctmj-57	82	20	surface	surface	NOUN
ctmj-57	82	21	damage	damage	NOUN
ctmj-57	82	22	in	in	ADP
ctmj-57	82	23	a	a	DET
ctmj-57	82	24	rabbit	rabbit	NOUN
ctmj-57	82	25	dry	dry	ADJ
ctmj-57	82	26	eye	eye	NOUN
ctmj-57	82	27	model	model	NOUN
ctmj-57	82	28	.	.	PUNCT
ctmj-57	83	1	chinese	chinese	ADJ
ctmj-57	83	2	traditional	traditional	ADJ
ctmj-57	83	3	medicine	medicine	NOUN
ctmj-57	83	4	journal	journal	NOUN
ctmj-57	83	5	|	|	ADV
ctmj-57	83	6	2020	2020	NUM
ctmj-57	84	1	|	|	ADV
ctmj-57	84	2	vol	vol	NOUN
ctmj-57	84	3	3	3	NUM
ctmj-57	84	4	|	|	ADV
ctmj-57	84	5	issue	issue	VERB
ctmj-57	84	6	6	6	NUM
ctmj-57	84	7	issn	issn	NOUN
ctmj-57	84	8	:	:	PUNCT
ctmj-57	84	9	2693	2693	NUM
ctmj-57	84	10	6356	6356	NUM
ctmj-57	84	11	2020	2020	NUM
ctmj-57	84	12	|	|	ADV
ctmj-57	84	13	vol	vol	NOUN
ctmj-57	84	14	3	3	NUM
ctmj-57	85	1	|	|	ADV
ctmj-57	85	2	issue	issue	VERB
ctmj-57	85	3	6	6	NUM
ctmj-57	85	4	ctmj	ctmj	NOUN
ctmj-57	85	5	|	|	ADV
ctmj-57	85	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	85	7	figure	figure	NOUN
ctmj-57	85	8	1	1	NUM
ctmj-57	85	9	:	:	PUNCT
ctmj-57	85	10	combined	combined	ADJ
ctmj-57	85	11	treatment	treatment	NOUN
ctmj-57	85	12	with	with	ADP
ctmj-57	85	13	rmfs	rmfs	NOUN
ctmj-57	85	14	and	and	CCONJ
ctmj-57	85	15	hga	hga	PROPN
ctmj-57	85	16	repairs	repair	NOUN
ctmj-57	85	17	ocular	ocular	ADJ
ctmj-57	85	18	surface	surface	NOUN
ctmj-57	85	19	damage	damage	NOUN
ctmj-57	85	20	in	in	ADP
ctmj-57	85	21	the	the	DET
ctmj-57	85	22	rabbit	rabbit	NOUN
ctmj-57	85	23	dry	dry	PROPN
ctmj-57	85	24	eye	eye	NOUN
ctmj-57	85	25	model	model	NOUN
ctmj-57	85	26	.	.	PUNCT
ctmj-57	86	1	(	(	PUNCT
ctmj-57	86	2	a	a	X
ctmj-57	86	3	)	)	PUNCT
ctmj-57	86	4	the	the	DET
ctmj-57	86	5	schirmer	schirmer	PROPN
ctmj-57	86	6	’s	’s	PART
ctmj-57	86	7	test	test	NOUN
ctmj-57	86	8	to	to	PART
ctmj-57	86	9	evaluate	evaluate	VERB
ctmj-57	86	10	tear	tear	ADJ
ctmj-57	86	11	secretion	secretion	NOUN
ctmj-57	86	12	in	in	ADP
ctmj-57	86	13	the	the	DET
ctmj-57	86	14	respective	respective	ADJ
ctmj-57	86	15	groups	group	NOUN
ctmj-57	86	16	;	;	PUNCT
ctmj-57	86	17	(	(	PUNCT
ctmj-57	86	18	b	b	X
ctmj-57	86	19	)	)	PUNCT
ctmj-57	86	20	break	break	NOUN
ctmj-57	86	21	-	-	PUNCT
ctmj-57	86	22	up	up	ADP
ctmj-57	86	23	time	time	NOUN
ctmj-57	86	24	(	(	PUNCT
ctmj-57	86	25	but	but	CCONJ
ctmj-57	86	26	)	)	PUNCT
ctmj-57	86	27	and	and	CCONJ
ctmj-57	86	28	(	(	PUNCT
ctmj-57	86	29	c	c	X
ctmj-57	86	30	)	)	PUNCT
ctmj-57	86	31	pathological	pathological	ADJ
ctmj-57	86	32	sections	section	NOUN
ctmj-57	86	33	of	of	ADP
ctmj-57	86	34	the	the	DET
ctmj-57	86	35	lacrimal	lacrimal	ADJ
ctmj-57	86	36	gland	gland	NOUN
ctmj-57	86	37	tissue	tissue	NOUN
ctmj-57	86	38	was	be	AUX
ctmj-57	86	39	performed	perform	VERB
ctmj-57	86	40	by	by	ADP
ctmj-57	86	41	h&e	h&e	PROPN
ctmj-57	86	42	in	in	ADP
ctmj-57	86	43	the	the	DET
ctmj-57	86	44	various	various	ADJ
ctmj-57	86	45	groups	group	NOUN
ctmj-57	86	46	.	.	PUNCT
ctmj-57	87	1	*	*	PUNCT
ctmj-57	87	2	p	p	X
ctmj-57	87	3	<	<	X
ctmj-57	87	4	0.05	0.05	NUM
ctmj-57	87	5	,	,	PUNCT
ctmj-57	87	6	*	*	PUNCT
ctmj-57	87	7	*	*	PUNCT
ctmj-57	87	8	p	p	X
ctmj-57	87	9	<	<	X
ctmj-57	87	10	0.01	0.01	NUM
ctmj-57	87	11	,	,	PUNCT
ctmj-57	87	12	*	*	PUNCT
ctmj-57	87	13	*	*	PUNCT
ctmj-57	87	14	*	*	PUNCT
ctmj-57	88	1	p	p	X
ctmj-57	88	2	<	<	X
ctmj-57	88	3	0.001	0.001	NUM
ctmj-57	88	4	,	,	PUNCT
ctmj-57	88	5	compared	compare	VERB
ctmj-57	88	6	with	with	ADP
ctmj-57	88	7	control	control	NOUN
ctmj-57	88	8	group	group	NOUN
ctmj-57	88	9	;	;	PUNCT
ctmj-57	88	10	#	#	SYM
ctmj-57	88	11	p	p	X
ctmj-57	88	12	<	<	X
ctmj-57	88	13	0.05	0.05	NUM
ctmj-57	88	14	,	,	PUNCT
ctmj-57	88	15	#	#	SYM
ctmj-57	88	16	#	#	SYM
ctmj-57	88	17	p	p	X
ctmj-57	88	18	<	<	X
ctmj-57	88	19	0.01	0.01	NUM
ctmj-57	88	20	,	,	PUNCT
ctmj-57	89	1	#	#	SYM
ctmj-57	89	2	#	#	SYM
ctmj-57	89	3	#	#	SYM
ctmj-57	89	4	p	p	NOUN
ctmj-57	89	5	<	<	X
ctmj-57	89	6	0.001	0.001	NUM
ctmj-57	89	7	,	,	PUNCT
ctmj-57	89	8	vs.	vs.	NOUN
ctmj-57	89	9	model	model	NOUN
ctmj-57	89	10	group	group	NOUN
ctmj-57	89	11	;	;	PUNCT
ctmj-57	89	12	&	&	CCONJ
ctmj-57	89	13	p	p	X
ctmj-57	89	14	<	<	X
ctmj-57	89	15	0.05	0.05	NUM
ctmj-57	89	16	,	,	PUNCT
ctmj-57	89	17	&	&	CCONJ
ctmj-57	89	18	&	&	CCONJ
ctmj-57	89	19	p	p	X
ctmj-57	89	20	<	<	X
ctmj-57	89	21	0.01	0.01	NUM
ctmj-57	89	22	,	,	PUNCT
ctmj-57	89	23	&	&	CCONJ
ctmj-57	89	24	&	&	CCONJ
ctmj-57	89	25	&	&	CCONJ
ctmj-57	89	26	p	p	X
ctmj-57	89	27	<	<	X
ctmj-57	89	28	0.001	0.001	NUM
ctmj-57	89	29	,	,	PUNCT
ctmj-57	89	30	vs.	vs.	X
ctmj-57	89	31	model	model	NOUN
ctmj-57	89	32	+	+	CCONJ
ctmj-57	89	33	rmfs	rmfs	NOUN
ctmj-57	89	34	group	group	NOUN
ctmj-57	89	35	;	;	PUNCT
ctmj-57	89	36	^p	^p	PROPN
ctmj-57	89	37	<	<	X
ctmj-57	89	38	0.05	0.05	NUM
ctmj-57	89	39	,	,	PUNCT
ctmj-57	89	40	^^p	^^p	PUNCT
ctmj-57	89	41	<	<	X
ctmj-57	89	42	0.01	0.01	NUM
ctmj-57	89	43	,	,	PUNCT
ctmj-57	89	44	^^^p	^^^p	PUNCT
ctmj-57	89	45	<	<	X
ctmj-57	89	46	0.001	0.001	NUM
ctmj-57	89	47	vs.	vs.	X
ctmj-57	89	48	model	model	NOUN
ctmj-57	89	49	+	+	X
ctmj-57	89	50	hga	hga	PROPN
ctmj-57	89	51	group	group	NOUN
ctmj-57	89	52	treatment	treatment	NOUN
ctmj-57	89	53	with	with	ADP
ctmj-57	89	54	rmfs	rmfs	NOUN
ctmj-57	89	55	and	and	CCONJ
ctmj-57	89	56	hga	hga	PROPN
ctmj-57	89	57	inhibits	inhibit	VERB
ctmj-57	89	58	cell	cell	NOUN
ctmj-57	89	59	apoptosis	apoptosis	NOUN
ctmj-57	89	60	as	as	SCONJ
ctmj-57	89	61	depicted	depict	VERB
ctmj-57	89	62	in	in	ADP
ctmj-57	89	63	figure	figure	NOUN
ctmj-57	89	64	2	2	NUM
ctmj-57	89	65	a	a	PRON
ctmj-57	89	66	,	,	PUNCT
ctmj-57	89	67	apoptosis	apoptosis	NOUN
ctmj-57	89	68	rate	rate	NOUN
ctmj-57	89	69	in	in	ADP
ctmj-57	89	70	the	the	DET
ctmj-57	89	71	cornea	cornea	NOUN
ctmj-57	89	72	tissues	tissue	NOUN
ctmj-57	89	73	significantly	significantly	ADV
ctmj-57	89	74	increased	increase	VERB
ctmj-57	89	75	in	in	ADP
ctmj-57	89	76	model	model	NOUN
ctmj-57	89	77	group	group	NOUN
ctmj-57	89	78	compared	compare	VERB
ctmj-57	89	79	with	with	ADP
ctmj-57	89	80	control	control	NOUN
ctmj-57	89	81	group	group	NOUN
ctmj-57	89	82	(	(	PUNCT
ctmj-57	89	83	p	p	X
ctmj-57	89	84	<	<	X
ctmj-57	89	85	0.001	0.001	NUM
ctmj-57	89	86	)	)	PUNCT
ctmj-57	89	87	.	.	PUNCT
ctmj-57	90	1	however	however	ADV
ctmj-57	90	2	,	,	PUNCT
ctmj-57	90	3	the	the	DET
ctmj-57	90	4	rate	rate	NOUN
ctmj-57	90	5	of	of	ADP
ctmj-57	90	6	apoptosis	apoptosis	NOUN
ctmj-57	90	7	was	be	AUX
ctmj-57	90	8	found	find	VERB
ctmj-57	90	9	to	to	PART
ctmj-57	90	10	decrease	decrease	VERB
ctmj-57	90	11	significantly	significantly	ADV
ctmj-57	90	12	in	in	ADP
ctmj-57	90	13	both	both	DET
ctmj-57	90	14	treatment	treatment	NOUN
ctmj-57	90	15	groups	group	NOUN
ctmj-57	90	16	with	with	ADP
ctmj-57	90	17	a	a	DET
ctmj-57	90	18	more	more	ADV
ctmj-57	90	19	significant	significant	ADJ
ctmj-57	90	20	reduction	reduction	NOUN
ctmj-57	90	21	observed	observe	VERB
ctmj-57	90	22	in	in	ADP
ctmj-57	90	23	the	the	DET
ctmj-57	90	24	coadministration	coadministration	NOUN
ctmj-57	90	25	group	group	NOUN
ctmj-57	90	26	.	.	PUNCT
ctmj-57	91	1	this	this	DET
ctmj-57	91	2	trend	trend	NOUN
ctmj-57	91	3	was	be	AUX
ctmj-57	91	4	also	also	ADV
ctmj-57	91	5	observed	observe	VERB
ctmj-57	91	6	in	in	ADP
ctmj-57	91	7	the	the	DET
ctmj-57	91	8	regulation	regulation	NOUN
ctmj-57	91	9	of	of	ADP
ctmj-57	91	10	apoptosis	apoptosis	NOUN
ctmj-57	91	11	and	and	CCONJ
ctmj-57	91	12	anti	anti	ADJ
ctmj-57	91	13	-	-	ADJ
ctmj-57	91	14	apoptotic	apoptotic	ADJ
ctmj-57	91	15	proteins	protein	NOUN
ctmj-57	91	16	as	as	SCONJ
ctmj-57	91	17	revealed	reveal	VERB
ctmj-57	91	18	in	in	ADP
ctmj-57	91	19	the	the	DET
ctmj-57	91	20	western	western	ADJ
ctmj-57	91	21	blot	blot	NOUN
ctmj-57	91	22	results	result	NOUN
ctmj-57	91	23	.	.	PUNCT
ctmj-57	92	1	the	the	DET
ctmj-57	92	2	protein	protein	NOUN
ctmj-57	92	3	levels	level	NOUN
ctmj-57	92	4	of	of	ADP
ctmj-57	92	5	bax	bax	PROPN
ctmj-57	92	6	and	and	CCONJ
ctmj-57	92	7	cleaved	cleaved	ADJ
ctmj-57	92	8	caspase3	caspase3	NOUN
ctmj-57	92	9	were	be	AUX
ctmj-57	92	10	significantly	significantly	ADV
ctmj-57	92	11	increased	increase	VERB
ctmj-57	92	12	,	,	PUNCT
ctmj-57	92	13	while	while	SCONJ
ctmj-57	92	14	that	that	PRON
ctmj-57	92	15	of	of	ADP
ctmj-57	92	16	bcl2	bcl2	PROPN
ctmj-57	92	17	was	be	AUX
ctmj-57	92	18	significantly	significantly	ADV
ctmj-57	92	19	decreased	decrease	VERB
ctmj-57	92	20	in	in	ADP
ctmj-57	92	21	the	the	DET
ctmj-57	92	22	model	model	NOUN
ctmj-57	92	23	groups	group	NOUN
ctmj-57	92	24	(	(	PUNCT
ctmj-57	92	25	figure	figure	NOUN
ctmj-57	92	26	2	2	NUM
ctmj-57	92	27	b	b	NOUN
ctmj-57	92	28	)	)	PUNCT
ctmj-57	92	29	.	.	PUNCT
ctmj-57	93	1	interestingly	interestingly	ADV
ctmj-57	93	2	,	,	PUNCT
ctmj-57	93	3	this	this	DET
ctmj-57	93	4	observation	observation	NOUN
ctmj-57	93	5	was	be	AUX
ctmj-57	93	6	significantly	significantly	ADV
ctmj-57	93	7	reversed	reverse	VERB
ctmj-57	93	8	by	by	ADP
ctmj-57	93	9	the	the	DET
ctmj-57	93	10	combination	combination	NOUN
ctmj-57	93	11	of	of	ADP
ctmj-57	93	12	rmfs	rmfs	NOUN
ctmj-57	93	13	and	and	CCONJ
ctmj-57	93	14	hga	hga	PROPN
ctmj-57	93	15	.	.	PUNCT
ctmj-57	94	1	taken	take	VERB
ctmj-57	94	2	together	together	ADV
ctmj-57	94	3	,	,	PUNCT
ctmj-57	94	4	the	the	DET
ctmj-57	94	5	combined	combined	ADJ
ctmj-57	94	6	treatment	treatment	NOUN
ctmj-57	94	7	with	with	ADP
ctmj-57	94	8	rmfs	rmfs	NOUN
ctmj-57	94	9	and	and	CCONJ
ctmj-57	94	10	hga	hga	NOUN
ctmj-57	94	11	inhibited	inhibited	ADJ
ctmj-57	94	12	cell	cell	NOUN
ctmj-57	94	13	apoptosis	apoptosis	NOUN
ctmj-57	94	14	of	of	ADP
ctmj-57	94	15	cornea	cornea	NOUN
ctmj-57	94	16	tissues	tissue	NOUN
ctmj-57	94	17	in	in	ADP
ctmj-57	94	18	rabbit	rabbit	NOUN
ctmj-57	94	19	dry	dry	ADJ
ctmj-57	94	20	eye	eye	NOUN
ctmj-57	94	21	model	model	NOUN
ctmj-57	94	22	.	.	PUNCT
ctmj-57	95	1	treatment	treatment	NOUN
ctmj-57	95	2	with	with	ADP
ctmj-57	95	3	rmfs	rmfs	NOUN
ctmj-57	95	4	and	and	CCONJ
ctmj-57	95	5	hga	hga	PROPN
ctmj-57	95	6	regulates	regulate	VERB
ctmj-57	95	7	th17	th17	PROPN
ctmj-57	95	8	/	/	SYM
ctmj-57	95	9	treg	treg	PROPN
ctmj-57	95	10	related	relate	VERB
ctmj-57	95	11	cytokine	cytokine	NOUN
ctmj-57	95	12	balance	balance	NOUN
ctmj-57	95	13	flow	flow	NOUN
ctmj-57	95	14	cytometry	cytometry	NOUN
ctmj-57	95	15	results	result	NOUN
ctmj-57	95	16	show	show	VERB
ctmj-57	95	17	that	that	SCONJ
ctmj-57	95	18	the	the	DET
ctmj-57	95	19	dry	dry	ADJ
ctmj-57	95	20	eye	eye	NOUN
ctmj-57	95	21	model	model	NOUN
ctmj-57	95	22	group	group	NOUN
ctmj-57	95	23	had	have	VERB
ctmj-57	95	24	a	a	DET
ctmj-57	95	25	significantly	significantly	ADV
ctmj-57	95	26	increased	increase	VERB
ctmj-57	95	27	proportion	proportion	NOUN
ctmj-57	95	28	of	of	ADP
ctmj-57	95	29	th17	th17	NOUN
ctmj-57	95	30	cells	cell	NOUN
ctmj-57	95	31	in	in	ADP
ctmj-57	95	32	the	the	DET
ctmj-57	95	33	lacrimal	lacrimal	ADJ
ctmj-57	95	34	gland	gland	NOUN
ctmj-57	95	35	,	,	PUNCT
ctmj-57	95	36	while	while	SCONJ
ctmj-57	95	37	rmfs	rmf	NOUN
ctmj-57	95	38	combined	combine	VERB
ctmj-57	95	39	with	with	ADP
ctmj-57	95	40	hga	hga	PROPN
ctmj-57	95	41	significantly	significantly	ADV
ctmj-57	95	42	suppressed	suppress	VERB
ctmj-57	95	43	this	this	DET
ctmj-57	95	44	effect	effect	NOUN
ctmj-57	95	45	(	(	PUNCT
ctmj-57	95	46	figure	figure	NOUN
ctmj-57	95	47	3	3	NUM
ctmj-57	95	48	a	a	NOUN
ctmj-57	95	49	)	)	PUNCT
ctmj-57	95	50	.	.	PUNCT
ctmj-57	96	1	the	the	DET
ctmj-57	96	2	proportion	proportion	NOUN
ctmj-57	96	3	of	of	ADP
ctmj-57	96	4	treg	treg	PROPN
ctmj-57	96	5	cells	cell	NOUN
ctmj-57	96	6	in	in	ADP
ctmj-57	96	7	the	the	DET
ctmj-57	96	8	lacrimal	lacrimal	ADJ
ctmj-57	96	9	gland	gland	NOUN
ctmj-57	96	10	was	be	AUX
ctmj-57	96	11	slightly	slightly	ADV
ctmj-57	96	12	increased	increase	VERB
ctmj-57	96	13	in	in	ADP
ctmj-57	96	14	the	the	DET
ctmj-57	96	15	model	model	NOUN
ctmj-57	96	16	group	group	NOUN
ctmj-57	96	17	(	(	PUNCT
ctmj-57	96	18	p	p	X
ctmj-57	96	19	<	<	X
ctmj-57	96	20	0.05	0.05	NUM
ctmj-57	96	21	)	)	PUNCT
ctmj-57	96	22	,	,	PUNCT
ctmj-57	96	23	significantly	significantly	ADV
ctmj-57	96	24	increased	increase	VERB
ctmj-57	96	25	in	in	ADP
ctmj-57	96	26	the	the	DET
ctmj-57	96	27	rmfs	rmfs	NOUN
ctmj-57	96	28	or	or	CCONJ
ctmj-57	96	29	hga	hga	PROPN
ctmj-57	96	30	group	group	NOUN
ctmj-57	96	31	(	(	PUNCT
ctmj-57	96	32	p	p	X
ctmj-57	96	33	<	<	X
ctmj-57	96	34	0.001	0.001	NUM
ctmj-57	96	35	)	)	PUNCT
ctmj-57	96	36	,	,	PUNCT
ctmj-57	96	37	with	with	ADP
ctmj-57	96	38	the	the	DET
ctmj-57	96	39	most	most	ADV
ctmj-57	96	40	significant	significant	ADJ
ctmj-57	96	41	increase	increase	NOUN
ctmj-57	96	42	in	in	ADP
ctmj-57	96	43	treg	treg	PROPN
ctmj-57	96	44	cell	cell	NOUN
ctmj-57	96	45	population	population	NOUN
ctmj-57	96	46	seen	see	VERB
ctmj-57	96	47	in	in	ADP
ctmj-57	96	48	the	the	DET
ctmj-57	96	49	cotreatment	cotreatment	NOUN
ctmj-57	96	50	group	group	NOUN
ctmj-57	96	51	(	(	PUNCT
ctmj-57	96	52	p	p	X
ctmj-57	96	53	<	<	X
ctmj-57	96	54	0.001	0.001	NUM
ctmj-57	96	55	;	;	PUNCT
ctmj-57	96	56	figure	figure	NOUN
ctmj-57	96	57	3	3	NUM
ctmj-57	96	58	b	b	NOUN
ctmj-57	96	59	)	)	PUNCT
ctmj-57	96	60	.	.	PUNCT
ctmj-57	97	1	chinese	chinese	ADJ
ctmj-57	97	2	traditional	traditional	ADJ
ctmj-57	97	3	medicine	medicine	NOUN
ctmj-57	97	4	journal	journal	NOUN
ctmj-57	97	5	|	|	ADV
ctmj-57	97	6	2020	2020	NUM
ctmj-57	98	1	|	|	ADV
ctmj-57	98	2	vol	vol	NOUN
ctmj-57	98	3	3	3	NUM
ctmj-57	98	4	|	|	ADV
ctmj-57	98	5	issue	issue	VERB
ctmj-57	98	6	6	6	NUM
ctmj-57	98	7	issn	issn	NOUN
ctmj-57	98	8	:	:	PUNCT
ctmj-57	98	9	2693	2693	NUM
ctmj-57	98	10	6356	6356	NUM
ctmj-57	98	11	2020	2020	NUM
ctmj-57	98	12	|	|	ADV
ctmj-57	98	13	vol	vol	NOUN
ctmj-57	98	14	3	3	NUM
ctmj-57	99	1	|	|	ADV
ctmj-57	99	2	issue	issue	VERB
ctmj-57	99	3	6	6	NUM
ctmj-57	99	4	ctmj	ctmj	NOUN
ctmj-57	99	5	|	|	ADV
ctmj-57	99	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	PUNCT
ctmj-57	99	7	figure	figure	NOUN
ctmj-57	99	8	2	2	NUM
ctmj-57	99	9	:	:	PUNCT
ctmj-57	99	10	combined	combined	ADJ
ctmj-57	99	11	treatment	treatment	NOUN
ctmj-57	99	12	with	with	ADP
ctmj-57	99	13	rmfs	rmfs	NOUN
ctmj-57	99	14	and	and	CCONJ
ctmj-57	99	15	hga	hga	NOUN
ctmj-57	99	16	inhibited	inhibited	ADJ
ctmj-57	99	17	cell	cell	NOUN
ctmj-57	99	18	apoptosis	apoptosis	NOUN
ctmj-57	99	19	of	of	ADP
ctmj-57	99	20	ocular	ocular	ADJ
ctmj-57	99	21	surface	surface	NOUN
ctmj-57	99	22	in	in	ADP
ctmj-57	99	23	the	the	DET
ctmj-57	99	24	rabbit	rabbit	NOUN
ctmj-57	99	25	dry	dry	PROPN
ctmj-57	99	26	eye	eye	NOUN
ctmj-57	99	27	model	model	NOUN
ctmj-57	99	28	.	.	PUNCT
ctmj-57	100	1	(	(	PUNCT
ctmj-57	100	2	a	a	X
ctmj-57	100	3	)	)	PUNCT
ctmj-57	100	4	cell	cell	NOUN
ctmj-57	100	5	apoptosis	apoptosis	NOUN
ctmj-57	100	6	as	as	SCONJ
ctmj-57	100	7	determined	determine	VERB
ctmj-57	100	8	by	by	ADP
ctmj-57	100	9	flow	flow	NOUN
ctmj-57	100	10	cytometry	cytometry	NOUN
ctmj-57	100	11	and	and	CCONJ
ctmj-57	100	12	(	(	PUNCT
ctmj-57	100	13	b	b	NOUN
ctmj-57	100	14	)	)	PUNCT
ctmj-57	100	15	protein	protein	NOUN
ctmj-57	100	16	levels	level	NOUN
ctmj-57	100	17	of	of	ADP
ctmj-57	100	18	bax	bax	PROPN
ctmj-57	100	19	,	,	PUNCT
ctmj-57	100	20	cleaved	cleaved	ADJ
ctmj-57	100	21	caspase3	caspase3	NOUN
ctmj-57	100	22	and	and	CCONJ
ctmj-57	100	23	bcl2	bcl2	PROPN
ctmj-57	100	24	was	be	AUX
ctmj-57	100	25	measured	measure	VERB
ctmj-57	100	26	by	by	ADP
ctmj-57	100	27	wb	wb	PROPN
ctmj-57	100	28	in	in	ADP
ctmj-57	100	29	the	the	DET
ctmj-57	100	30	model	model	NOUN
ctmj-57	100	31	group	group	NOUN
ctmj-57	100	32	treated	treat	VERB
ctmj-57	100	33	with	with	ADP
ctmj-57	100	34	the	the	DET
ctmj-57	100	35	indicated	indicate	VERB
ctmj-57	100	36	drug	drug	NOUN
ctmj-57	100	37	.	.	PUNCT
ctmj-57	101	1	*	*	PUNCT
ctmj-57	101	2	p	p	X
ctmj-57	101	3	<	<	X
ctmj-57	101	4	0.05	0.05	NUM
ctmj-57	101	5	,	,	PUNCT
ctmj-57	101	6	*	*	PUNCT
ctmj-57	101	7	*	*	PUNCT
ctmj-57	101	8	p	p	X
ctmj-57	101	9	<	<	X
ctmj-57	101	10	0.01	0.01	NUM
ctmj-57	101	11	,	,	PUNCT
ctmj-57	101	12	*	*	PUNCT
ctmj-57	101	13	*	*	PUNCT
ctmj-57	101	14	*	*	PUNCT
ctmj-57	101	15	p	p	X
ctmj-57	101	16	<	<	X
ctmj-57	101	17	0.001	0.001	NUM
ctmj-57	101	18	,	,	PUNCT
ctmj-57	101	19	vs.	vs.	X
ctmj-57	101	20	control	control	NOUN
ctmj-57	101	21	group	group	NOUN
ctmj-57	101	22	;	;	PUNCT
ctmj-57	101	23	#	#	NOUN
ctmj-57	101	24	p	p	X
ctmj-57	101	25	<	<	X
ctmj-57	101	26	0.05	0.05	NUM
ctmj-57	101	27	,	,	PUNCT
ctmj-57	101	28	#	#	SYM
ctmj-57	101	29	#	#	NOUN
ctmj-57	101	30	p	p	X
ctmj-57	101	31	<	<	X
ctmj-57	101	32	0.01	0.01	NUM
ctmj-57	101	33	,	,	PUNCT
ctmj-57	101	34	#	#	SYM
ctmj-57	101	35	#	#	SYM
ctmj-57	101	36	#	#	NOUN
ctmj-57	101	37	p	p	NOUN
ctmj-57	101	38	<	<	X
ctmj-57	101	39	0.001	0.001	NUM
ctmj-57	101	40	,	,	PUNCT
ctmj-57	101	41	vs.	vs.	NOUN
ctmj-57	101	42	model	model	NOUN
ctmj-57	101	43	group	group	NOUN
ctmj-57	101	44	;	;	PUNCT
ctmj-57	101	45	&	&	CCONJ
ctmj-57	101	46	p	p	X
ctmj-57	101	47	<	<	X
ctmj-57	101	48	0.05	0.05	NUM
ctmj-57	101	49	,	,	PUNCT
ctmj-57	101	50	&	&	CCONJ
ctmj-57	101	51	&	&	CCONJ
ctmj-57	101	52	p	p	X
ctmj-57	101	53	<	<	X
ctmj-57	101	54	0.01	0.01	NUM
ctmj-57	101	55	,	,	PUNCT
ctmj-57	101	56	&	&	CCONJ
ctmj-57	101	57	&	&	CCONJ
ctmj-57	101	58	&	&	CCONJ
ctmj-57	101	59	p	p	X
ctmj-57	101	60	<	<	X
ctmj-57	101	61	0.001	0.001	NUM
ctmj-57	101	62	,	,	PUNCT
ctmj-57	101	63	vs.	vs.	X
ctmj-57	101	64	model	model	NOUN
ctmj-57	101	65	+	+	CCONJ
ctmj-57	101	66	rmfs	rmfs	NOUN
ctmj-57	101	67	group	group	NOUN
ctmj-57	101	68	;	;	PUNCT
ctmj-57	101	69	^p	^p	PROPN
ctmj-57	101	70	<	<	X
ctmj-57	101	71	0.05	0.05	NUM
ctmj-57	101	72	,	,	PUNCT
ctmj-57	101	73	^^p	^^p	PUNCT
ctmj-57	101	74	<	<	X
ctmj-57	101	75	0.01	0.01	NUM
ctmj-57	101	76	,	,	PUNCT
ctmj-57	101	77	^^^p	^^^p	PUNCT
ctmj-57	101	78	<	<	NOUN
ctmj-57	101	79	0.001	0.001	NUM
ctmj-57	101	80	,	,	PUNCT
ctmj-57	101	81	vs.	vs.	NOUN
ctmj-57	101	82	model	model	NOUN
ctmj-57	101	83	+	+	CCONJ
ctmj-57	101	84	hga	hga	PROPN
ctmj-57	101	85	group	group	NOUN
ctmj-57	101	86	th17	th17	PROPN
ctmj-57	101	87	and	and	CCONJ
ctmj-57	101	88	foxp3	foxp3	PROPN
ctmj-57	101	89	,	,	PUNCT
ctmj-57	101	90	the	the	DET
ctmj-57	101	91	transcription	transcription	NOUN
ctmj-57	101	92	factor	factor	NOUN
ctmj-57	101	93	associated	associate	VERB
ctmj-57	101	94	with	with	ADP
ctmj-57	101	95	treg	treg	PROPN
ctmj-57	101	96	,	,	PUNCT
ctmj-57	101	97	were	be	AUX
ctmj-57	101	98	upregulated	upregulate	VERB
ctmj-57	101	99	in	in	ADP
ctmj-57	101	100	the	the	DET
ctmj-57	101	101	model	model	NOUN
ctmj-57	101	102	group	group	NOUN
ctmj-57	101	103	compared	compare	VERB
ctmj-57	101	104	to	to	ADP
ctmj-57	101	105	control	control	PROPN
ctmj-57	101	106	group	group	NOUN
ctmj-57	101	107	,	,	PUNCT
ctmj-57	101	108	while	while	SCONJ
ctmj-57	101	109	the	the	DET
ctmj-57	101	110	combination	combination	NOUN
ctmj-57	101	111	of	of	ADP
ctmj-57	101	112	rmfs	rmfs	NOUN
ctmj-57	101	113	and	and	CCONJ
ctmj-57	101	114	hga	hga	NOUN
ctmj-57	101	115	significantly	significantly	ADV
ctmj-57	101	116	inhibited	inhibit	VERB
ctmj-57	101	117	rorγt	rorγt	NOUN
ctmj-57	101	118	expression	expression	NOUN
ctmj-57	101	119	but	but	CCONJ
ctmj-57	101	120	caused	cause	VERB
ctmj-57	101	121	a	a	DET
ctmj-57	101	122	further	further	ADJ
ctmj-57	101	123	increase	increase	NOUN
ctmj-57	101	124	in	in	ADP
ctmj-57	101	125	foxp3	foxp3	NOUN
ctmj-57	101	126	expression	expression	NOUN
ctmj-57	101	127	(	(	PUNCT
ctmj-57	101	128	p	p	X
ctmj-57	101	129	<	<	X
ctmj-57	101	130	0.001	0.001	NUM
ctmj-57	101	131	;	;	PUNCT
ctmj-57	101	132	figure	figure	NOUN
ctmj-57	101	133	3	3	NUM
ctmj-57	101	134	c	c	NOUN
ctmj-57	101	135	)	)	PUNCT
ctmj-57	101	136	.	.	PUNCT
ctmj-57	102	1	treatment	treatment	NOUN
ctmj-57	102	2	with	with	ADP
ctmj-57	102	3	rmfs	rmfs	NOUN
ctmj-57	102	4	and	and	CCONJ
ctmj-57	102	5	hga	hga	PROPN
ctmj-57	102	6	inhibited	inhibit	VERB
ctmj-57	102	7	the	the	DET
ctmj-57	102	8	jak2	jak2	PROPN
ctmj-57	102	9	/	/	SYM
ctmj-57	102	10	stat3	stat3	NOUN
ctmj-57	102	11	pathway	pathway	NOUN
ctmj-57	102	12	as	as	SCONJ
ctmj-57	102	13	depicted	depict	VERB
ctmj-57	102	14	in	in	ADP
ctmj-57	102	15	figure	figure	NOUN
ctmj-57	102	16	4	4	NUM
ctmj-57	102	17	,	,	PUNCT
ctmj-57	102	18	the	the	DET
ctmj-57	102	19	protein	protein	NOUN
ctmj-57	102	20	levels	level	NOUN
ctmj-57	102	21	of	of	ADP
ctmj-57	102	22	p	p	PROPN
ctmj-57	102	23	-	-	PUNCT
ctmj-57	102	24	jak2	jak2	NOUN
ctmj-57	102	25	and	and	CCONJ
ctmj-57	102	26	p	p	X
ctmj-57	102	27	-	-	PUNCT
ctmj-57	102	28	stat3	stat3	NOUN
ctmj-57	102	29	were	be	AUX
ctmj-57	102	30	upregulated	upregulate	VERB
ctmj-57	102	31	in	in	ADP
ctmj-57	102	32	the	the	DET
ctmj-57	102	33	model	model	NOUN
ctmj-57	102	34	group	group	NOUN
ctmj-57	102	35	,	,	PUNCT
ctmj-57	102	36	while	while	SCONJ
ctmj-57	102	37	the	the	DET
ctmj-57	102	38	combination	combination	NOUN
ctmj-57	102	39	of	of	ADP
ctmj-57	102	40	rmfs	rmfs	NOUN
ctmj-57	102	41	and	and	CCONJ
ctmj-57	102	42	hga	hga	PROPN
ctmj-57	102	43	treatment	treatment	NOUN
ctmj-57	102	44	decreased	decrease	VERB
ctmj-57	102	45	the	the	DET
ctmj-57	102	46	protein	protein	NOUN
ctmj-57	102	47	levels	level	NOUN
ctmj-57	102	48	of	of	ADP
ctmj-57	102	49	p	p	PROPN
ctmj-57	102	50	-	-	PUNCT
ctmj-57	102	51	jak2	jak2	NOUN
ctmj-57	102	52	as	as	ADV
ctmj-57	102	53	well	well	ADV
ctmj-57	102	54	as	as	ADP
ctmj-57	102	55	pstat3	pstat3	NOUN
ctmj-57	102	56	(	(	PUNCT
ctmj-57	102	57	p	p	X
ctmj-57	102	58	<	<	X
ctmj-57	102	59	0.001	0.001	NUM
ctmj-57	102	60	)	)	PUNCT
ctmj-57	102	61	.	.	PUNCT
ctmj-57	103	1	taken	take	VERB
ctmj-57	103	2	together	together	ADV
ctmj-57	103	3	,	,	PUNCT
ctmj-57	103	4	the	the	DET
ctmj-57	103	5	combination	combination	NOUN
ctmj-57	103	6	of	of	ADP
ctmj-57	103	7	runmufengye	runmufengye	NOUN
ctmj-57	103	8	soup	soup	PROPN
ctmj-57	103	9	and	and	CCONJ
ctmj-57	103	10	hydroxysugar	hydroxysugar	PROPN
ctmj-57	103	11	glycolic	glycolic	NOUN
ctmj-57	103	12	acid	acid	PROPN
ctmj-57	103	13	eye	eye	NOUN
ctmj-57	103	14	drops	drop	NOUN
ctmj-57	103	15	inhibited	inhibit	VERB
ctmj-57	103	16	the	the	DET
ctmj-57	103	17	jak2	jak2	PROPN
ctmj-57	103	18	/	/	SYM
ctmj-57	103	19	stat3	stat3	NOUN
ctmj-57	103	20	pathway	pathway	NOUN
ctmj-57	103	21	.	.	PUNCT
ctmj-57	104	1	discussion	discussion	NOUN
ctmj-57	104	2	dry	dry	ADJ
ctmj-57	104	3	eye	eye	NOUN
ctmj-57	104	4	disease	disease	NOUN
ctmj-57	104	5	is	be	AUX
ctmj-57	104	6	a	a	DET
ctmj-57	104	7	multifactorial	multifactorial	ADJ
ctmj-57	104	8	ocular	ocular	ADJ
ctmj-57	104	9	surface	surface	NOUN
ctmj-57	104	10	disease	disease	NOUN
ctmj-57	104	11	characterized	characterize	VERB
ctmj-57	104	12	by	by	ADP
ctmj-57	104	13	tear	tear	ADJ
ctmj-57	104	14	film	film	NOUN
ctmj-57	104	15	homeostasis	homeostasis	NOUN
ctmj-57	104	16	,	,	PUNCT
ctmj-57	104	17	ocular	ocular	ADJ
ctmj-57	104	18	surface	surface	NOUN
ctmj-57	104	19	inflammatory	inflammatory	ADJ
ctmj-57	104	20	response	response	NOUN
ctmj-57	104	21	and	and	CCONJ
ctmj-57	104	22	damage	damage	NOUN
ctmj-57	104	23	and	and	CCONJ
ctmj-57	104	24	ocular	ocular	ADJ
ctmj-57	104	25	discomfort	discomfort	NOUN
ctmj-57	104	26	.	.	PUNCT
ctmj-57	105	1	it	it	PRON
ctmj-57	105	2	is	be	AUX
ctmj-57	105	3	highly	highly	ADV
ctmj-57	105	4	prevalent	prevalent	ADJ
ctmj-57	105	5	and	and	CCONJ
ctmj-57	105	6	with	with	ADP
ctmj-57	105	7	symptoms	symptom	NOUN
ctmj-57	105	8	such	such	ADJ
ctmj-57	105	9	as	as	ADP
ctmj-57	105	10	foreign	foreign	ADJ
ctmj-57	105	11	body	body	NOUN
ctmj-57	105	12	sensation	sensation	NOUN
ctmj-57	105	13	,	,	PUNCT
ctmj-57	105	14	burning	burn	VERB
ctmj-57	105	15	and	and	CCONJ
ctmj-57	105	16	stinging	sting	VERB
ctmj-57	105	17	,	,	PUNCT
ctmj-57	105	18	seriously	seriously	ADV
ctmj-57	105	19	affect	affect	VERB
ctmj-57	105	20	an	an	DET
ctmj-57	105	21	individual	individual	NOUN
ctmj-57	105	22	's	's	PART
ctmj-57	105	23	quality	quality	NOUN
ctmj-57	105	24	of	of	ADP
ctmj-57	105	25	life	life	NOUN
ctmj-57	105	26	and	and	CCONJ
ctmj-57	105	27	may	may	AUX
ctmj-57	105	28	lead	lead	VERB
ctmj-57	105	29	to	to	ADP
ctmj-57	105	30	loss	loss	NOUN
ctmj-57	105	31	of	of	ADP
ctmj-57	105	32	vision	vision	NOUN
ctmj-57	105	33	or	or	CCONJ
ctmj-57	105	34	blindness	blindness	NOUN
ctmj-57	105	35	if	if	SCONJ
ctmj-57	105	36	not	not	PART
ctmj-57	105	37	treated	treat	VERB
ctmj-57	105	38	promptly	promptly	ADV
ctmj-57	105	39	and	and	CCONJ
ctmj-57	105	40	appropriately	appropriately	ADV
ctmj-57	105	41	[	[	X
ctmj-57	105	42	1	1	NUM
ctmj-57	105	43	]	]	PUNCT
ctmj-57	105	44	.	.	PUNCT
ctmj-57	106	1	however	however	ADV
ctmj-57	106	2	,	,	PUNCT
ctmj-57	106	3	the	the	DET
ctmj-57	106	4	clinical	clinical	ADJ
ctmj-57	106	5	therapy	therapy	NOUN
ctmj-57	106	6	of	of	ADP
ctmj-57	106	7	ded	ded	PROPN
ctmj-57	106	8	is	be	AUX
ctmj-57	106	9	difficult	difficult	ADJ
ctmj-57	106	10	and	and	CCONJ
ctmj-57	106	11	effective	effective	ADJ
ctmj-57	106	12	treatments	treatment	NOUN
ctmj-57	106	13	are	be	AUX
ctmj-57	106	14	still	still	ADV
ctmj-57	106	15	lacking	lack	VERB
ctmj-57	106	16	.	.	PUNCT
ctmj-57	107	1	chinese	chinese	ADJ
ctmj-57	107	2	traditional	traditional	ADJ
ctmj-57	107	3	medicine	medicine	NOUN
ctmj-57	107	4	journal	journal	NOUN
ctmj-57	107	5	|	|	ADV
ctmj-57	107	6	2020	2020	NUM
ctmj-57	108	1	|	|	ADV
ctmj-57	108	2	vol	vol	NOUN
ctmj-57	108	3	3	3	NUM
ctmj-57	108	4	|	|	ADV
ctmj-57	108	5	issue	issue	VERB
ctmj-57	108	6	6	6	NUM
ctmj-57	108	7	issn	issn	NOUN
ctmj-57	108	8	:	:	PUNCT
ctmj-57	108	9	2693	2693	NUM
ctmj-57	108	10	6356	6356	NUM
ctmj-57	108	11	2020	2020	NUM
ctmj-57	108	12	|	|	ADV
ctmj-57	108	13	vol	vol	NOUN
ctmj-57	108	14	3	3	NUM
ctmj-57	109	1	|	|	ADV
ctmj-57	109	2	issue	issue	VERB
ctmj-57	109	3	6	6	NUM
ctmj-57	109	4	ctmj	ctmj	NOUN
ctmj-57	109	5	|	|	ADV
ctmj-57	109	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	109	7	figure	figure	NOUN
ctmj-57	109	8	3	3	NUM
ctmj-57	109	9	:	:	PUNCT
ctmj-57	109	10	combined	combined	ADJ
ctmj-57	109	11	treatment	treatment	NOUN
ctmj-57	109	12	with	with	ADP
ctmj-57	109	13	rmfs	rmfs	NOUN
ctmj-57	109	14	and	and	CCONJ
ctmj-57	109	15	hga	hga	PROPN
ctmj-57	109	16	regulates	regulate	VERB
ctmj-57	109	17	th17	th17	PROPN
ctmj-57	109	18	/	/	SYM
ctmj-57	109	19	treg	treg	PROPN
ctmj-57	109	20	related	relate	VERB
ctmj-57	109	21	cytokine	cytokine	NOUN
ctmj-57	109	22	balance	balance	NOUN
ctmj-57	109	23	in	in	ADP
ctmj-57	109	24	the	the	DET
ctmj-57	109	25	rabbit	rabbit	NOUN
ctmj-57	109	26	dry	dry	PROPN
ctmj-57	109	27	eye	eye	NOUN
ctmj-57	109	28	model	model	NOUN
ctmj-57	109	29	.	.	PUNCT
ctmj-57	110	1	the	the	DET
ctmj-57	110	2	proportion	proportion	NOUN
ctmj-57	110	3	of	of	ADP
ctmj-57	110	4	(	(	PUNCT
ctmj-57	110	5	a	a	NOUN
ctmj-57	110	6	)	)	PUNCT
ctmj-57	110	7	th17	th17	PROPN
ctmj-57	110	8	and	and	CCONJ
ctmj-57	110	9	(	(	PUNCT
ctmj-57	110	10	b	b	NOUN
ctmj-57	110	11	)	)	PUNCT
ctmj-57	110	12	treg	treg	PROPN
ctmj-57	110	13	cells	cell	NOUN
ctmj-57	110	14	in	in	ADP
ctmj-57	110	15	lacrimal	lacrimal	ADJ
ctmj-57	110	16	gland	gland	NOUN
ctmj-57	110	17	tissues	tissue	NOUN
ctmj-57	110	18	of	of	ADP
ctmj-57	110	19	the	the	DET
ctmj-57	110	20	model	model	NOUN
ctmj-57	110	21	group	group	NOUN
ctmj-57	110	22	treated	treat	VERB
ctmj-57	110	23	with	with	ADP
ctmj-57	110	24	rmfs	rmfs	NOUN
ctmj-57	110	25	and	and	CCONJ
ctmj-57	110	26	hga	hga	NOUN
ctmj-57	110	27	alone	alone	ADV
ctmj-57	110	28	or	or	CCONJ
ctmj-57	110	29	combined	combine	VERB
ctmj-57	110	30	was	be	AUX
ctmj-57	110	31	measured	measure	VERB
ctmj-57	110	32	by	by	ADP
ctmj-57	110	33	flow	flow	NOUN
ctmj-57	110	34	cytometry	cytometry	NOUN
ctmj-57	110	35	(	(	PUNCT
ctmj-57	110	36	c	c	X
ctmj-57	110	37	)	)	PUNCT
ctmj-57	110	38	the	the	DET
ctmj-57	110	39	protein	protein	NOUN
ctmj-57	110	40	level	level	NOUN
ctmj-57	110	41	of	of	ADP
ctmj-57	110	42	rorγt	rorγt	NOUN
ctmj-57	110	43	and	and	CCONJ
ctmj-57	110	44	foxp3	foxp3	NOUN
ctmj-57	110	45	was	be	AUX
ctmj-57	110	46	measured	measure	VERB
ctmj-57	110	47	by	by	ADP
ctmj-57	110	48	western	western	ADJ
ctmj-57	110	49	blotting	blotting	NOUN
ctmj-57	110	50	.	.	PUNCT
ctmj-57	111	1	*	*	PUNCT
ctmj-57	111	2	p	p	X
ctmj-57	111	3	<	<	X
ctmj-57	111	4	0.05	0.05	NUM
ctmj-57	111	5	,	,	PUNCT
ctmj-57	111	6	*	*	PUNCT
ctmj-57	111	7	*	*	PUNCT
ctmj-57	111	8	p	p	X
ctmj-57	111	9	<	<	X
ctmj-57	111	10	0.01	0.01	NUM
ctmj-57	111	11	,	,	PUNCT
ctmj-57	111	12	*	*	PUNCT
ctmj-57	111	13	*	*	PUNCT
ctmj-57	111	14	*	*	PUNCT
ctmj-57	111	15	p	p	X
ctmj-57	111	16	<	<	X
ctmj-57	111	17	0.001	0.001	NUM
ctmj-57	111	18	,	,	PUNCT
ctmj-57	111	19	vs.	vs.	X
ctmj-57	111	20	control	control	NOUN
ctmj-57	111	21	group	group	NOUN
ctmj-57	111	22	;	;	PUNCT
ctmj-57	111	23	#	#	SYM
ctmj-57	111	24	p	p	X
ctmj-57	111	25	<	<	X
ctmj-57	111	26	0.05	0.05	NUM
ctmj-57	111	27	,	,	PUNCT
ctmj-57	111	28	#	#	SYM
ctmj-57	111	29	#	#	SYM
ctmj-57	111	30	p	p	X
ctmj-57	111	31	<	<	X
ctmj-57	111	32	0.01	0.01	NUM
ctmj-57	111	33	,	,	PUNCT
ctmj-57	112	1	#	#	SYM
ctmj-57	112	2	#	#	SYM
ctmj-57	112	3	#	#	SYM
ctmj-57	112	4	p	p	NOUN
ctmj-57	112	5	<	<	X
ctmj-57	112	6	0.001	0.001	NUM
ctmj-57	112	7	,	,	PUNCT
ctmj-57	112	8	vs.	vs.	NOUN
ctmj-57	112	9	model	model	NOUN
ctmj-57	112	10	group	group	NOUN
ctmj-57	112	11	;	;	PUNCT
ctmj-57	112	12	&	&	CCONJ
ctmj-57	112	13	p	p	X
ctmj-57	112	14	<	<	X
ctmj-57	112	15	0.05	0.05	NUM
ctmj-57	112	16	,	,	PUNCT
ctmj-57	112	17	&	&	CCONJ
ctmj-57	112	18	&	&	CCONJ
ctmj-57	112	19	p	p	X
ctmj-57	112	20	<	<	X
ctmj-57	112	21	0.01	0.01	NUM
ctmj-57	112	22	,	,	PUNCT
ctmj-57	112	23	&	&	CCONJ
ctmj-57	112	24	&	&	CCONJ
ctmj-57	112	25	&	&	CCONJ
ctmj-57	112	26	p	p	X
ctmj-57	112	27	<	<	X
ctmj-57	112	28	0.001	0.001	NUM
ctmj-57	112	29	,	,	PUNCT
ctmj-57	112	30	vs.	vs.	X
ctmj-57	112	31	model	model	NOUN
ctmj-57	112	32	+	+	CCONJ
ctmj-57	112	33	rmfs	rmfs	NOUN
ctmj-57	112	34	group	group	NOUN
ctmj-57	112	35	;	;	PUNCT
ctmj-57	112	36	^p	^p	PROPN
ctmj-57	112	37	<	<	X
ctmj-57	112	38	0.05	0.05	NUM
ctmj-57	112	39	,	,	PUNCT
ctmj-57	112	40	^^p	^^p	PUNCT
ctmj-57	112	41	<	<	X
ctmj-57	112	42	0.01	0.01	NUM
ctmj-57	112	43	,	,	PUNCT
ctmj-57	112	44	^^^p	^^^p	PUNCT
ctmj-57	112	45	<	<	NOUN
ctmj-57	112	46	0.001	0.001	NUM
ctmj-57	112	47	,	,	PUNCT
ctmj-57	112	48	vs.	vs.	NOUN
ctmj-57	112	49	model	model	NOUN
ctmj-57	112	50	+	+	CCONJ
ctmj-57	112	51	hga	hga	PROPN
ctmj-57	112	52	group	group	NOUN
ctmj-57	112	53	figure	figure	NOUN
ctmj-57	112	54	4	4	NUM
ctmj-57	112	55	:	:	PUNCT
ctmj-57	112	56	combined	combined	ADJ
ctmj-57	112	57	treatment	treatment	NOUN
ctmj-57	112	58	with	with	ADP
ctmj-57	112	59	rmfs	rmfs	NOUN
ctmj-57	112	60	and	and	CCONJ
ctmj-57	112	61	hga	hga	PROPN
ctmj-57	112	62	inhibited	inhibit	VERB
ctmj-57	112	63	the	the	DET
ctmj-57	112	64	jak2	jak2	PROPN
ctmj-57	112	65	/	/	SYM
ctmj-57	112	66	stat3	stat3	NOUN
ctmj-57	112	67	pathway	pathway	NOUN
ctmj-57	112	68	.	.	PUNCT
ctmj-57	113	1	the	the	DET
ctmj-57	113	2	protein	protein	NOUN
ctmj-57	113	3	levels	level	NOUN
ctmj-57	113	4	of	of	ADP
ctmj-57	113	5	p	p	PROPN
ctmj-57	113	6	-	-	PUNCT
ctmj-57	113	7	jak2	jak2	NOUN
ctmj-57	113	8	,	,	PUNCT
ctmj-57	113	9	jak2	jak2	PROPN
ctmj-57	113	10	,	,	PUNCT
ctmj-57	113	11	p	p	ADJ
ctmj-57	113	12	-	-	PUNCT
ctmj-57	113	13	stat3	stat3	NOUN
ctmj-57	113	14	and	and	CCONJ
ctmj-57	113	15	stat3	stat3	NOUN
ctmj-57	113	16	in	in	ADP
ctmj-57	113	17	the	the	DET
ctmj-57	113	18	various	various	ADJ
ctmj-57	113	19	groups	group	NOUN
ctmj-57	113	20	as	as	SCONJ
ctmj-57	113	21	shown	show	VERB
ctmj-57	113	22	by	by	ADP
ctmj-57	113	23	western	western	ADJ
ctmj-57	113	24	blot	blot	NOUN
ctmj-57	113	25	.	.	PUNCT
ctmj-57	114	1	*	*	PUNCT
ctmj-57	114	2	p	p	X
ctmj-57	114	3	<	<	X
ctmj-57	114	4	0.05	0.05	NUM
ctmj-57	114	5	,	,	PUNCT
ctmj-57	114	6	*	*	PUNCT
ctmj-57	114	7	*	*	PUNCT
ctmj-57	114	8	p	p	X
ctmj-57	114	9	<	<	X
ctmj-57	114	10	0.01	0.01	NUM
ctmj-57	114	11	,	,	PUNCT
ctmj-57	114	12	*	*	PUNCT
ctmj-57	114	13	*	*	PUNCT
ctmj-57	114	14	*	*	PUNCT
ctmj-57	114	15	p	p	X
ctmj-57	114	16	<	<	X
ctmj-57	114	17	0.001	0.001	NUM
ctmj-57	114	18	,	,	PUNCT
ctmj-57	114	19	vs.	vs.	X
ctmj-57	114	20	control	control	NOUN
ctmj-57	114	21	group	group	NOUN
ctmj-57	114	22	;	;	PUNCT
ctmj-57	114	23	#	#	SYM
ctmj-57	114	24	p	p	X
ctmj-57	114	25	<	<	X
ctmj-57	114	26	0.05	0.05	NUM
ctmj-57	114	27	,	,	PUNCT
ctmj-57	114	28	#	#	SYM
ctmj-57	114	29	#	#	SYM
ctmj-57	114	30	p	p	X
ctmj-57	114	31	<	<	X
ctmj-57	114	32	0.01	0.01	NUM
ctmj-57	114	33	,	,	PUNCT
ctmj-57	115	1	#	#	SYM
ctmj-57	115	2	#	#	SYM
ctmj-57	115	3	#	#	SYM
ctmj-57	115	4	p	p	NOUN
ctmj-57	115	5	<	<	X
ctmj-57	115	6	0.001	0.001	NUM
ctmj-57	115	7	,	,	PUNCT
ctmj-57	115	8	vs.	vs.	NOUN
ctmj-57	115	9	model	model	NOUN
ctmj-57	115	10	group	group	NOUN
ctmj-57	115	11	;	;	PUNCT
ctmj-57	115	12	&	&	CCONJ
ctmj-57	115	13	p	p	X
ctmj-57	115	14	<	<	X
ctmj-57	115	15	0.05	0.05	NUM
ctmj-57	115	16	,	,	PUNCT
ctmj-57	115	17	&	&	CCONJ
ctmj-57	115	18	&	&	CCONJ
ctmj-57	115	19	p	p	X
ctmj-57	115	20	<	<	X
ctmj-57	115	21	0.01	0.01	NUM
ctmj-57	115	22	,	,	PUNCT
ctmj-57	115	23	&	&	CCONJ
ctmj-57	115	24	&	&	CCONJ
ctmj-57	115	25	&	&	CCONJ
ctmj-57	115	26	p	p	X
ctmj-57	115	27	<	<	X
ctmj-57	115	28	0.001	0.001	NUM
ctmj-57	115	29	,	,	PUNCT
ctmj-57	115	30	vs.	vs.	X
ctmj-57	115	31	model	model	NOUN
ctmj-57	115	32	+	+	CCONJ
ctmj-57	115	33	rmfs	rmfs	NOUN
ctmj-57	115	34	group	group	NOUN
ctmj-57	115	35	;	;	PUNCT
ctmj-57	115	36	^p	^p	PROPN
ctmj-57	115	37	<	<	X
ctmj-57	115	38	0.05	0.05	NUM
ctmj-57	115	39	,	,	PUNCT
ctmj-57	115	40	^^p	^^p	PUNCT
ctmj-57	115	41	<	<	X
ctmj-57	115	42	0.01	0.01	NUM
ctmj-57	115	43	,	,	PUNCT
ctmj-57	115	44	^^^p	^^^p	PUNCT
ctmj-57	115	45	<	<	NOUN
ctmj-57	115	46	0.001	0.001	NUM
ctmj-57	115	47	,	,	PUNCT
ctmj-57	115	48	vs.	vs.	NOUN
ctmj-57	115	49	model	model	NOUN
ctmj-57	115	50	+	+	CCONJ
ctmj-57	115	51	hga	hga	PROPN
ctmj-57	115	52	group	group	NOUN
ctmj-57	115	53	recently	recently	ADV
ctmj-57	115	54	,	,	PUNCT
ctmj-57	115	55	chinese	chinese	ADJ
ctmj-57	115	56	medicine	medicine	NOUN
ctmj-57	115	57	has	have	AUX
ctmj-57	115	58	also	also	ADV
ctmj-57	115	59	played	play	VERB
ctmj-57	115	60	an	an	DET
ctmj-57	115	61	important	important	ADJ
ctmj-57	115	62	role	role	NOUN
ctmj-57	115	63	in	in	ADP
ctmj-57	115	64	the	the	DET
ctmj-57	115	65	treatment	treatment	NOUN
ctmj-57	115	66	of	of	ADP
ctmj-57	115	67	dry	dry	ADJ
ctmj-57	115	68	eye	eye	NOUN
ctmj-57	115	69	disease	disease	NOUN
ctmj-57	115	70	.	.	PUNCT
ctmj-57	116	1	for	for	ADP
ctmj-57	116	2	example	example	NOUN
ctmj-57	116	3	,	,	PUNCT
ctmj-57	116	4	astragaloside	astragaloside	ADJ
ctmj-57	116	5	iv	iv	PROPN
ctmj-57	116	6	is	be	AUX
ctmj-57	116	7	a	a	DET
ctmj-57	116	8	single	single	ADJ
ctmj-57	116	9	compound	compound	NOUN
ctmj-57	116	10	extracted	extract	VERB
ctmj-57	116	11	from	from	ADP
ctmj-57	116	12	astragalus	astragalus	NOUN
ctmj-57	116	13	membranaceus	membranaceus	NOUN
ctmj-57	116	14	.	.	PUNCT
ctmj-57	117	1	it	it	PRON
ctmj-57	117	2	has	have	VERB
ctmj-57	117	3	a	a	DET
ctmj-57	117	4	protective	protective	ADJ
ctmj-57	117	5	effect	effect	NOUN
ctmj-57	117	6	on	on	ADP
ctmj-57	117	7	the	the	DET
ctmj-57	117	8	dry	dry	ADJ
ctmj-57	117	9	eye	eye	NOUN
ctmj-57	117	10	model	model	NOUN
ctmj-57	117	11	induced	induce	VERB
ctmj-57	117	12	by	by	ADP
ctmj-57	117	13	benzalkonium	benzalkonium	NOUN
ctmj-57	117	14	chloride	chloride	NOUN
ctmj-57	117	15	(	(	PUNCT
ctmj-57	117	16	bac	bac	PROPN
ctmj-57	117	17	)	)	PUNCT
ctmj-57	117	18	and	and	CCONJ
ctmj-57	117	19	showed	show	VERB
ctmj-57	117	20	clinical	clinical	ADJ
ctmj-57	117	21	amelioration	amelioration	NOUN
ctmj-57	117	22	effected	effect	VERB
ctmj-57	117	23	by	by	ADP
ctmj-57	117	24	regulating	regulate	VERB
ctmj-57	117	25	the	the	DET
ctmj-57	117	26	muc1	muc1	PROPN
ctmj-57	117	27	-	-	PUNCT
ctmj-57	117	28	erbb1	erbb1	NOUN
ctmj-57	117	29	pathway	pathway	NOUN
ctmj-57	118	1	[	[	X
ctmj-57	118	2	9	9	NUM
ctmj-57	118	3	]	]	PUNCT
ctmj-57	118	4	.	.	PUNCT
ctmj-57	119	1	buddleja	buddleja	PROPN
ctmj-57	119	2	officinalis	officinalis	ADJ
ctmj-57	119	3	maxim	maxim	NOUN
ctmj-57	119	4	eye	eye	NOUN
ctmj-57	119	5	drops	drop	NOUN
ctmj-57	119	6	downregulated	downregulate	VERB
ctmj-57	119	7	the	the	DET
ctmj-57	119	8	expressions	expression	NOUN
ctmj-57	119	9	of	of	ADP
ctmj-57	119	10	apoptotic	apoptotic	ADJ
ctmj-57	119	11	factors	factor	NOUN
ctmj-57	119	12	bax	bax	PROPN
ctmj-57	119	13	,	,	PUNCT
ctmj-57	119	14	fas	fas	NOUN
ctmj-57	119	15	and	and	CCONJ
ctmj-57	119	16	fasl	fasl	PROPN
ctmj-57	119	17	in	in	ADP
ctmj-57	119	18	the	the	DET
ctmj-57	119	19	lacrimal	lacrimal	ADJ
ctmj-57	119	20	gland	gland	NOUN
ctmj-57	119	21	of	of	ADP
ctmj-57	119	22	the	the	DET
ctmj-57	119	23	dry	dry	ADJ
ctmj-57	119	24	eye	eye	NOUN
ctmj-57	119	25	rabbit	rabbit	NOUN
ctmj-57	119	26	model	model	NOUN
ctmj-57	119	27	,	,	PUNCT
ctmj-57	119	28	thereby	thereby	ADV
ctmj-57	119	29	inhibiting	inhibit	VERB
ctmj-57	119	30	lacrimal	lacrimal	ADJ
ctmj-57	119	31	cell	cell	NOUN
ctmj-57	119	32	apoptosis	apoptosis	NOUN
ctmj-57	119	33	and	and	CCONJ
ctmj-57	119	34	maintaining	maintain	VERB
ctmj-57	119	35	the	the	DET
ctmj-57	119	36	basal	basal	ADJ
ctmj-57	119	37	amount	amount	NOUN
ctmj-57	119	38	of	of	ADP
ctmj-57	119	39	lacrimal	lacrimal	ADJ
ctmj-57	119	40	secretion	secretion	NOUN
ctmj-57	119	41	[	[	X
ctmj-57	119	42	10	10	NUM
ctmj-57	119	43	]	]	PUNCT
ctmj-57	119	44	.	.	PUNCT
ctmj-57	120	1	in	in	ADP
ctmj-57	120	2	this	this	DET
ctmj-57	120	3	study	study	NOUN
ctmj-57	120	4	,	,	PUNCT
ctmj-57	120	5	the	the	DET
ctmj-57	120	6	efficacy	efficacy	NOUN
ctmj-57	120	7	of	of	ADP
ctmj-57	120	8	rmfs	rmfs	NOUN
ctmj-57	120	9	in	in	ADP
ctmj-57	120	10	treating	treat	VERB
ctmj-57	120	11	dry	dry	ADJ
ctmj-57	120	12	eye	eye	NOUN
ctmj-57	120	13	disease	disease	NOUN
ctmj-57	120	14	was	be	AUX
ctmj-57	120	15	investigated	investigate	VERB
ctmj-57	120	16	.	.	PUNCT
ctmj-57	121	1	rmfs	rmfs	NOUN
ctmj-57	121	2	is	be	AUX
ctmj-57	121	3	composed	compose	VERB
ctmj-57	121	4	of	of	ADP
ctmj-57	121	5	lilii	lilii	NOUN
ctmj-57	121	6	bulbus	bulbus	PROPN
ctmj-57	121	7	(	(	PUNCT
ctmj-57	121	8	baihe	baihe	NOUN
ctmj-57	121	9	)	)	PUNCT
ctmj-57	121	10	,	,	PUNCT
ctmj-57	121	11	rehmanniae	rehmanniae	PROPN
ctmj-57	121	12	radix	radix	PROPN
ctmj-57	121	13	praeparata	praeparata	PROPN
ctmj-57	121	14	(	(	PUNCT
ctmj-57	121	15	shudi	shudi	PROPN
ctmj-57	121	16	)	)	PUNCT
ctmj-57	121	17	,	,	PUNCT
ctmj-57	121	18	angelicae	angelicae	NOUN
ctmj-57	121	19	sinensis	sinensis	NOUN
ctmj-57	121	20	radix	radix	PROPN
ctmj-57	121	21	(	(	PUNCT
ctmj-57	121	22	danggui	danggui	NOUN
ctmj-57	121	23	)	)	PUNCT
ctmj-57	121	24	,	,	PUNCT
ctmj-57	121	25	atractylodes	atractylode	VERB
ctmj-57	121	26	chinese	chinese	ADJ
ctmj-57	121	27	traditional	traditional	ADJ
ctmj-57	121	28	medicine	medicine	NOUN
ctmj-57	121	29	journal	journal	NOUN
ctmj-57	121	30	|	|	ADV
ctmj-57	121	31	2020	2020	NUM
ctmj-57	121	32	|	|	ADV
ctmj-57	121	33	vol	vol	NOUN
ctmj-57	121	34	3	3	NUM
ctmj-57	121	35	|	|	ADV
ctmj-57	121	36	issue	issue	VERB
ctmj-57	121	37	6	6	NUM
ctmj-57	121	38	issn	issn	NOUN
ctmj-57	121	39	:	:	PUNCT
ctmj-57	121	40	2693	2693	NUM
ctmj-57	121	41	6356	6356	NUM
ctmj-57	121	42	2020	2020	NUM
ctmj-57	121	43	|	|	ADV
ctmj-57	121	44	vol	vol	NOUN
ctmj-57	121	45	3	3	NUM
ctmj-57	121	46	|	|	ADV
ctmj-57	121	47	issue	issue	VERB
ctmj-57	121	48	6	6	NUM
ctmj-57	121	49	ctmj	ctmj	NOUN
ctmj-57	121	50	|	|	ADV
ctmj-57	121	51	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	121	52	macrocephala	macrocephala	NOUN
ctmj-57	121	53	koidz	koidz	NOUN
ctmj-57	121	54	.	.	PUNCT
ctmj-57	122	1	(	(	PUNCT
ctmj-57	122	2	baizhu	baizhu	NOUN
ctmj-57	122	3	)	)	PUNCT
ctmj-57	122	4	,	,	PUNCT
ctmj-57	122	5	rhizoma	rhizoma	ADJ
ctmj-57	122	6	dioscoreae	dioscoreae	NOUN
ctmj-57	122	7	(	(	PUNCT
ctmj-57	122	8	shanyao	shanyao	NOUN
ctmj-57	122	9	)	)	PUNCT
ctmj-57	122	10	,	,	PUNCT
ctmj-57	122	11	fructus	fructus	NOUN
ctmj-57	122	12	ligustri	ligustri	ADJ
ctmj-57	122	13	lucidi	lucidi	PROPN
ctmj-57	122	14	(	(	PUNCT
ctmj-57	122	15	nvzhenzi	nvzhenzi	PROPN
ctmj-57	122	16	)	)	PUNCT
ctmj-57	122	17	,	,	PUNCT
ctmj-57	122	18	amygdalus	amygdalus	ADJ
ctmj-57	122	19	communis	communis	X
ctmj-57	122	20	vas	vas	X
ctmj-57	122	21	(	(	PUNCT
ctmj-57	122	22	xingren	xingren	PROPN
ctmj-57	122	23	)	)	PUNCT
ctmj-57	122	24	,	,	PUNCT
ctmj-57	122	25	glehniae	glehniae	PROPN
ctmj-57	122	26	radix	radix	PROPN
ctmj-57	122	27	(	(	PUNCT
ctmj-57	122	28	shashen	shashen	PROPN
ctmj-57	122	29	)	)	PUNCT
ctmj-57	122	30	,	,	PUNCT
ctmj-57	122	31	polygonati	polygonati	PROPN
ctmj-57	122	32	odorati	odorati	PROPN
ctmj-57	122	33	rhizoma	rhizoma	NOUN
ctmj-57	122	34	(	(	PUNCT
ctmj-57	122	35	yuzhu	yuzhu	PROPN
ctmj-57	122	36	)	)	PUNCT
ctmj-57	122	37	,	,	PUNCT
ctmj-57	122	38	platycodon	platycodon	NOUN
ctmj-57	122	39	grandiforus	grandiforus	NOUN
ctmj-57	122	40	(	(	PUNCT
ctmj-57	122	41	jiegeng	jiegeng	PROPN
ctmj-57	122	42	)	)	PUNCT
ctmj-57	122	43	,	,	PUNCT
ctmj-57	122	44	buddlejae	buddlejae	ADV
ctmj-57	122	45	flos	flos	X
ctmj-57	122	46	(	(	PUNCT
ctmj-57	122	47	mimenghua	mimenghua	PROPN
ctmj-57	122	48	)	)	PUNCT
ctmj-57	122	49	,	,	PUNCT
ctmj-57	122	50	chrysanthemi	chrysanthemi	PROPN
ctmj-57	122	51	flos	flos	PROPN
ctmj-57	122	52	(	(	PUNCT
ctmj-57	122	53	juhua	juhua	PROPN
ctmj-57	122	54	)	)	PUNCT
ctmj-57	122	55	and	and	CCONJ
ctmj-57	122	56	licorice	licorice	NOUN
ctmj-57	122	57	(	(	PUNCT
ctmj-57	122	58	gancao	gancao	NOUN
ctmj-57	122	59	)	)	PUNCT
ctmj-57	122	60	.	.	PUNCT
ctmj-57	123	1	rmfs	rmfs	PROPN
ctmj-57	123	2	has	have	VERB
ctmj-57	123	3	the	the	DET
ctmj-57	123	4	effect	effect	NOUN
ctmj-57	123	5	of	of	ADP
ctmj-57	123	6	protecting	protect	VERB
ctmj-57	123	7	the	the	DET
ctmj-57	123	8	liver	liver	NOUN
ctmj-57	123	9	,	,	PUNCT
ctmj-57	123	10	strengthening	strengthen	VERB
ctmj-57	123	11	the	the	DET
ctmj-57	123	12	spleen	spleen	NOUN
ctmj-57	123	13	,	,	PUNCT
ctmj-57	123	14	tonifying	tonifye	VERB
ctmj-57	123	15	the	the	DET
ctmj-57	123	16	liver	liver	NOUN
ctmj-57	123	17	and	and	CCONJ
ctmj-57	123	18	the	the	DET
ctmj-57	123	19	kidney	kidney	NOUN
ctmj-57	123	20	,	,	PUNCT
ctmj-57	123	21	fixing	fix	VERB
ctmj-57	123	22	the	the	DET
ctmj-57	123	23	lungs	lung	NOUN
ctmj-57	123	24	,	,	PUNCT
ctmj-57	123	25	dispersing	disperse	VERB
ctmj-57	123	26	wind	wind	NOUN
ctmj-57	123	27	,	,	PUNCT
ctmj-57	123	28	brightening	brighten	VERB
ctmj-57	123	29	the	the	DET
ctmj-57	123	30	eyes	eye	NOUN
ctmj-57	123	31	and	and	CCONJ
ctmj-57	123	32	generating	generating	NOUN
ctmj-57	123	33	fluids	fluid	NOUN
ctmj-57	123	34	,	,	PUNCT
ctmj-57	123	35	which	which	PRON
ctmj-57	123	36	repair	repair	VERB
ctmj-57	123	37	the	the	DET
ctmj-57	123	38	tear	tear	ADJ
ctmj-57	123	39	film	film	NOUN
ctmj-57	123	40	function	function	NOUN
ctmj-57	123	41	,	,	PUNCT
ctmj-57	123	42	thereby	thereby	ADV
ctmj-57	123	43	improving	improve	VERB
ctmj-57	123	44	the	the	DET
ctmj-57	123	45	symptoms	symptom	NOUN
ctmj-57	123	46	of	of	ADP
ctmj-57	123	47	dry	dry	ADJ
ctmj-57	123	48	eyes	eye	NOUN
ctmj-57	123	49	.	.	PUNCT
ctmj-57	124	1	in	in	ADP
ctmj-57	124	2	this	this	DET
ctmj-57	124	3	study	study	NOUN
ctmj-57	124	4	,	,	PUNCT
ctmj-57	124	5	it	it	PRON
ctmj-57	124	6	was	be	AUX
ctmj-57	124	7	demonstrated	demonstrate	VERB
ctmj-57	124	8	that	that	SCONJ
ctmj-57	124	9	rmfs	rmfs	NOUN
ctmj-57	124	10	could	could	AUX
ctmj-57	124	11	improve	improve	VERB
ctmj-57	124	12	dry	dry	ADJ
ctmj-57	124	13	eye	eye	NOUN
ctmj-57	124	14	symptoms	symptom	NOUN
ctmj-57	124	15	and	and	CCONJ
ctmj-57	124	16	repair	repair	VERB
ctmj-57	124	17	ocular	ocular	ADJ
ctmj-57	124	18	surface	surface	NOUN
ctmj-57	124	19	damage	damage	NOUN
ctmj-57	124	20	.	.	PUNCT
ctmj-57	125	1	hypromellose	hypromellose	NOUN
ctmj-57	125	2	2910	2910	NUM
ctmj-57	125	3	,	,	PUNCT
ctmj-57	125	4	dextran	dextran	NOUN
ctmj-57	125	5	70	70	NUM
ctmj-57	125	6	and	and	CCONJ
ctmj-57	125	7	glycerol	glycerol	NOUN
ctmj-57	125	8	eye	eye	NOUN
ctmj-57	125	9	drops	drop	NOUN
ctmj-57	125	10	(	(	PUNCT
ctmj-57	125	11	hga	hga	NOUN
ctmj-57	125	12	)	)	PUNCT
ctmj-57	125	13	are	be	AUX
ctmj-57	125	14	artificial	artificial	ADJ
ctmj-57	125	15	tears	tear	NOUN
ctmj-57	125	16	with	with	ADP
ctmj-57	125	17	the	the	DET
ctmj-57	125	18	same	same	ADJ
ctmj-57	125	19	ph	ph	VERB
ctmj-57	125	20	,	,	PUNCT
ctmj-57	125	21	ionic	ionic	ADJ
ctmj-57	125	22	concentration	concentration	NOUN
ctmj-57	125	23	and	and	CCONJ
ctmj-57	125	24	protein	protein	NOUN
ctmj-57	125	25	composition	composition	NOUN
ctmj-57	125	26	as	as	ADP
ctmj-57	125	27	normal	normal	ADJ
ctmj-57	125	28	human	human	ADJ
ctmj-57	125	29	tears	tear	NOUN
ctmj-57	125	30	,	,	PUNCT
ctmj-57	125	31	which	which	PRON
ctmj-57	125	32	improve	improve	VERB
ctmj-57	125	33	clinical	clinical	ADJ
ctmj-57	125	34	symptoms	symptom	NOUN
ctmj-57	125	35	and	and	CCONJ
ctmj-57	125	36	are	be	AUX
ctmj-57	125	37	commonly	commonly	ADV
ctmj-57	125	38	used	use	VERB
ctmj-57	125	39	in	in	ADP
ctmj-57	125	40	the	the	DET
ctmj-57	125	41	treatment	treatment	NOUN
ctmj-57	125	42	of	of	ADP
ctmj-57	125	43	dry	dry	ADJ
ctmj-57	125	44	eye	eye	NOUN
ctmj-57	125	45	[	[	X
ctmj-57	125	46	11	11	NUM
ctmj-57	125	47	]	]	PUNCT
ctmj-57	125	48	.	.	PUNCT
ctmj-57	126	1	however	however	ADV
ctmj-57	126	2	,	,	PUNCT
ctmj-57	126	3	the	the	DET
ctmj-57	126	4	drug	drug	NOUN
ctmj-57	126	5	is	be	AUX
ctmj-57	126	6	only	only	ADV
ctmj-57	126	7	a	a	DET
ctmj-57	126	8	symptomatic	symptomatic	ADJ
ctmj-57	126	9	treatment	treatment	NOUN
ctmj-57	126	10	,	,	PUNCT
ctmj-57	126	11	as	as	SCONJ
ctmj-57	126	12	it	it	PRON
ctmj-57	126	13	does	do	AUX
ctmj-57	126	14	not	not	PART
ctmj-57	126	15	completely	completely	ADV
ctmj-57	126	16	cure	cure	VERB
ctmj-57	126	17	dry	dry	ADJ
ctmj-57	126	18	eye	eye	NOUN
ctmj-57	126	19	,	,	PUNCT
ctmj-57	126	20	and	and	CCONJ
ctmj-57	126	21	it	it	PRON
ctmj-57	126	22	is	be	AUX
ctmj-57	126	23	not	not	PART
ctmj-57	126	24	effective	effective	ADJ
ctmj-57	126	25	for	for	ADP
ctmj-57	126	26	some	some	DET
ctmj-57	126	27	patients	patient	NOUN
ctmj-57	126	28	.	.	PUNCT
ctmj-57	127	1	the	the	DET
ctmj-57	127	2	results	result	NOUN
ctmj-57	127	3	of	of	ADP
ctmj-57	127	4	this	this	DET
ctmj-57	127	5	study	study	NOUN
ctmj-57	127	6	show	show	VERB
ctmj-57	127	7	that	that	SCONJ
ctmj-57	127	8	the	the	DET
ctmj-57	127	9	combined	combined	ADJ
ctmj-57	127	10	chinese	chinese	ADJ
ctmj-57	127	11	and	and	CCONJ
ctmj-57	127	12	western	western	ADJ
ctmj-57	127	13	medicine	medicine	NOUN
ctmj-57	127	14	therapy	therapy	NOUN
ctmj-57	127	15	based	base	VERB
ctmj-57	127	16	on	on	ADP
ctmj-57	127	17	rmfs	rmfs	NOUN
ctmj-57	127	18	and	and	CCONJ
ctmj-57	127	19	hga	hga	PROPN
ctmj-57	127	20	has	have	VERB
ctmj-57	127	21	a	a	DET
ctmj-57	127	22	therapeutic	therapeutic	ADJ
ctmj-57	127	23	effect	effect	NOUN
ctmj-57	127	24	on	on	ADP
ctmj-57	127	25	dry	dry	ADJ
ctmj-57	127	26	eye	eye	NOUN
ctmj-57	127	27	patients	patient	NOUN
ctmj-57	127	28	.	.	PUNCT
ctmj-57	128	1	however	however	ADV
ctmj-57	128	2	,	,	PUNCT
ctmj-57	128	3	the	the	DET
ctmj-57	128	4	specific	specific	ADJ
ctmj-57	128	5	mechanism	mechanism	NOUN
ctmj-57	128	6	of	of	ADP
ctmj-57	128	7	the	the	DET
ctmj-57	128	8	effect	effect	NOUN
ctmj-57	128	9	of	of	ADP
ctmj-57	128	10	the	the	DET
ctmj-57	128	11	combined	combine	VERB
ctmj-57	128	12	treatment	treatment	NOUN
ctmj-57	128	13	is	be	AUX
ctmj-57	128	14	not	not	PART
ctmj-57	128	15	clear	clear	ADJ
ctmj-57	128	16	.	.	PUNCT
ctmj-57	129	1	by	by	ADP
ctmj-57	129	2	elucidating	elucidate	VERB
ctmj-57	129	3	its	its	PRON
ctmj-57	129	4	molecular	molecular	ADJ
ctmj-57	129	5	mechanism	mechanism	NOUN
ctmj-57	129	6	,	,	PUNCT
ctmj-57	129	7	it	it	PRON
ctmj-57	129	8	is	be	AUX
ctmj-57	129	9	possible	possible	ADJ
ctmj-57	129	10	to	to	PART
ctmj-57	129	11	provide	provide	VERB
ctmj-57	129	12	theoretical	theoretical	ADJ
ctmj-57	129	13	guidance	guidance	NOUN
ctmj-57	129	14	for	for	ADP
ctmj-57	129	15	its	its	PRON
ctmj-57	129	16	clinical	clinical	ADJ
ctmj-57	129	17	application	application	NOUN
ctmj-57	129	18	.	.	PUNCT
ctmj-57	130	1	here	here	ADV
ctmj-57	130	2	,	,	PUNCT
ctmj-57	130	3	it	it	PRON
ctmj-57	130	4	was	be	AUX
ctmj-57	130	5	demonstrated	demonstrate	VERB
ctmj-57	130	6	that	that	SCONJ
ctmj-57	130	7	the	the	DET
ctmj-57	130	8	combined	combined	ADJ
ctmj-57	130	9	treatment	treatment	NOUN
ctmj-57	130	10	with	with	ADP
ctmj-57	130	11	rmfs	rmfs	NOUN
ctmj-57	130	12	and	and	CCONJ
ctmj-57	130	13	hga	hga	NOUN
ctmj-57	130	14	is	be	AUX
ctmj-57	130	15	able	able	ADJ
ctmj-57	130	16	to	to	PART
ctmj-57	130	17	modify	modify	VERB
ctmj-57	130	18	the	the	DET
ctmj-57	130	19	symptoms	symptom	NOUN
ctmj-57	130	20	of	of	ADP
ctmj-57	130	21	dry	dry	ADJ
ctmj-57	130	22	eyes	eye	NOUN
ctmj-57	130	23	,	,	PUNCT
ctmj-57	130	24	including	include	VERB
ctmj-57	130	25	increasing	increase	VERB
ctmj-57	130	26	tear	tear	ADJ
ctmj-57	130	27	secretion	secretion	NOUN
ctmj-57	130	28	as	as	ADV
ctmj-57	130	29	well	well	ADV
ctmj-57	130	30	as	as	ADP
ctmj-57	130	31	repairing	repair	VERB
ctmj-57	130	32	ocular	ocular	ADJ
ctmj-57	130	33	surface	surface	NOUN
ctmj-57	130	34	damage	damage	NOUN
ctmj-57	130	35	.	.	PUNCT
ctmj-57	131	1	modern	modern	ADJ
ctmj-57	131	2	medicine	medicine	NOUN
ctmj-57	131	3	believes	believe	VERB
ctmj-57	131	4	that	that	SCONJ
ctmj-57	131	5	the	the	DET
ctmj-57	131	6	occurrence	occurrence	NOUN
ctmj-57	131	7	of	of	ADP
ctmj-57	131	8	dry	dry	ADJ
ctmj-57	131	9	eye	eye	NOUN
ctmj-57	131	10	is	be	AUX
ctmj-57	131	11	closely	closely	ADV
ctmj-57	131	12	related	relate	VERB
ctmj-57	131	13	to	to	ADP
ctmj-57	131	14	neuroinflammation	neuroinflammation	NOUN
ctmj-57	131	15	,	,	PUNCT
ctmj-57	131	16	apoptosis	apoptosis	NOUN
ctmj-57	131	17	and	and	CCONJ
ctmj-57	131	18	reduced	reduced	ADJ
ctmj-57	131	19	levels	level	NOUN
ctmj-57	131	20	of	of	ADP
ctmj-57	131	21	sex	sex	NOUN
ctmj-57	131	22	hormones	hormone	NOUN
ctmj-57	131	23	,	,	PUNCT
ctmj-57	131	24	and	and	CCONJ
ctmj-57	131	25	that	that	SCONJ
ctmj-57	131	26	these	these	DET
ctmj-57	131	27	factors	factor	NOUN
ctmj-57	131	28	promote	promote	VERB
ctmj-57	131	29	and	and	CCONJ
ctmj-57	131	30	influence	influence	VERB
ctmj-57	131	31	each	each	DET
ctmj-57	131	32	other	other	ADJ
ctmj-57	131	33	[	[	X
ctmj-57	131	34	3	3	NUM
ctmj-57	131	35	-	-	SYM
ctmj-57	131	36	5	5	NUM
ctmj-57	131	37	]	]	PUNCT
ctmj-57	131	38	.	.	PUNCT
ctmj-57	132	1	the	the	DET
ctmj-57	132	2	apoptosis	apoptosis	NOUN
ctmj-57	132	3	of	of	ADP
ctmj-57	132	4	the	the	DET
ctmj-57	132	5	corneal	corneal	ADJ
ctmj-57	132	6	and	and	CCONJ
ctmj-57	132	7	conjunctiva	conjunctiva	NOUN
ctmj-57	132	8	epithelium	epithelium	NOUN
ctmj-57	132	9	caused	cause	VERB
ctmj-57	132	10	by	by	ADP
ctmj-57	132	11	immune	immune	ADJ
ctmj-57	132	12	inflammatory	inflammatory	ADJ
ctmj-57	132	13	response	response	NOUN
ctmj-57	132	14	in	in	ADP
ctmj-57	132	15	the	the	DET
ctmj-57	132	16	lacrimal	lacrimal	ADJ
ctmj-57	132	17	gland	gland	NOUN
ctmj-57	132	18	is	be	AUX
ctmj-57	132	19	the	the	DET
ctmj-57	132	20	main	main	ADJ
ctmj-57	132	21	cause	cause	NOUN
ctmj-57	132	22	of	of	ADP
ctmj-57	132	23	the	the	DET
ctmj-57	132	24	deterioration	deterioration	NOUN
ctmj-57	132	25	of	of	ADP
ctmj-57	132	26	the	the	DET
ctmj-57	132	27	dry	dry	ADJ
ctmj-57	132	28	eye	eye	NOUN
ctmj-57	132	29	disease	disease	NOUN
ctmj-57	132	30	[	[	X
ctmj-57	132	31	12	12	NUM
ctmj-57	132	32	]	]	PUNCT
ctmj-57	132	33	.	.	PUNCT
ctmj-57	133	1	as	as	SCONJ
ctmj-57	133	2	reported	report	VERB
ctmj-57	133	3	in	in	ADP
ctmj-57	133	4	the	the	DET
ctmj-57	133	5	present	present	ADJ
ctmj-57	133	6	study	study	NOUN
ctmj-57	133	7	,	,	PUNCT
ctmj-57	133	8	the	the	DET
ctmj-57	133	9	corneal	corneal	ADJ
ctmj-57	133	10	epithelial	epithelial	ADJ
ctmj-57	133	11	tissue	tissue	NOUN
ctmj-57	133	12	in	in	ADP
ctmj-57	133	13	the	the	DET
ctmj-57	133	14	rabbit	rabbit	NOUN
ctmj-57	133	15	dry	dry	PROPN
ctmj-57	133	16	eye	eye	NOUN
ctmj-57	133	17	model	model	NOUN
ctmj-57	133	18	had	have	VERB
ctmj-57	133	19	more	more	ADJ
ctmj-57	133	20	apoptotic	apoptotic	ADJ
ctmj-57	133	21	cells	cell	NOUN
ctmj-57	133	22	than	than	ADP
ctmj-57	133	23	control	control	NOUN
ctmj-57	133	24	group	group	NOUN
ctmj-57	133	25	and	and	CCONJ
ctmj-57	133	26	combined	combined	ADJ
ctmj-57	133	27	treatment	treatment	NOUN
ctmj-57	133	28	with	with	ADP
ctmj-57	133	29	rmfs	rmfs	NOUN
ctmj-57	133	30	and	and	CCONJ
ctmj-57	133	31	hga	hga	PROPN
ctmj-57	133	32	reduced	reduce	VERB
ctmj-57	133	33	the	the	DET
ctmj-57	133	34	number	number	NOUN
ctmj-57	133	35	of	of	ADP
ctmj-57	133	36	apoptotic	apoptotic	ADJ
ctmj-57	133	37	cells	cell	NOUN
ctmj-57	133	38	of	of	ADP
ctmj-57	133	39	cornea	cornea	NOUN
ctmj-57	133	40	tissues	tissue	NOUN
ctmj-57	133	41	in	in	ADP
ctmj-57	133	42	the	the	DET
ctmj-57	133	43	rabbit	rabbit	NOUN
ctmj-57	133	44	dry	dry	PROPN
ctmj-57	133	45	eye	eye	NOUN
ctmj-57	133	46	model	model	NOUN
ctmj-57	133	47	.	.	PUNCT
ctmj-57	134	1	in	in	ADP
ctmj-57	134	2	recent	recent	ADJ
ctmj-57	134	3	years	year	NOUN
ctmj-57	134	4	,	,	PUNCT
ctmj-57	134	5	regulatory	regulatory	ADJ
ctmj-57	134	6	t	t	NOUN
ctmj-57	134	7	cells	cell	NOUN
ctmj-57	134	8	(	(	PUNCT
ctmj-57	134	9	treg	treg	PROPN
ctmj-57	134	10	)	)	PUNCT
ctmj-57	134	11	and	and	CCONJ
ctmj-57	134	12	helper	helper	NOUN
ctmj-57	134	13	t	t	PROPN
ctmj-57	134	14	cell	cell	NOUN
ctmj-57	134	15	subset	subset	VERB
ctmj-57	134	16	17	17	NUM
ctmj-57	134	17	(	(	PUNCT
ctmj-57	134	18	th17	th17	NOUN
ctmj-57	134	19	)	)	PUNCT
ctmj-57	134	20	cells	cell	NOUN
ctmj-57	134	21	have	have	AUX
ctmj-57	134	22	been	be	AUX
ctmj-57	134	23	found	find	VERB
ctmj-57	134	24	to	to	PART
ctmj-57	134	25	play	play	VERB
ctmj-57	134	26	a	a	DET
ctmj-57	134	27	very	very	ADV
ctmj-57	134	28	important	important	ADJ
ctmj-57	134	29	role	role	NOUN
ctmj-57	134	30	in	in	ADP
ctmj-57	134	31	immune	immune	ADJ
ctmj-57	134	32	inflammatory	inflammatory	ADJ
ctmj-57	134	33	diseases	disease	NOUN
ctmj-57	134	34	[	[	X
ctmj-57	134	35	5	5	NUM
ctmj-57	134	36	]	]	PUNCT
ctmj-57	134	37	.	.	PUNCT
ctmj-57	135	1	among	among	ADP
ctmj-57	135	2	them	they	PRON
ctmj-57	135	3	,	,	PUNCT
ctmj-57	135	4	th17	th17	PROPN
ctmj-57	135	5	cells	cell	NOUN
ctmj-57	135	6	promote	promote	VERB
ctmj-57	135	7	inflammatory	inflammatory	ADJ
ctmj-57	135	8	responses	response	NOUN
ctmj-57	135	9	by	by	ADP
ctmj-57	135	10	secreting	secrete	VERB
ctmj-57	135	11	il-17	il-17	ADP
ctmj-57	135	12	,	,	PUNCT
ctmj-57	135	13	a	a	DET
ctmj-57	135	14	cytokine	cytokine	NOUN
ctmj-57	135	15	,	,	PUNCT
ctmj-57	135	16	and	and	CCONJ
ctmj-57	135	17	retinoic	retinoic	ADJ
ctmj-57	135	18	acid	acid	NOUN
ctmj-57	135	19	-	-	PUNCT
ctmj-57	135	20	related	relate	VERB
ctmj-57	135	21	orphan	orphan	NOUN
ctmj-57	135	22	receptor	receptor	NOUN
ctmj-57	135	23	γt	γt	NOUN
ctmj-57	135	24	(	(	PUNCT
ctmj-57	135	25	rorγt	rorγt	NOUN
ctmj-57	135	26	)	)	PUNCT
ctmj-57	135	27	,	,	PUNCT
ctmj-57	135	28	a	a	DET
ctmj-57	135	29	specific	specific	ADJ
ctmj-57	135	30	transcription	transcription	NOUN
ctmj-57	135	31	factor	factor	NOUN
ctmj-57	135	32	whose	whose	DET
ctmj-57	135	33	expression	expression	NOUN
ctmj-57	135	34	directly	directly	ADV
ctmj-57	135	35	affect	affect	VERB
ctmj-57	135	36	the	the	DET
ctmj-57	135	37	differentiation	differentiation	NOUN
ctmj-57	135	38	and	and	CCONJ
ctmj-57	135	39	function	function	NOUN
ctmj-57	135	40	of	of	ADP
ctmj-57	135	41	th17	th17	PROPN
ctmj-57	135	42	cells	cell	NOUN
ctmj-57	135	43	[	[	X
ctmj-57	135	44	13,14	13,14	NUM
ctmj-57	135	45	]	]	PUNCT
ctmj-57	135	46	.	.	PUNCT
ctmj-57	136	1	treg	treg	PROPN
ctmj-57	136	2	has	have	VERB
ctmj-57	136	3	an	an	DET
ctmj-57	136	4	immunosuppressive	immunosuppressive	ADJ
ctmj-57	136	5	function	function	NOUN
ctmj-57	136	6	,	,	PUNCT
ctmj-57	136	7	preventing	prevent	VERB
ctmj-57	136	8	the	the	DET
ctmj-57	136	9	activation	activation	NOUN
ctmj-57	136	10	of	of	ADP
ctmj-57	136	11	autoimmune	autoimmune	ADJ
ctmj-57	136	12	t	t	NOUN
ctmj-57	136	13	cells	cell	NOUN
ctmj-57	136	14	,	,	PUNCT
ctmj-57	136	15	regulating	regulate	VERB
ctmj-57	136	16	the	the	DET
ctmj-57	136	17	body	body	NOUN
ctmj-57	136	18	's	's	PART
ctmj-57	136	19	immune	immune	ADJ
ctmj-57	136	20	response	response	NOUN
ctmj-57	136	21	,	,	PUNCT
ctmj-57	136	22	maintaining	maintain	VERB
ctmj-57	136	23	immune	immune	ADJ
ctmj-57	136	24	homeostasis	homeostasis	NOUN
ctmj-57	136	25	and	and	CCONJ
ctmj-57	136	26	suppressing	suppress	VERB
ctmj-57	136	27	the	the	DET
ctmj-57	136	28	development	development	NOUN
ctmj-57	136	29	of	of	ADP
ctmj-57	136	30	immune	immune	ADJ
ctmj-57	136	31	diseases	disease	NOUN
ctmj-57	136	32	[	[	X
ctmj-57	136	33	11,15	11,15	NUM
ctmj-57	136	34	]	]	X
ctmj-57	136	35	.	.	PUNCT
ctmj-57	137	1	thus	thus	ADV
ctmj-57	137	2	,	,	PUNCT
ctmj-57	137	3	th17	th17	PROPN
ctmj-57	137	4	and	and	CCONJ
ctmj-57	137	5	treg	treg	PROPN
ctmj-57	137	6	cells	cell	NOUN
ctmj-57	137	7	exhibit	exhibit	VERB
ctmj-57	137	8	functional	functional	ADJ
ctmj-57	137	9	antagonism	antagonism	NOUN
ctmj-57	137	10	towards	towards	ADP
ctmj-57	137	11	each	each	DET
ctmj-57	137	12	other	other	ADJ
ctmj-57	137	13	,	,	PUNCT
ctmj-57	137	14	which	which	PRON
ctmj-57	137	15	may	may	AUX
ctmj-57	137	16	be	be	AUX
ctmj-57	137	17	an	an	DET
ctmj-57	137	18	important	important	ADJ
ctmj-57	137	19	factor	factor	NOUN
ctmj-57	137	20	in	in	ADP
ctmj-57	137	21	the	the	DET
ctmj-57	137	22	homeostasis	homeostasis	NOUN
ctmj-57	137	23	of	of	ADP
ctmj-57	137	24	immune	immune	ADJ
ctmj-57	137	25	function	function	NOUN
ctmj-57	137	26	.	.	PUNCT
ctmj-57	138	1	it	it	PRON
ctmj-57	138	2	has	have	AUX
ctmj-57	138	3	been	be	AUX
ctmj-57	138	4	found	find	VERB
ctmj-57	138	5	that	that	SCONJ
ctmj-57	138	6	the	the	DET
ctmj-57	138	7	development	development	NOUN
ctmj-57	138	8	of	of	ADP
ctmj-57	138	9	dry	dry	ADJ
ctmj-57	138	10	eye	eye	NOUN
ctmj-57	138	11	disease	disease	NOUN
ctmj-57	138	12	was	be	AUX
ctmj-57	138	13	associated	associate	VERB
ctmj-57	138	14	with	with	ADP
ctmj-57	138	15	a	a	DET
ctmj-57	138	16	disruption	disruption	NOUN
ctmj-57	138	17	in	in	ADP
ctmj-57	138	18	the	the	DET
ctmj-57	138	19	homeostatic	homeostatic	ADJ
ctmj-57	138	20	balance	balance	NOUN
ctmj-57	138	21	of	of	ADP
ctmj-57	138	22	treg	treg	PROPN
ctmj-57	138	23	/	/	SYM
ctmj-57	138	24	th17	th17	PROPN
ctmj-57	138	25	cells	cell	NOUN
ctmj-57	138	26	,	,	PUNCT
ctmj-57	138	27	and	and	CCONJ
ctmj-57	138	28	that	that	SCONJ
ctmj-57	138	29	blocking	blocking	NOUN
ctmj-57	138	30	il-17	il-17	NUM
ctmj-57	138	31	significantly	significantly	ADV
ctmj-57	138	32	reduced	reduce	VERB
ctmj-57	138	33	the	the	DET
ctmj-57	138	34	severity	severity	NOUN
ctmj-57	138	35	and	and	CCONJ
ctmj-57	138	36	progression	progression	NOUN
ctmj-57	138	37	of	of	ADP
ctmj-57	138	38	the	the	DET
ctmj-57	138	39	disease	disease	NOUN
ctmj-57	138	40	by	by	ADP
ctmj-57	138	41	restoring	restore	VERB
ctmj-57	138	42	the	the	DET
ctmj-57	138	43	treg	treg	PROPN
ctmj-57	138	44	/	/	SYM
ctmj-57	138	45	th17	th17	PROPN
ctmj-57	138	46	cell	cell	NOUN
ctmj-57	138	47	ratio	ratio	NOUN
ctmj-57	139	1	[	[	X
ctmj-57	139	2	6	6	NUM
ctmj-57	139	3	]	]	PUNCT
ctmj-57	139	4	.	.	PUNCT
ctmj-57	140	1	a	a	DET
ctmj-57	140	2	number	number	NOUN
ctmj-57	140	3	of	of	ADP
ctmj-57	140	4	subsequent	subsequent	ADJ
ctmj-57	140	5	studies	study	NOUN
ctmj-57	140	6	have	have	AUX
ctmj-57	140	7	confirmed	confirm	VERB
ctmj-57	140	8	that	that	SCONJ
ctmj-57	140	9	the	the	DET
ctmj-57	140	10	inflammatory	inflammatory	ADJ
ctmj-57	140	11	response	response	NOUN
ctmj-57	140	12	mediated	mediate	VERB
ctmj-57	140	13	by	by	ADP
ctmj-57	140	14	an	an	DET
ctmj-57	140	15	imbalance	imbalance	NOUN
ctmj-57	140	16	in	in	ADP
ctmj-57	140	17	the	the	DET
ctmj-57	140	18	th17	th17	PROPN
ctmj-57	140	19	/	/	SYM
ctmj-57	140	20	treg	treg	PROPN
ctmj-57	140	21	cell	cell	NOUN
ctmj-57	140	22	ratio	ratio	NOUN
ctmj-57	140	23	was	be	AUX
ctmj-57	140	24	an	an	DET
ctmj-57	140	25	important	important	ADJ
ctmj-57	140	26	cause	cause	NOUN
ctmj-57	140	27	of	of	ADP
ctmj-57	140	28	dry	dry	ADJ
ctmj-57	140	29	eye	eye	NOUN
ctmj-57	140	30	and	and	CCONJ
ctmj-57	140	31	that	that	SCONJ
ctmj-57	140	32	drugs	drug	NOUN
ctmj-57	140	33	increased	increase	VERB
ctmj-57	140	34	tear	tear	ADJ
ctmj-57	140	35	film	film	NOUN
ctmj-57	140	36	rupture	rupture	NOUN
ctmj-57	140	37	time	time	NOUN
ctmj-57	140	38	and	and	CCONJ
ctmj-57	140	39	tear	tear	ADJ
ctmj-57	140	40	production	production	NOUN
ctmj-57	140	41	by	by	ADP
ctmj-57	140	42	modulating	modulate	VERB
ctmj-57	140	43	the	the	DET
ctmj-57	140	44	th17	th17	PROPN
ctmj-57	140	45	/	/	SYM
ctmj-57	140	46	treg	treg	PROPN
ctmj-57	140	47	cell	cell	NOUN
ctmj-57	140	48	ratio	ratio	NOUN
ctmj-57	140	49	,	,	PUNCT
ctmj-57	140	50	thereby	thereby	ADV
ctmj-57	140	51	restoring	restore	VERB
ctmj-57	140	52	the	the	DET
ctmj-57	140	53	histological	histological	ADJ
ctmj-57	140	54	changes	change	NOUN
ctmj-57	140	55	in	in	ADP
ctmj-57	140	56	tissues	tissue	NOUN
ctmj-57	140	57	such	such	ADJ
ctmj-57	140	58	as	as	ADP
ctmj-57	140	59	cornea	cornea	NOUN
ctmj-57	140	60	,	,	PUNCT
ctmj-57	140	61	conjunctiva	conjunctiva	NOUN
ctmj-57	140	62	and	and	CCONJ
ctmj-57	140	63	lacrimal	lacrimal	ADJ
ctmj-57	140	64	glands	gland	NOUN
ctmj-57	140	65	caused	cause	VERB
ctmj-57	140	66	by	by	ADP
ctmj-57	140	67	dry	dry	ADJ
ctmj-57	140	68	eye	eye	NOUN
ctmj-57	141	1	[	[	X
ctmj-57	141	2	16	16	NUM
ctmj-57	141	3	-	-	SYM
ctmj-57	141	4	18	18	NUM
ctmj-57	141	5	]	]	PUNCT
ctmj-57	141	6	.	.	PUNCT
ctmj-57	142	1	therefore	therefore	ADV
ctmj-57	142	2	,	,	PUNCT
ctmj-57	142	3	maintaining	maintain	VERB
ctmj-57	142	4	the	the	DET
ctmj-57	142	5	homeostatic	homeostatic	ADJ
ctmj-57	142	6	balance	balance	NOUN
ctmj-57	142	7	of	of	ADP
ctmj-57	142	8	th17	th17	PROPN
ctmj-57	142	9	/	/	SYM
ctmj-57	142	10	treg	treg	PROPN
ctmj-57	142	11	cells	cell	NOUN
ctmj-57	142	12	may	may	AUX
ctmj-57	142	13	contribute	contribute	VERB
ctmj-57	142	14	to	to	ADP
ctmj-57	142	15	the	the	DET
ctmj-57	142	16	treatment	treatment	NOUN
ctmj-57	142	17	of	of	ADP
ctmj-57	142	18	dry	dry	ADJ
ctmj-57	142	19	eye	eye	NOUN
ctmj-57	142	20	.	.	PUNCT
ctmj-57	143	1	in	in	ADP
ctmj-57	143	2	the	the	DET
ctmj-57	143	3	present	present	ADJ
ctmj-57	143	4	study	study	NOUN
ctmj-57	143	5	,	,	PUNCT
ctmj-57	143	6	an	an	DET
ctmj-57	143	7	imbalance	imbalance	NOUN
ctmj-57	143	8	in	in	ADP
ctmj-57	143	9	th17/	th17/	PROPN
ctmj-57	143	10	treg	treg	PROPN
ctmj-57	143	11	ratio	ratio	PROPN
ctmj-57	143	12	was	be	AUX
ctmj-57	143	13	found	find	VERB
ctmj-57	143	14	in	in	ADP
ctmj-57	143	15	the	the	DET
ctmj-57	143	16	lacrimal	lacrimal	ADJ
ctmj-57	143	17	gland	gland	NOUN
ctmj-57	143	18	of	of	ADP
ctmj-57	143	19	the	the	DET
ctmj-57	143	20	model	model	NOUN
ctmj-57	143	21	group	group	NOUN
ctmj-57	143	22	and	and	CCONJ
ctmj-57	143	23	co	co	NOUN
ctmj-57	143	24	-	-	NOUN
ctmj-57	143	25	treatment	treatment	NOUN
ctmj-57	143	26	with	with	ADP
ctmj-57	143	27	of	of	ADP
ctmj-57	143	28	rmfs	rmfs	NOUN
ctmj-57	143	29	and	and	CCONJ
ctmj-57	143	30	hga	hga	PROPN
ctmj-57	143	31	regulated	regulate	VERB
ctmj-57	143	32	the	the	DET
ctmj-57	143	33	balance	balance	NOUN
ctmj-57	143	34	of	of	ADP
ctmj-57	143	35	th17	th17	PROPN
ctmj-57	143	36	/	/	SYM
ctmj-57	143	37	treg	treg	PROPN
ctmj-57	143	38	related	relate	VERB
ctmj-57	143	39	cytokine	cytokine	NOUN
ctmj-57	143	40	in	in	ADP
ctmj-57	143	41	the	the	DET
ctmj-57	143	42	rabbit	rabbit	NOUN
ctmj-57	143	43	dry	dry	PROPN
ctmj-57	143	44	eye	eye	NOUN
ctmj-57	143	45	model	model	NOUN
ctmj-57	143	46	.	.	PUNCT
ctmj-57	144	1	the	the	DET
ctmj-57	144	2	janus	janus	PROPN
ctmj-57	144	3	kinase	kinase	PROPN
ctmj-57	144	4	2	2	NUM
ctmj-57	144	5	signal	signal	NOUN
ctmj-57	144	6	transducer	transducer	NOUN
ctmj-57	144	7	/	/	SYM
ctmj-57	144	8	transcription	transcription	NOUN
ctmj-57	144	9	activator	activator	NOUN
ctmj-57	144	10	3	3	NUM
ctmj-57	144	11	(	(	PUNCT
ctmj-57	144	12	jak2	jak2	PROPN
ctmj-57	144	13	/	/	SYM
ctmj-57	144	14	stat3	stat3	NOUN
ctmj-57	144	15	)	)	PUNCT
ctmj-57	144	16	signaling	signal	VERB
ctmj-57	144	17	pathway	pathway	NOUN
ctmj-57	144	18	regulates	regulate	VERB
ctmj-57	144	19	inflammatory	inflammatory	ADJ
ctmj-57	144	20	mediators	mediator	NOUN
ctmj-57	144	21	involved	involve	VERB
ctmj-57	144	22	in	in	ADP
ctmj-57	144	23	extracellular	extracellular	ADJ
ctmj-57	144	24	signaling	signal	VERB
ctmj-57	144	25	pathways	pathway	NOUN
ctmj-57	144	26	and	and	CCONJ
ctmj-57	144	27	plays	play	VERB
ctmj-57	144	28	an	an	DET
ctmj-57	144	29	overall	overall	ADJ
ctmj-57	144	30	regulatory	regulatory	ADJ
ctmj-57	144	31	role	role	NOUN
ctmj-57	144	32	in	in	ADP
ctmj-57	144	33	inflammatory	inflammatory	ADJ
ctmj-57	144	34	responses	response	NOUN
ctmj-57	144	35	and	and	CCONJ
ctmj-57	144	36	cell	cell	NOUN
ctmj-57	144	37	survival	survival	NOUN
ctmj-57	144	38	[	[	X
ctmj-57	144	39	19	19	NUM
ctmj-57	144	40	]	]	PUNCT
ctmj-57	144	41	.	.	PUNCT
ctmj-57	145	1	most	most	ADV
ctmj-57	145	2	importantly	importantly	ADV
ctmj-57	145	3	,	,	PUNCT
ctmj-57	145	4	the	the	DET
ctmj-57	145	5	jak2	jak2	PROPN
ctmj-57	145	6	/	/	SYM
ctmj-57	145	7	stat3	stat3	NOUN
ctmj-57	145	8	signaling	signal	VERB
ctmj-57	145	9	pathway	pathway	NOUN
ctmj-57	145	10	is	be	AUX
ctmj-57	145	11	also	also	ADV
ctmj-57	145	12	involved	involve	VERB
ctmj-57	145	13	in	in	ADP
ctmj-57	145	14	the	the	DET
ctmj-57	145	15	regulation	regulation	NOUN
ctmj-57	145	16	of	of	ADP
ctmj-57	145	17	th17	th17	PROPN
ctmj-57	145	18	/	/	SYM
ctmj-57	145	19	treg	treg	PROPN
ctmj-57	145	20	homeostasis	homeostasis	NOUN
ctmj-57	145	21	[	[	X
ctmj-57	145	22	20	20	NUM
ctmj-57	145	23	]	]	PUNCT
ctmj-57	145	24	.	.	PUNCT
ctmj-57	146	1	in	in	ADP
ctmj-57	146	2	t	t	PROPN
ctmj-57	146	3	lymphocytes	lymphocyte	NOUN
ctmj-57	146	4	,	,	PUNCT
ctmj-57	146	5	activated	activate	VERB
ctmj-57	146	6	stat3	stat3	NOUN
ctmj-57	146	7	mediates	mediate	VERB
ctmj-57	146	8	its	its	PRON
ctmj-57	146	9	downstream	downstream	ADJ
ctmj-57	146	10	signaling	signal	VERB
ctmj-57	146	11	pathway	pathway	NOUN
ctmj-57	146	12	to	to	PART
ctmj-57	146	13	enhance	enhance	VERB
ctmj-57	146	14	rorγt	rorγt	NOUN
ctmj-57	146	15	expression	expression	NOUN
ctmj-57	146	16	in	in	ADP
ctmj-57	146	17	initial	initial	ADJ
ctmj-57	146	18	cd4	cd4	PROPN
ctmj-57	146	19	+	+	PROPN
ctmj-57	146	20	t	t	NOUN
ctmj-57	146	21	lymphocytes	lymphocyte	NOUN
ctmj-57	146	22	,	,	PUNCT
ctmj-57	146	23	thereby	thereby	ADV
ctmj-57	146	24	contributing	contribute	VERB
ctmj-57	146	25	to	to	ADP
ctmj-57	146	26	the	the	DET
ctmj-57	146	27	differentiation	differentiation	NOUN
ctmj-57	146	28	of	of	ADP
ctmj-57	146	29	cd4	cd4	PROPN
ctmj-57	146	30	+	+	PROPN
ctmj-57	146	31	t	t	NOUN
ctmj-57	146	32	cells	cell	NOUN
ctmj-57	146	33	to	to	ADP
ctmj-57	146	34	th17	th17	NOUN
ctmj-57	146	35	[	[	X
ctmj-57	146	36	21	21	NUM
ctmj-57	146	37	]	]	PUNCT
ctmj-57	146	38	.	.	PUNCT
ctmj-57	147	1	previous	previous	ADJ
ctmj-57	147	2	reports	report	NOUN
ctmj-57	147	3	have	have	AUX
ctmj-57	147	4	established	establish	VERB
ctmj-57	147	5	that	that	SCONJ
ctmj-57	147	6	the	the	DET
ctmj-57	147	7	expression	expression	NOUN
ctmj-57	147	8	levels	level	NOUN
ctmj-57	147	9	of	of	ADP
ctmj-57	147	10	jak2	jak2	PROPN
ctmj-57	147	11	and	and	CCONJ
ctmj-57	147	12	stat3	stat3	NOUN
ctmj-57	147	13	are	be	AUX
ctmj-57	147	14	significantly	significantly	ADV
ctmj-57	147	15	increased	increase	VERB
ctmj-57	147	16	in	in	ADP
ctmj-57	147	17	the	the	DET
ctmj-57	147	18	lacrimal	lacrimal	ADJ
ctmj-57	147	19	gland	gland	NOUN
ctmj-57	147	20	of	of	ADP
ctmj-57	147	21	a	a	DET
ctmj-57	147	22	dry	dry	ADJ
ctmj-57	147	23	eye	eye	NOUN
ctmj-57	147	24	inflammation	inflammation	NOUN
ctmj-57	147	25	model	model	NOUN
ctmj-57	147	26	and	and	CCONJ
ctmj-57	147	27	tear	tear	ADJ
ctmj-57	147	28	secretion	secretion	NOUN
ctmj-57	147	29	in	in	ADP
ctmj-57	147	30	this	this	DET
ctmj-57	147	31	model	model	NOUN
ctmj-57	147	32	is	be	AUX
ctmj-57	147	33	promoted	promote	VERB
ctmj-57	147	34	by	by	ADP
ctmj-57	147	35	inhibiting	inhibit	VERB
ctmj-57	147	36	the	the	DET
ctmj-57	147	37	activation	activation	NOUN
ctmj-57	147	38	of	of	ADP
ctmj-57	147	39	the	the	DET
ctmj-57	147	40	jak2	jak2	PROPN
ctmj-57	147	41	/	/	SYM
ctmj-57	147	42	stat3	stat3	NOUN
ctmj-57	147	43	signaling	signal	VERB
ctmj-57	147	44	pathway	pathway	NOUN
ctmj-57	148	1	[	[	X
ctmj-57	148	2	22,23	22,23	NOUN
ctmj-57	148	3	]	]	X
ctmj-57	148	4	.	.	PUNCT
ctmj-57	149	1	as	as	SCONJ
ctmj-57	149	2	reported	report	VERB
ctmj-57	149	3	in	in	ADP
ctmj-57	149	4	this	this	DET
ctmj-57	149	5	study	study	NOUN
ctmj-57	149	6	,	,	PUNCT
ctmj-57	149	7	the	the	DET
ctmj-57	149	8	combination	combination	NOUN
ctmj-57	149	9	treatment	treatment	NOUN
ctmj-57	149	10	with	with	ADP
ctmj-57	149	11	rmfs	rmfs	NOUN
ctmj-57	149	12	and	and	CCONJ
ctmj-57	149	13	hga	hga	PROPN
ctmj-57	149	14	remarkably	remarkably	ADV
ctmj-57	149	15	decreased	decrease	VERB
ctmj-57	149	16	the	the	DET
ctmj-57	149	17	protein	protein	NOUN
ctmj-57	149	18	levels	level	NOUN
ctmj-57	149	19	of	of	ADP
ctmj-57	149	20	the	the	DET
ctmj-57	149	21	p	p	PROPN
ctmj-57	149	22	-	-	PUNCT
ctmj-57	149	23	jak2	jak2	NOUN
ctmj-57	149	24	and	and	CCONJ
ctmj-57	149	25	p	p	NOUN
ctmj-57	149	26	-	-	PUNCT
ctmj-57	149	27	stat3	stat3	NOUN
ctmj-57	149	28	in	in	ADP
ctmj-57	149	29	the	the	DET
ctmj-57	149	30	model	model	NOUN
ctmj-57	149	31	group	group	NOUN
ctmj-57	149	32	.	.	PUNCT
ctmj-57	150	1	chinese	chinese	ADJ
ctmj-57	150	2	traditional	traditional	ADJ
ctmj-57	150	3	medicine	medicine	NOUN
ctmj-57	150	4	journal	journal	NOUN
ctmj-57	150	5	|	|	ADV
ctmj-57	150	6	2020	2020	NUM
ctmj-57	151	1	|	|	ADV
ctmj-57	151	2	vol	vol	NOUN
ctmj-57	151	3	3	3	NUM
ctmj-57	151	4	|	|	ADV
ctmj-57	151	5	issue	issue	VERB
ctmj-57	151	6	6	6	NUM
ctmj-57	151	7	issn	issn	NOUN
ctmj-57	151	8	:	:	PUNCT
ctmj-57	151	9	2693	2693	NUM
ctmj-57	151	10	6356	6356	NUM
ctmj-57	151	11	2020	2020	NUM
ctmj-57	151	12	|	|	ADV
ctmj-57	151	13	vol	vol	NOUN
ctmj-57	151	14	3	3	NUM
ctmj-57	152	1	|	|	ADV
ctmj-57	152	2	issue	issue	VERB
ctmj-57	152	3	6	6	NUM
ctmj-57	152	4	ctmj	ctmj	NOUN
ctmj-57	152	5	|	|	ADV
ctmj-57	152	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	152	7	conclusion	conclusion	VERB
ctmj-57	152	8	the	the	DET
ctmj-57	152	9	combination	combination	NOUN
ctmj-57	152	10	of	of	ADP
ctmj-57	152	11	rmfs	rmfs	NOUN
ctmj-57	152	12	and	and	CCONJ
ctmj-57	152	13	hga	hga	PROPN
ctmj-57	152	14	regulates	regulate	VERB
ctmj-57	152	15	th17	th17	PROPN
ctmj-57	152	16	/	/	SYM
ctmj-57	152	17	treg	treg	PROPN
ctmj-57	152	18	balance	balance	NOUN
ctmj-57	152	19	to	to	PART
ctmj-57	152	20	inhibit	inhibit	VERB
ctmj-57	152	21	inflammatory	inflammatory	ADJ
ctmj-57	152	22	response	response	NOUN
ctmj-57	152	23	and	and	CCONJ
ctmj-57	152	24	reduces	reduce	VERB
ctmj-57	152	25	cell	cell	NOUN
ctmj-57	152	26	apoptosis	apoptosis	NOUN
ctmj-57	152	27	by	by	ADP
ctmj-57	152	28	inhibiting	inhibit	VERB
ctmj-57	152	29	the	the	DET
ctmj-57	152	30	jak	jak	PROPN
ctmj-57	152	31	/	/	SYM
ctmj-57	152	32	stat3	stat3	NOUN
ctmj-57	152	33	pathway	pathway	NOUN
ctmj-57	152	34	.	.	PUNCT
ctmj-57	153	1	this	this	DET
ctmj-57	153	2	treatment	treatment	NOUN
ctmj-57	153	3	could	could	AUX
ctmj-57	153	4	be	be	AUX
ctmj-57	153	5	a	a	DET
ctmj-57	153	6	potential	potential	ADJ
ctmj-57	153	7	therapeutic	therapeutic	ADJ
ctmj-57	153	8	strategy	strategy	NOUN
ctmj-57	153	9	for	for	ADP
ctmj-57	153	10	the	the	DET
ctmj-57	153	11	management	management	NOUN
ctmj-57	153	12	of	of	ADP
ctmj-57	153	13	dry	dry	ADJ
ctmj-57	153	14	eye	eye	NOUN
ctmj-57	153	15	disease	disease	NOUN
ctmj-57	153	16	.	.	PUNCT
ctmj-57	154	1	however	however	ADV
ctmj-57	154	2	,	,	PUNCT
ctmj-57	154	3	this	this	DET
ctmj-57	154	4	study	study	NOUN
ctmj-57	154	5	lacks	lack	VERB
ctmj-57	154	6	clinical	clinical	ADJ
ctmj-57	154	7	data	datum	NOUN
ctmj-57	154	8	to	to	PART
ctmj-57	154	9	show	show	VERB
ctmj-57	154	10	the	the	DET
ctmj-57	154	11	efficacy	efficacy	NOUN
ctmj-57	154	12	and	and	CCONJ
ctmj-57	154	13	safety	safety	NOUN
ctmj-57	154	14	of	of	ADP
ctmj-57	154	15	combined	combined	ADJ
ctmj-57	154	16	treatment	treatment	NOUN
ctmj-57	154	17	with	with	ADP
ctmj-57	154	18	rmfs	rmfs	NOUN
ctmj-57	154	19	and	and	CCONJ
ctmj-57	154	20	hga	hga	NOUN
ctmj-57	154	21	.	.	PUNCT
ctmj-57	155	1	furthermore	furthermore	ADV
ctmj-57	155	2	,	,	PUNCT
ctmj-57	155	3	there	there	PRON
ctmj-57	155	4	may	may	AUX
ctmj-57	155	5	be	be	AUX
ctmj-57	155	6	other	other	ADJ
ctmj-57	155	7	molecular	molecular	ADJ
ctmj-57	155	8	mechanisms	mechanism	NOUN
ctmj-57	155	9	of	of	ADP
ctmj-57	155	10	action	action	NOUN
ctmj-57	155	11	for	for	ADP
ctmj-57	155	12	the	the	DET
ctmj-57	155	13	combination	combination	NOUN
ctmj-57	155	14	of	of	ADP
ctmj-57	155	15	rmfs	rmfs	NOUN
ctmj-57	155	16	and	and	CCONJ
ctmj-57	155	17	hga	hga	NOUN
ctmj-57	155	18	in	in	ADP
ctmj-57	155	19	treatment	treatment	NOUN
ctmj-57	155	20	of	of	ADP
ctmj-57	155	21	dry	dry	ADJ
ctmj-57	155	22	eyes	eye	NOUN
ctmj-57	155	23	that	that	PRON
ctmj-57	155	24	are	be	AUX
ctmj-57	155	25	yet	yet	ADV
ctmj-57	155	26	to	to	PART
ctmj-57	155	27	be	be	AUX
ctmj-57	155	28	identified	identify	VERB
ctmj-57	155	29	.	.	PUNCT
ctmj-57	156	1	therefore	therefore	ADV
ctmj-57	156	2	,	,	PUNCT
ctmj-57	156	3	future	future	ADJ
ctmj-57	156	4	studies	study	NOUN
ctmj-57	156	5	should	should	AUX
ctmj-57	156	6	focus	focus	VERB
ctmj-57	156	7	on	on	ADP
ctmj-57	156	8	clinical	clinical	ADJ
ctmj-57	156	9	data	datum	NOUN
ctmj-57	156	10	collection	collection	NOUN
ctmj-57	156	11	to	to	PART
ctmj-57	156	12	investigate	investigate	VERB
ctmj-57	156	13	the	the	DET
ctmj-57	156	14	efficacy	efficacy	NOUN
ctmj-57	156	15	and	and	CCONJ
ctmj-57	156	16	safety	safety	NOUN
ctmj-57	156	17	of	of	ADP
ctmj-57	156	18	the	the	DET
ctmj-57	156	19	combination	combination	NOUN
ctmj-57	156	20	.	.	PUNCT
ctmj-57	157	1	in	in	ADP
ctmj-57	157	2	addition	addition	NOUN
ctmj-57	157	3	,	,	PUNCT
ctmj-57	157	4	other	other	ADJ
ctmj-57	157	5	pathogenic	pathogenic	ADJ
ctmj-57	157	6	mechanisms	mechanism	NOUN
ctmj-57	157	7	of	of	ADP
ctmj-57	157	8	dry	dry	ADJ
ctmj-57	157	9	eye	eye	NOUN
ctmj-57	157	10	disease	disease	NOUN
ctmj-57	157	11	need	need	VERB
ctmj-57	157	12	to	to	PART
ctmj-57	157	13	be	be	AUX
ctmj-57	157	14	investigated	investigate	VERB
ctmj-57	157	15	.	.	PUNCT
ctmj-57	158	1	references	reference	NOUN
ctmj-57	158	2	1	1	NUM
ctmj-57	158	3	.	.	PUNCT
ctmj-57	159	1	jones	jones	PROPN
ctmj-57	159	2	l	l	PROPN
ctmj-57	159	3	,	,	PUNCT
ctmj-57	159	4	downie	downie	PROPN
ctmj-57	159	5	le	le	PROPN
ctmj-57	159	6	,	,	PUNCT
ctmj-57	159	7	korb	korb	PROPN
ctmj-57	159	8	d	d	PROPN
ctmj-57	159	9	,	,	PUNCT
ctmj-57	159	10	benitez	benitez	PROPN
ctmj-57	159	11	-	-	PUNCT
ctmj-57	159	12	delcastillo	delcastillo	PROPN
ctmj-57	159	13	jm	jm	PROPN
ctmj-57	159	14	,	,	PUNCT
ctmj-57	159	15	dana	dana	PROPN
ctmj-57	159	16	r	r	PROPN
ctmj-57	159	17	,	,	PUNCT
ctmj-57	159	18	deng	deng	PROPN
ctmj-57	159	19	sx	sx	PROPN
ctmj-57	159	20	,	,	PUNCT
ctmj-57	159	21	dong	dong	PROPN
ctmj-57	159	22	pn	pn	PROPN
ctmj-57	159	23	,	,	PUNCT
ctmj-57	159	24	geerling	geerle	VERB
ctmj-57	159	25	g	g	PROPN
ctmj-57	159	26	,	,	PUNCT
ctmj-57	159	27	hida	hida	PROPN
ctmj-57	159	28	ry	ry	PROPN
ctmj-57	159	29	,	,	PUNCT
ctmj-57	159	30	liu	liu	PROPN
ctmj-57	159	31	y	y	PROPN
ctmj-57	159	32	,	,	PUNCT
ctmj-57	159	33	et	et	PROPN
ctmj-57	159	34	al	al	PROPN
ctmj-57	159	35	.	.	PROPN
ctmj-57	160	1	tfos	tfos	PROPN
ctmj-57	160	2	dews	dews	PROPN
ctmj-57	160	3	ii	ii	PROPN
ctmj-57	160	4	management	management	NOUN
ctmj-57	160	5	and	and	CCONJ
ctmj-57	160	6	therapy	therapy	NOUN
ctmj-57	160	7	report	report	NOUN
ctmj-57	160	8	.	.	PUNCT
ctmj-57	161	1	ocul	ocul	NOUN
ctmj-57	161	2	surf	surf	PROPN
ctmj-57	161	3	2017	2017	NUM
ctmj-57	161	4	;	;	PUNCT
ctmj-57	161	5	15(3	15(3	NUM
ctmj-57	161	6	):	):	PUNCT
ctmj-57	161	7	575	575	NUM
ctmj-57	161	8	-	-	SYM
ctmj-57	161	9	628	628	NUM
ctmj-57	161	10	.	.	PUNCT
ctmj-57	162	1	2	2	NUM
ctmj-57	162	2	.	.	X
ctmj-57	162	3	sutu	sutu	PROPN
ctmj-57	162	4	c	c	PROPN
ctmj-57	162	5	,	,	PUNCT
ctmj-57	162	6	fukuoka	fukuoka	PROPN
ctmj-57	162	7	h	h	NOUN
ctmj-57	162	8	,	,	PUNCT
ctmj-57	162	9	afshari	afshari	ADJ
ctmj-57	162	10	na	na	NOUN
ctmj-57	162	11	.	.	NOUN
ctmj-57	162	12	mechanisms	mechanism	NOUN
ctmj-57	162	13	and	and	CCONJ
ctmj-57	162	14	management	management	NOUN
ctmj-57	162	15	of	of	ADP
ctmj-57	162	16	dry	dry	ADJ
ctmj-57	162	17	eye	eye	NOUN
ctmj-57	162	18	in	in	ADP
ctmj-57	162	19	cataract	cataract	NOUN
ctmj-57	162	20	surgery	surgery	NOUN
ctmj-57	162	21	patients	patient	NOUN
ctmj-57	162	22	.	.	PUNCT
ctmj-57	163	1	curr	curr	PROPN
ctmj-57	163	2	opin	opin	PROPN
ctmj-57	163	3	ophthalmol	ophthalmol	PROPN
ctmj-57	163	4	2016	2016	NUM
ctmj-57	163	5	;	;	PUNCT
ctmj-57	163	6	27(1	27(1	NUM
ctmj-57	163	7	):	):	PUNCT
ctmj-57	163	8	24	24	NUM
ctmj-57	163	9	-	-	SYM
ctmj-57	163	10	30	30	NUM
ctmj-57	163	11	.	.	PUNCT
ctmj-57	164	1	3	3	X
ctmj-57	164	2	.	.	PUNCT
ctmj-57	164	3	tsubota	tsubota	PROPN
ctmj-57	164	4	k	k	NOUN
ctmj-57	164	5	,	,	PUNCT
ctmj-57	164	6	pflugfelder	pflugfelder	PROPN
ctmj-57	164	7	sc	sc	PROPN
ctmj-57	164	8	,	,	PUNCT
ctmj-57	164	9	liu	liu	PROPN
ctmj-57	164	10	z	z	PROPN
ctmj-57	164	11	,	,	PUNCT
ctmj-57	164	12	baudouin	baudouin	PROPN
ctmj-57	164	13	c	c	NOUN
ctmj-57	164	14	,	,	PUNCT
ctmj-57	164	15	kim	kim	PROPN
ctmj-57	164	16	hm	hm	PROPN
ctmj-57	164	17	,	,	PUNCT
ctmj-57	164	18	messmer	messmer	PROPN
ctmj-57	164	19	em	em	PRON
ctmj-57	164	20	,	,	PUNCT
ctmj-57	164	21	kruse	kruse	PROPN
ctmj-57	164	22	f	f	PROPN
ctmj-57	164	23	,	,	PUNCT
ctmj-57	164	24	liang	liang	PROPN
ctmj-57	164	25	l	l	PROPN
ctmj-57	164	26	,	,	PUNCT
ctmj-57	164	27	carreno	carreno	NOUN
ctmj-57	164	28	-	-	PUNCT
ctmj-57	164	29	galeano	galeano	PROPN
ctmj-57	164	30	jt	jt	PROPN
ctmj-57	164	31	,	,	PUNCT
ctmj-57	164	32	rolando	rolando	PROPN
ctmj-57	164	33	m	m	PROPN
ctmj-57	164	34	et	et	PROPN
ctmj-57	164	35	al	al	PROPN
ctmj-57	164	36	.	.	PUNCT
ctmj-57	164	37	defining	define	VERB
ctmj-57	164	38	dry	dry	ADJ
ctmj-57	164	39	eye	eye	NOUN
ctmj-57	164	40	from	from	ADP
ctmj-57	164	41	a	a	DET
ctmj-57	164	42	clinical	clinical	ADJ
ctmj-57	164	43	perspective	perspective	NOUN
ctmj-57	164	44	.	.	PUNCT
ctmj-57	165	1	int	int	PROPN
ctmj-57	165	2	j	j	PROPN
ctmj-57	165	3	mol	mol	ADP
ctmj-57	165	4	sci	sci	PROPN
ctmj-57	165	5	2020	2020	NUM
ctmj-57	165	6	;	;	PUNCT
ctmj-57	165	7	21(23	21(23	NOUN
ctmj-57	165	8	):	):	PUNCT
ctmj-57	165	9	9271	9271	NUM
ctmj-57	165	10	.	.	PUNCT
ctmj-57	166	1	doi	doi	NOUN
ctmj-57	166	2	:	:	PUNCT
ctmj-57	166	3	10.3390	10.3390	NUM
ctmj-57	166	4	/	/	SYM
ctmj-57	166	5	ijms21239271	ijms21239271	PROPN
ctmj-57	166	6	4	4	NUM
ctmj-57	166	7	.	.	PUNCT
ctmj-57	166	8	bjordal	bjordal	NOUN
ctmj-57	166	9	o	o	PROPN
ctmj-57	166	10	,	,	PUNCT
ctmj-57	166	11	norheim	norheim	PROPN
ctmj-57	166	12	kb	kb	PROPN
ctmj-57	166	13	,	,	PUNCT
ctmj-57	166	14	rødahl	rødahl	VERB
ctmj-57	166	15	e	e	NOUN
ctmj-57	166	16	,	,	PUNCT
ctmj-57	166	17	jonsson	jonsson	PROPN
ctmj-57	166	18	r	r	PROPN
ctmj-57	166	19	,	,	PUNCT
ctmj-57	166	20	omdal	omdal	ADJ
ctmj-57	166	21	r.	r.	PROPN
ctmj-57	166	22	primary	primary	PROPN
ctmj-57	166	23	sjögren	sjögren	PROPN
ctmj-57	166	24	's	's	PART
ctmj-57	166	25	syndrome	syndrome	NOUN
ctmj-57	166	26	and	and	CCONJ
ctmj-57	166	27	the	the	DET
ctmj-57	166	28	eye	eye	NOUN
ctmj-57	166	29	.	.	PUNCT
ctmj-57	167	1	surv	surv	VERB
ctmj-57	167	2	ophthalmol	ophthalmol	PROPN
ctmj-57	167	3	2020	2020	NUM
ctmj-57	167	4	;	;	PUNCT
ctmj-57	167	5	65(2	65(2	NUM
ctmj-57	167	6	):	):	PUNCT
ctmj-57	167	7	119	119	NUM
ctmj-57	167	8	-	-	SYM
ctmj-57	167	9	132	132	NUM
ctmj-57	167	10	.	.	NOUN
ctmj-57	168	1	5	5	NUM
ctmj-57	168	2	.	.	X
ctmj-57	168	3	lee	lee	PROPN
ctmj-57	168	4	gr	gr	PROPN
ctmj-57	168	5	.	.	PUNCT
ctmj-57	169	1	the	the	DET
ctmj-57	169	2	balance	balance	NOUN
ctmj-57	169	3	of	of	ADP
ctmj-57	169	4	th17	th17	PROPN
ctmj-57	169	5	versus	versus	ADP
ctmj-57	169	6	treg	treg	PROPN
ctmj-57	169	7	cells	cell	NOUN
ctmj-57	169	8	in	in	ADP
ctmj-57	169	9	autoimmunity	autoimmunity	NOUN
ctmj-57	169	10	.	.	PUNCT
ctmj-57	170	1	int	int	PROPN
ctmj-57	170	2	j	j	PROPN
ctmj-57	170	3	mol	mol	ADP
ctmj-57	170	4	sci	sci	PROPN
ctmj-57	170	5	2018	2018	NUM
ctmj-57	170	6	;	;	PUNCT
ctmj-57	170	7	19(3	19(3	NUM
ctmj-57	170	8	):	):	PUNCT
ctmj-57	171	1	730	730	NUM
ctmj-57	171	2	.	.	PUNCT
ctmj-57	171	3	doi	doi	NOUN
ctmj-57	171	4	:	:	PUNCT
ctmj-57	171	5	10.3390	10.3390	NUM
ctmj-57	171	6	/	/	SYM
ctmj-57	171	7	ijms19030730	ijms19030730	NOUN
ctmj-57	171	8	.	.	PUNCT
ctmj-57	172	1	6	6	NUM
ctmj-57	172	2	.	.	X
ctmj-57	172	3	chauhan	chauhan	PROPN
ctmj-57	172	4	sk	sk	PROPN
ctmj-57	172	5	,	,	PUNCT
ctmj-57	172	6	el	el	PROPN
ctmj-57	172	7	annan	annan	PROPN
ctmj-57	172	8	j	j	PROPN
ctmj-57	172	9	,	,	PUNCT
ctmj-57	172	10	ecoiffier	ecoiffier	NOUN
ctmj-57	172	11	t	t	PROPN
ctmj-57	172	12	,	,	PUNCT
ctmj-57	172	13	goyal	goyal	PROPN
ctmj-57	172	14	s	s	PROPN
ctmj-57	172	15	,	,	PUNCT
ctmj-57	172	16	zhang	zhang	PROPN
ctmj-57	172	17	q	q	PROPN
ctmj-57	172	18	,	,	PUNCT
ctmj-57	172	19	saban	saban	PROPN
ctmj-57	172	20	dr	dr	PROPN
ctmj-57	172	21	,	,	PUNCT
ctmj-57	172	22	dana	dana	PROPN
ctmj-57	172	23	r.	r.	PROPN
ctmj-57	172	24	autoimmunity	autoimmunity	PROPN
ctmj-57	172	25	in	in	ADP
ctmj-57	172	26	dry	dry	ADJ
ctmj-57	172	27	eye	eye	NOUN
ctmj-57	172	28	is	be	AUX
ctmj-57	172	29	due	due	ADJ
ctmj-57	172	30	to	to	ADP
ctmj-57	172	31	resistance	resistance	NOUN
ctmj-57	172	32	of	of	ADP
ctmj-57	172	33	th17	th17	PROPN
ctmj-57	172	34	to	to	ADP
ctmj-57	172	35	treg	treg	PROPN
ctmj-57	172	36	suppression	suppression	NOUN
ctmj-57	172	37	.	.	PUNCT
ctmj-57	173	1	j	j	PROPN
ctmj-57	173	2	immunol	immunol	NOUN
ctmj-57	173	3	2009	2009	NUM
ctmj-57	173	4	;	;	PUNCT
ctmj-57	173	5	182(3	182(3	NUM
ctmj-57	173	6	):	):	PUNCT
ctmj-57	173	7	1247	1247	NUM
ctmj-57	173	8	-	-	SYM
ctmj-57	173	9	1252	1252	NUM
ctmj-57	173	10	.	.	PUNCT
ctmj-57	174	1	7	7	X
ctmj-57	174	2	.	.	X
ctmj-57	174	3	health	health	PROPN
ctmj-57	174	4	nio	nio	PROPN
ctmj-57	174	5	:	:	PUNCT
ctmj-57	174	6	guide	guide	VERB
ctmj-57	174	7	for	for	ADP
ctmj-57	174	8	the	the	DET
ctmj-57	174	9	care	care	NOUN
ctmj-57	174	10	and	and	CCONJ
ctmj-57	174	11	use	use	NOUN
ctmj-57	174	12	of	of	ADP
ctmj-57	174	13	laboratory	laboratory	NOUN
ctmj-57	174	14	animals	animal	NOUN
ctmj-57	174	15	:	:	PUNCT
ctmj-57	174	16	national	national	ADJ
ctmj-57	174	17	academies	academy	NOUN
ctmj-57	174	18	;	;	PUNCT
ctmj-57	174	19	1985	1985	NUM
ctmj-57	174	20	.	.	PUNCT
ctmj-57	175	1	8	8	NUM
ctmj-57	175	2	.	.	X
ctmj-57	175	3	ding	ding	PROPN
ctmj-57	175	4	n	n	CCONJ
ctmj-57	175	5	,	,	PUNCT
ctmj-57	175	6	wei	wei	PROPN
ctmj-57	175	7	q	q	PROPN
ctmj-57	175	8	,	,	PUNCT
ctmj-57	175	9	deng	deng	PROPN
ctmj-57	175	10	w	w	PROPN
ctmj-57	175	11	,	,	PUNCT
ctmj-57	175	12	sun	sun	PROPN
ctmj-57	175	13	x	x	SYM
ctmj-57	175	14	,	,	PUNCT
ctmj-57	175	15	zhang	zhang	PROPN
ctmj-57	175	16	j	j	PROPN
ctmj-57	175	17	,	,	PUNCT
ctmj-57	175	18	gao	gao	PROPN
ctmj-57	175	19	w.	w.	PROPN
ctmj-57	175	20	electroacupuncture	electroacupuncture	PROPN
ctmj-57	175	21	alleviates	alleviate	VERB
ctmj-57	175	22	inflammation	inflammation	NOUN
ctmj-57	175	23	of	of	ADP
ctmj-57	175	24	dry	dry	ADJ
ctmj-57	175	25	eye	eye	NOUN
ctmj-57	175	26	diseases	disease	NOUN
ctmj-57	175	27	by	by	ADP
ctmj-57	175	28	regulating	regulate	VERB
ctmj-57	175	29	the	the	DET
ctmj-57	175	30	α7nachr	α7nachr	NOUN
ctmj-57	175	31	/	/	SYM
ctmj-57	175	32	nf	nf	NOUN
ctmj-57	175	33	-	-	PUNCT
ctmj-57	175	34	κb	κb	NOUN
ctmj-57	175	35	signaling	signal	VERB
ctmj-57	175	36	pathway	pathway	NOUN
ctmj-57	175	37	.	.	PUNCT
ctmj-57	176	1	oxid	oxid	PROPN
ctmj-57	176	2	med	med	ADJ
ctmj-57	176	3	cell	cell	NOUN
ctmj-57	176	4	longev	longev	NOUN
ctmj-57	176	5	2021	2021	NUM
ctmj-57	176	6	;	;	PUNCT
ctmj-57	176	7	2021	2021	NUM
ctmj-57	176	8	:	:	PUNCT
ctmj-57	176	9	6673610	6673610	NUM
ctmj-57	176	10	.	.	PUNCT
ctmj-57	177	1	doi	doi	NOUN
ctmj-57	177	2	:	:	PUNCT
ctmj-57	177	3	10.1155/2021/6673610	10.1155/2021/6673610	NUM
ctmj-57	177	4	.	.	NOUN
ctmj-57	177	5	9	9	NUM
ctmj-57	177	6	.	.	X
ctmj-57	177	7	chu	chu	PROPN
ctmj-57	177	8	l	l	PROPN
ctmj-57	177	9	,	,	PUNCT
ctmj-57	177	10	ma	ma	PROPN
ctmj-57	177	11	s	s	PROPN
ctmj-57	177	12	,	,	PUNCT
ctmj-57	177	13	chen	chen	PROPN
ctmj-57	177	14	z	z	PROPN
ctmj-57	177	15	,	,	PUNCT
ctmj-57	177	16	cao	cao	PROPN
ctmj-57	177	17	w.	w.	PROPN
ctmj-57	177	18	astragalus	astragalus	PROPN
ctmj-57	177	19	ⅳ	ⅳ	NOUN
ctmj-57	177	20	ameliorates	ameliorate	VERB
ctmj-57	177	21	the	the	DET
ctmj-57	177	22	dry	dry	ADJ
ctmj-57	177	23	eye	eye	NOUN
ctmj-57	177	24	injury	injury	NOUN
ctmj-57	177	25	in	in	ADP
ctmj-57	177	26	rabbit	rabbit	NOUN
ctmj-57	177	27	model	model	NOUN
ctmj-57	177	28	via	via	ADP
ctmj-57	177	29	muc1	muc1	PROPN
ctmj-57	177	30	-	-	PUNCT
ctmj-57	177	31	erbb1	erbb1	NOUN
ctmj-57	177	32	pathway	pathway	NOUN
ctmj-57	177	33	.	.	PUNCT
ctmj-57	178	1	eur	eur	PROPN
ctmj-57	178	2	j	j	PROPN
ctmj-57	178	3	histochem	histochem	PROPN
ctmj-57	178	4	2021	2021	NUM
ctmj-57	178	5	;	;	PUNCT
ctmj-57	178	6	65(2	65(2	NUM
ctmj-57	178	7	):	):	PUNCT
ctmj-57	178	8	3198	3198	NUM
ctmj-57	178	9	.	.	PUNCT
ctmj-57	179	1	doi	doi	NOUN
ctmj-57	179	2	:	:	PUNCT
ctmj-57	179	3	10.4081	10.4081	NUM
ctmj-57	179	4	/	/	SYM
ctmj-57	179	5	ejh.2021.3198	ejh.2021.3198	NOUN
ctmj-57	179	6	.	.	PUNCT
ctmj-57	180	1	10	10	NUM
ctmj-57	180	2	.	.	PUNCT
ctmj-57	181	1	qin	qin	PROPN
ctmj-57	181	2	g	g	PROPN
ctmj-57	181	3	,	,	PUNCT
ctmj-57	181	4	zhou	zhou	PROPN
ctmj-57	181	5	y	y	PROPN
ctmj-57	181	6	,	,	PUNCT
ctmj-57	181	7	peng	peng	PROPN
ctmj-57	181	8	j	j	PROPN
ctmj-57	181	9	,	,	PUNCT
ctmj-57	181	10	zhang	zhang	PROPN
ctmj-57	181	11	y	y	PROPN
ctmj-57	181	12	,	,	PUNCT
ctmj-57	181	13	peng	peng	PROPN
ctmj-57	181	14	x	x	PROPN
ctmj-57	181	15	,	,	PUNCT
ctmj-57	181	16	peng	peng	PROPN
ctmj-57	181	17	q	q	PROPN
ctmj-57	181	18	,	,	PUNCT
ctmj-57	181	19	yang	yang	PROPN
ctmj-57	181	20	y.	y.	PROPN
ctmj-57	181	21	the	the	DET
ctmj-57	181	22	effect	effect	NOUN
ctmj-57	181	23	of	of	ADP
ctmj-57	181	24	buddleja	buddleja	ADJ
ctmj-57	181	25	officinalis	officinalis	ADJ
ctmj-57	181	26	maxim	maxim	NOUN
ctmj-57	181	27	eye	eye	NOUN
ctmj-57	181	28	drops	drop	NOUN
ctmj-57	181	29	on	on	ADP
ctmj-57	181	30	morphology	morphology	NOUN
ctmj-57	181	31	and	and	CCONJ
ctmj-57	181	32	apoptosis	apoptosis	NOUN
ctmj-57	181	33	in	in	ADP
ctmj-57	181	34	lacrimal	lacrimal	ADJ
ctmj-57	181	35	gland	gland	NOUN
ctmj-57	181	36	of	of	ADP
ctmj-57	181	37	experimental	experimental	ADJ
ctmj-57	181	38	dry	dry	ADJ
ctmj-57	181	39	eye	eye	NOUN
ctmj-57	181	40	rabbit	rabbit	NOUN
ctmj-57	181	41	model	model	NOUN
ctmj-57	181	42	.	.	PUNCT
ctmj-57	182	1	j	j	PROPN
ctmj-57	182	2	ophthalmol	ophthalmol	PROPN
ctmj-57	182	3	2019	2019	NUM
ctmj-57	182	4	;	;	PUNCT
ctmj-57	182	5	2019:5916243	2019:5916243	NUM
ctmj-57	182	6	.	.	PUNCT
ctmj-57	183	1	doi	doi	NOUN
ctmj-57	183	2	:	:	PUNCT
ctmj-57	183	3	10.1155/2019/5916243	10.1155/2019/5916243	NUM
ctmj-57	183	4	.	.	PUNCT
ctmj-57	184	1	11	11	NUM
ctmj-57	184	2	.	.	PUNCT
ctmj-57	185	1	wolf	wolf	PROPN
ctmj-57	185	2	d	d	PROPN
ctmj-57	185	3	,	,	PUNCT
ctmj-57	185	4	gerhardt	gerhardt	PROPN
ctmj-57	185	5	t	t	PROPN
ctmj-57	185	6	,	,	PUNCT
ctmj-57	185	7	winkels	winkels	PROPN
ctmj-57	185	8	h	h	PROPN
ctmj-57	185	9	,	,	PUNCT
ctmj-57	185	10	michel	michel	PROPN
ctmj-57	185	11	na	na	PROPN
ctmj-57	185	12	,	,	PUNCT
ctmj-57	185	13	pramod	pramod	PROPN
ctmj-57	185	14	ab	ab	PROPN
ctmj-57	185	15	,	,	PUNCT
ctmj-57	185	16	ghosheh	ghosheh	PROPN
ctmj-57	185	17	y	y	PROPN
ctmj-57	185	18	,	,	PUNCT
ctmj-57	185	19	brunel	brunel	PROPN
ctmj-57	185	20	s	s	PROPN
ctmj-57	185	21	,	,	PUNCT
ctmj-57	185	22	buscher	buscher	PROPN
ctmj-57	185	23	k	k	PROPN
ctmj-57	185	24	,	,	PUNCT
ctmj-57	185	25	miller	miller	PROPN
ctmj-57	185	26	j	j	PROPN
ctmj-57	185	27	,	,	PUNCT
ctmj-57	185	28	mcardle	mcardle	PROPN
ctmj-57	185	29	s	s	PROPN
ctmj-57	185	30	et	et	PROPN
ctmj-57	185	31	al	al	PROPN
ctmj-57	185	32	.	.	PROPN
ctmj-57	185	33	pathogenic	pathogenic	ADJ
ctmj-57	185	34	autoimmunity	autoimmunity	NOUN
ctmj-57	185	35	in	in	ADP
ctmj-57	185	36	atherosclerosis	atherosclerosis	NOUN
ctmj-57	185	37	evolves	evolve	VERB
ctmj-57	185	38	from	from	ADP
ctmj-57	185	39	initially	initially	ADV
ctmj-57	185	40	protective	protective	ADJ
ctmj-57	185	41	apolipoprotein	apolipoprotein	ADJ
ctmj-57	185	42	b(100)-reactive	b(100)-reactive	ADJ
ctmj-57	185	43	cd4(+	cd4(+	NOUN
ctmj-57	185	44	)	)	PUNCT
ctmj-57	185	45	tregulatory	tregulatory	ADJ
ctmj-57	185	46	cells	cell	NOUN
ctmj-57	185	47	.	.	PUNCT
ctmj-57	186	1	circulation	circulation	NOUN
ctmj-57	186	2	2020	2020	NUM
ctmj-57	186	3	;	;	PUNCT
ctmj-57	186	4	142(13	142(13	NUM
ctmj-57	186	5	):	):	PUNCT
ctmj-57	186	6	12791293	12791293	NUM
ctmj-57	186	7	.	.	PUNCT
ctmj-57	187	1	12	12	NUM
ctmj-57	187	2	.	.	PUNCT
ctmj-57	188	1	mei	mei	PROPN
ctmj-57	188	2	c	c	PROPN
ctmj-57	188	3	,	,	PUNCT
ctmj-57	188	4	jie	jie	PROPN
ctmj-57	188	5	l	l	PROPN
ctmj-57	188	6	,	,	PUNCT
ctmj-57	188	7	jun	jun	PROPN
ctmj-57	188	8	p	p	PROPN
ctmj-57	188	9	,	,	PUNCT
ctmj-57	188	10	yu	yu	PROPN
ctmj-57	188	11	h	h	NOUN
ctmj-57	188	12	,	,	PUNCT
ctmj-57	188	13	weijie	weijie	PROPN
ctmj-57	188	14	o	o	NOUN
ctmj-57	188	15	,	,	PUNCT
ctmj-57	188	16	xiaoqing	xiaoqing	PROPN
ctmj-57	188	17	l	l	PROPN
ctmj-57	188	18	,	,	PUNCT
ctmj-57	188	19	zhibin	zhibin	PROPN
ctmj-57	188	20	s	s	PROPN
ctmj-57	188	21	,	,	PUNCT
ctmj-57	188	22	changdong	changdong	PROPN
ctmj-57	188	23	l	l	PROPN
ctmj-57	188	24	,	,	PUNCT
ctmj-57	188	25	yi	yi	PROPN
ctmj-57	188	26	w	w	PROPN
ctmj-57	188	27	,	,	PUNCT
ctmj-57	188	28	qinghua	qinghua	PROPN
ctmj-57	188	29	p.	p.	PROPN
ctmj-57	188	30	linarin	linarin	PROPN
ctmj-57	188	31	ameliorates	ameliorate	VERB
ctmj-57	188	32	innate	innate	ADJ
ctmj-57	188	33	inflammatory	inflammatory	ADJ
ctmj-57	188	34	response	response	NOUN
ctmj-57	188	35	in	in	ADP
ctmj-57	188	36	an	an	DET
ctmj-57	188	37	experimental	experimental	ADJ
ctmj-57	188	38	dry	dry	ADJ
ctmj-57	188	39	eye	eye	NOUN
ctmj-57	188	40	model	model	NOUN
ctmj-57	188	41	via	via	ADP
ctmj-57	188	42	modulation	modulation	NOUN
ctmj-57	188	43	of	of	ADP
ctmj-57	188	44	the	the	DET
ctmj-57	188	45	nlrp3	nlrp3	NOUN
ctmj-57	188	46	inflammasome	inflammasome	NOUN
ctmj-57	188	47	.	.	PUNCT
ctmj-57	189	1	digital	digital	ADJ
ctmj-57	189	2	chin	chin	NOUN
ctmj-57	189	3	med	med	PROPN
ctmj-57	189	4	2021	2021	NUM
ctmj-57	189	5	;	;	PUNCT
ctmj-57	189	6	4(1	4(1	NOUN
ctmj-57	189	7	):	):	PUNCT
ctmj-57	189	8	42	42	NUM
ctmj-57	189	9	-	-	SYM
ctmj-57	189	10	53	53	NUM
ctmj-57	189	11	.	.	NOUN
ctmj-57	189	12	13	13	NUM
ctmj-57	189	13	.	.	PUNCT
ctmj-57	190	1	yang	yang	PROPN
ctmj-57	190	2	x	x	PROPN
ctmj-57	190	3	,	,	PUNCT
ctmj-57	190	4	zhou	zhou	PROPN
ctmj-57	190	5	f	f	PROPN
ctmj-57	190	6	,	,	PUNCT
ctmj-57	190	7	yuan	yuan	NOUN
ctmj-57	190	8	p	p	X
ctmj-57	190	9	,	,	PUNCT
ctmj-57	190	10	dou	dou	NOUN
ctmj-57	190	11	g	g	NOUN
ctmj-57	190	12	,	,	PUNCT
ctmj-57	190	13	liu	liu	PROPN
ctmj-57	190	14	x	x	PROPN
ctmj-57	190	15	,	,	PUNCT
ctmj-57	190	16	liu	liu	PROPN
ctmj-57	190	17	s	s	PROPN
ctmj-57	190	18	,	,	PUNCT
ctmj-57	190	19	wang	wang	PROPN
ctmj-57	190	20	x	x	PROPN
ctmj-57	190	21	,	,	PUNCT
ctmj-57	190	22	jin	jin	PROPN
ctmj-57	190	23	r	r	PROPN
ctmj-57	190	24	,	,	PUNCT
ctmj-57	190	25	dong	dong	PROPN
ctmj-57	190	26	y	y	PROPN
ctmj-57	190	27	,	,	PUNCT
ctmj-57	190	28	zhou	zhou	PROPN
ctmj-57	190	29	j	j	PROPN
ctmj-57	190	30	et	et	PROPN
ctmj-57	190	31	al	al	PROPN
ctmj-57	190	32	.	.	PROPN
ctmj-57	190	33	t	t	PROPN
ctmj-57	190	34	celldepleting	celldeplete	VERB
ctmj-57	190	35	nanoparticles	nanoparticle	NOUN
ctmj-57	190	36	ameliorate	ameliorate	VERB
ctmj-57	190	37	bone	bone	NOUN
ctmj-57	190	38	loss	loss	NOUN
ctmj-57	190	39	by	by	ADP
ctmj-57	190	40	reducing	reduce	VERB
ctmj-57	190	41	activated	activate	VERB
ctmj-57	190	42	t	t	NOUN
ctmj-57	190	43	cells	cell	NOUN
ctmj-57	190	44	and	and	CCONJ
ctmj-57	190	45	regulating	regulate	VERB
ctmj-57	190	46	the	the	DET
ctmj-57	190	47	treg	treg	PROPN
ctmj-57	190	48	/	/	SYM
ctmj-57	190	49	th17	th17	PROPN
ctmj-57	190	50	balance	balance	NOUN
ctmj-57	190	51	.	.	PUNCT
ctmj-57	191	1	bioact	bioact	ADJ
ctmj-57	191	2	mater	mater	NOUN
ctmj-57	191	3	2021	2021	NUM
ctmj-57	191	4	;	;	PUNCT
ctmj-57	191	5	6(10	6(10	NUM
ctmj-57	191	6	):	):	PUNCT
ctmj-57	191	7	3150	3150	NUM
ctmj-57	191	8	-	-	SYM
ctmj-57	191	9	3163	3163	NUM
ctmj-57	191	10	.	.	PUNCT
ctmj-57	192	1	14	14	NUM
ctmj-57	192	2	.	.	PUNCT
ctmj-57	193	1	britton	britton	PROPN
ctmj-57	193	2	gj	gj	PROPN
ctmj-57	193	3	,	,	PUNCT
ctmj-57	193	4	contijoch	contijoch	PROPN
ctmj-57	193	5	ej	ej	PROPN
ctmj-57	193	6	,	,	PUNCT
ctmj-57	193	7	spindler	spindler	PROPN
ctmj-57	193	8	mp	mp	PROPN
ctmj-57	193	9	,	,	PUNCT
ctmj-57	193	10	aggarwala	aggarwala	PROPN
ctmj-57	193	11	v	v	NOUN
ctmj-57	193	12	,	,	PUNCT
ctmj-57	193	13	dogan	dogan	PROPN
ctmj-57	193	14	b	b	PROPN
ctmj-57	193	15	,	,	PUNCT
ctmj-57	193	16	bongers	bonger	VERB
ctmj-57	193	17	g	g	NOUN
ctmj-57	193	18	,	,	PUNCT
ctmj-57	193	19	san	san	PROPN
ctmj-57	193	20	mateo	mateo	PROPN
ctmj-57	193	21	l	l	PROPN
ctmj-57	193	22	,	,	PUNCT
ctmj-57	193	23	baltus	baltus	PROPN
ctmj-57	193	24	a	a	PROPN
ctmj-57	193	25	,	,	PUNCT
ctmj-57	193	26	das	das	PROPN
ctmj-57	193	27	a	a	PRON
ctmj-57	193	28	,	,	PUNCT
ctmj-57	193	29	gevers	gever	NOUN
ctmj-57	193	30	d	d	PROPN
ctmj-57	193	31	et	et	PROPN
ctmj-57	193	32	al	al	PROPN
ctmj-57	193	33	.	.	PROPN
ctmj-57	193	34	defined	define	VERB
ctmj-57	193	35	microbiota	microbiota	NOUN
ctmj-57	193	36	transplant	transplant	NOUN
ctmj-57	193	37	restores	restore	VERB
ctmj-57	193	38	th17	th17	PROPN
ctmj-57	193	39	/	/	SYM
ctmj-57	193	40	rorγt(+	rorγt(+	NOUN
ctmj-57	193	41	)	)	PUNCT
ctmj-57	193	42	regulatory	regulatory	ADJ
ctmj-57	193	43	t	t	NOUN
ctmj-57	193	44	cell	cell	NOUN
ctmj-57	193	45	balance	balance	NOUN
ctmj-57	193	46	in	in	ADP
ctmj-57	193	47	mice	mouse	NOUN
ctmj-57	193	48	colonized	colonize	VERB
ctmj-57	193	49	with	with	ADP
ctmj-57	193	50	inflammatory	inflammatory	ADJ
ctmj-57	193	51	bowel	bowel	NOUN
ctmj-57	193	52	disease	disease	NOUN
ctmj-57	193	53	microbiotas	microbiota	NOUN
ctmj-57	193	54	.	.	PUNCT
ctmj-57	194	1	proc	proc	PROPN
ctmj-57	194	2	natl	natl	PROPN
ctmj-57	194	3	acad	acad	PROPN
ctmj-57	194	4	sci	sci	PROPN
ctmj-57	194	5	usa	usa	PROPN
ctmj-57	194	6	2020	2020	NUM
ctmj-57	194	7	;	;	PUNCT
ctmj-57	194	8	117(35	117(35	NUM
ctmj-57	194	9	):	):	PUNCT
ctmj-57	194	10	21536	21536	NUM
ctmj-57	194	11	-	-	SYM
ctmj-57	194	12	21545	21545	NUM
ctmj-57	194	13	.	.	PUNCT
ctmj-57	195	1	15	15	NUM
ctmj-57	195	2	.	.	PUNCT
ctmj-57	195	3	meckiff	meckiff	ADJ
ctmj-57	195	4	bj	bj	NOUN
ctmj-57	195	5	,	,	PUNCT
ctmj-57	195	6	ramírez	ramírez	NOUN
ctmj-57	195	7	-	-	PUNCT
ctmj-57	195	8	suástegui	suástegui	NOUN
ctmj-57	195	9	c	c	NOUN
ctmj-57	195	10	,	,	PUNCT
ctmj-57	195	11	fajardo	fajardo	PROPN
ctmj-57	195	12	v	v	PROPN
ctmj-57	195	13	,	,	PUNCT
ctmj-57	195	14	chee	chee	NOUN
ctmj-57	195	15	sj	sj	NOUN
ctmj-57	195	16	,	,	PUNCT
ctmj-57	195	17	kusnadi	kusnadi	NOUN
ctmj-57	195	18	a	a	NOUN
ctmj-57	195	19	,	,	PUNCT
ctmj-57	195	20	simon	simon	PROPN
ctmj-57	195	21	h	h	PROPN
ctmj-57	195	22	,	,	PUNCT
ctmj-57	195	23	eschweiler	eschweiler	NOUN
ctmj-57	195	24	s	s	PROPN
ctmj-57	195	25	,	,	PUNCT
ctmj-57	195	26	grifoni	grifoni	VERB
ctmj-57	195	27	a	a	PRON
ctmj-57	195	28	,	,	PUNCT
ctmj-57	195	29	pelosi	pelosi	PROPN
ctmj-57	195	30	e	e	NOUN
ctmj-57	195	31	,	,	PUNCT
ctmj-57	195	32	weiskopf	weiskopf	PUNCT
ctmj-57	195	33	d	d	X
ctmj-57	195	34	et	et	PROPN
ctmj-57	195	35	al	al	PROPN
ctmj-57	195	36	.	.	PROPN
ctmj-57	195	37	imbalance	imbalance	NOUN
ctmj-57	195	38	of	of	ADP
ctmj-57	195	39	regulatory	regulatory	ADJ
ctmj-57	195	40	and	and	CCONJ
ctmj-57	195	41	cytotoxic	cytotoxic	ADJ
ctmj-57	195	42	sars	sar	NOUN
ctmj-57	195	43	-	-	PUNCT
ctmj-57	195	44	cov-2	cov-2	NOUN
ctmj-57	195	45	-	-	ADJ
ctmj-57	195	46	reactive	reactive	ADJ
ctmj-57	195	47	cd4(+	cd4(+	NOUN
ctmj-57	195	48	)	)	PUNCT
ctmj-57	195	49	t	t	NOUN
ctmj-57	195	50	cells	cell	NOUN
ctmj-57	195	51	in	in	ADP
ctmj-57	195	52	covid-19	covid-19	PROPN
ctmj-57	195	53	.	.	PUNCT
ctmj-57	195	54	cell	cell	NOUN
ctmj-57	195	55	2020	2020	NUM
ctmj-57	195	56	;	;	PUNCT
ctmj-57	195	57	183(5	183(5	NUM
ctmj-57	195	58	):	):	PUNCT
ctmj-57	195	59	1340	1340	NUM
ctmj-57	195	60	-	-	SYM
ctmj-57	195	61	1353.e1316	1353.e1316	VERB
ctmj-57	195	62	.	.	PROPN
ctmj-57	196	1	16	16	NUM
ctmj-57	196	2	.	.	PUNCT
ctmj-57	197	1	fu	fu	PROPN
ctmj-57	197	2	r	r	PROPN
ctmj-57	197	3	,	,	PUNCT
ctmj-57	197	4	jiang	jiang	PROPN
ctmj-57	197	5	y	y	PROPN
ctmj-57	197	6	,	,	PUNCT
ctmj-57	197	7	zhou	zhou	PROPN
ctmj-57	197	8	j	j	PROPN
ctmj-57	197	9	,	,	PUNCT
ctmj-57	197	10	zhang	zhang	PROPN
ctmj-57	197	11	j.	j.	PROPN
ctmj-57	197	12	rebamipide	rebamipide	PROPN
ctmj-57	197	13	ophthalmic	ophthalmic	ADJ
ctmj-57	197	14	solution	solution	NOUN
ctmj-57	197	15	modulates	modulate	VERB
ctmj-57	197	16	the	the	DET
ctmj-57	197	17	ratio	ratio	NOUN
ctmj-57	197	18	of	of	ADP
ctmj-57	197	19	t	t	PROPN
ctmj-57	197	20	helper	helper	NOUN
ctmj-57	197	21	cell	cell	NOUN
ctmj-57	197	22	17	17	NUM
ctmj-57	197	23	/	/	SYM
ctmj-57	197	24	regulatory	regulatory	ADJ
ctmj-57	197	25	t	t	NOUN
ctmj-57	197	26	cells	cell	NOUN
ctmj-57	197	27	in	in	ADP
ctmj-57	197	28	dry	dry	ADJ
ctmj-57	197	29	eye	eye	NOUN
ctmj-57	197	30	disease	disease	NOUN
ctmj-57	197	31	mice	mouse	NOUN
ctmj-57	197	32	.	.	PUNCT
ctmj-57	198	1	mol	mol	ADP
ctmj-57	198	2	med	med	PROPN
ctmj-57	198	3	rep	rep	PROPN
ctmj-57	198	4	2019	2019	NUM
ctmj-57	198	5	;	;	PUNCT
ctmj-57	198	6	19(5	19(5	NUM
ctmj-57	198	7	):	):	PUNCT
ctmj-57	198	8	4011	4011	NUM
ctmj-57	198	9	-	-	SYM
ctmj-57	198	10	4018	4018	NUM
ctmj-57	198	11	.	.	PUNCT
ctmj-57	199	1	chinese	chinese	ADJ
ctmj-57	199	2	traditional	traditional	ADJ
ctmj-57	199	3	medicine	medicine	NOUN
ctmj-57	199	4	journal	journal	NOUN
ctmj-57	199	5	|	|	ADV
ctmj-57	199	6	2020	2020	NUM
ctmj-57	200	1	|	|	ADV
ctmj-57	200	2	vol	vol	NOUN
ctmj-57	200	3	3	3	NUM
ctmj-57	200	4	|	|	ADV
ctmj-57	200	5	issue	issue	VERB
ctmj-57	200	6	6	6	NUM
ctmj-57	200	7	issn	issn	NOUN
ctmj-57	200	8	:	:	PUNCT
ctmj-57	200	9	2693	2693	NUM
ctmj-57	200	10	6356	6356	NUM
ctmj-57	200	11	2020	2020	NUM
ctmj-57	200	12	|	|	ADV
ctmj-57	200	13	vol	vol	NOUN
ctmj-57	200	14	3	3	NUM
ctmj-57	201	1	|	|	ADV
ctmj-57	201	2	issue	issue	VERB
ctmj-57	201	3	6	6	NUM
ctmj-57	201	4	ctmj	ctmj	NOUN
ctmj-57	201	5	|	|	ADV
ctmj-57	201	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-57	201	7	17	17	NUM
ctmj-57	201	8	.	.	PUNCT
ctmj-57	202	1	taketani	taketani	PROPN
ctmj-57	202	2	y	y	PROPN
ctmj-57	202	3	,	,	PUNCT
ctmj-57	202	4	marmalidou	marmalidou	VERB
ctmj-57	202	5	a	a	PRON
ctmj-57	202	6	,	,	PUNCT
ctmj-57	202	7	dohlman	dohlman	NOUN
ctmj-57	202	8	th	th	NOUN
ctmj-57	202	9	,	,	PUNCT
ctmj-57	202	10	singh	singh	PROPN
ctmj-57	202	11	rb	rb	NOUN
ctmj-57	202	12	,	,	PUNCT
ctmj-57	202	13	amouzegar	amouzegar	VERB
ctmj-57	202	14	a	a	PRON
ctmj-57	202	15	,	,	PUNCT
ctmj-57	202	16	chauhan	chauhan	PROPN
ctmj-57	202	17	sk	sk	PROPN
ctmj-57	202	18	,	,	PUNCT
ctmj-57	202	19	chen	chen	PROPN
ctmj-57	202	20	y	y	PROPN
ctmj-57	202	21	,	,	PUNCT
ctmj-57	202	22	dana	dana	PROPN
ctmj-57	202	23	r.	r.	PROPN
ctmj-57	202	24	restoration	restoration	PROPN
ctmj-57	202	25	of	of	ADP
ctmj-57	202	26	regulatory	regulatory	ADJ
ctmj-57	202	27	t	t	PROPN
ctmj-57	202	28	-	-	PUNCT
ctmj-57	202	29	cell	cell	NOUN
ctmj-57	202	30	function	function	NOUN
ctmj-57	202	31	in	in	ADP
ctmj-57	202	32	dry	dry	ADJ
ctmj-57	202	33	eye	eye	NOUN
ctmj-57	202	34	disease	disease	NOUN
ctmj-57	202	35	by	by	ADP
ctmj-57	202	36	antagonizing	antagonize	VERB
ctmj-57	202	37	substance	substance	NOUN
ctmj-57	202	38	p	p	X
ctmj-57	202	39	/	/	SYM
ctmj-57	202	40	neurokinin-1	neurokinin-1	NUM
ctmj-57	202	41	receptor	receptor	NOUN
ctmj-57	202	42	.	.	PUNCT
ctmj-57	203	1	am	be	AUX
ctmj-57	203	2	j	j	PROPN
ctmj-57	203	3	pathol	pathol	NOUN
ctmj-57	203	4	2020	2020	NUM
ctmj-57	203	5	;	;	PUNCT
ctmj-57	203	6	190(9	190(9	NUM
ctmj-57	203	7	):	):	PUNCT
ctmj-57	203	8	1859	1859	NUM
ctmj-57	203	9	-	-	SYM
ctmj-57	203	10	1866	1866	NUM
ctmj-57	203	11	.	.	PUNCT
ctmj-57	204	1	18	18	NUM
ctmj-57	204	2	.	.	X
ctmj-57	204	3	ouyang	ouyang	PROPN
ctmj-57	204	4	w	w	PROPN
ctmj-57	204	5	,	,	PUNCT
ctmj-57	204	6	wu	wu	PROPN
ctmj-57	204	7	y	y	PROPN
ctmj-57	204	8	,	,	PUNCT
ctmj-57	204	9	lin	lin	PROPN
ctmj-57	204	10	x	x	PROPN
ctmj-57	204	11	,	,	PUNCT
ctmj-57	204	12	wang	wang	PROPN
ctmj-57	204	13	s	s	PROPN
ctmj-57	204	14	,	,	PUNCT
ctmj-57	204	15	yang	yang	PROPN
ctmj-57	204	16	y	y	PROPN
ctmj-57	204	17	,	,	PUNCT
ctmj-57	204	18	tang	tang	PROPN
ctmj-57	204	19	l	l	PROPN
ctmj-57	204	20	,	,	PUNCT
ctmj-57	204	21	liu	liu	PROPN
ctmj-57	204	22	z	z	PROPN
ctmj-57	204	23	,	,	PUNCT
ctmj-57	204	24	wu	wu	PROPN
ctmj-57	204	25	j	j	PROPN
ctmj-57	204	26	,	,	PUNCT
ctmj-57	204	27	huang	huang	PROPN
ctmj-57	204	28	c	c	PROPN
ctmj-57	204	29	,	,	PUNCT
ctmj-57	204	30	zhou	zhou	PROPN
ctmj-57	204	31	y	y	PROPN
ctmj-57	204	32	et	et	PROPN
ctmj-57	204	33	al	al	PROPN
ctmj-57	204	34	.	.	PROPN
ctmj-57	204	35	role	role	NOUN
ctmj-57	204	36	of	of	ADP
ctmj-57	204	37	cd4	cd4	PROPN
ctmj-57	204	38	+	+	PROPN
ctmj-57	204	39	t	t	PROPN
ctmj-57	204	40	helper	helper	NOUN
ctmj-57	204	41	cells	cell	NOUN
ctmj-57	204	42	in	in	ADP
ctmj-57	204	43	the	the	DET
ctmj-57	204	44	development	development	NOUN
ctmj-57	204	45	of	of	ADP
ctmj-57	204	46	bacinduced	bacinduce	VERB
ctmj-57	204	47	dry	dry	ADJ
ctmj-57	204	48	eye	eye	NOUN
ctmj-57	204	49	syndrome	syndrome	NOUN
ctmj-57	204	50	in	in	ADP
ctmj-57	204	51	mice	mouse	NOUN
ctmj-57	204	52	.	.	PUNCT
ctmj-57	205	1	invest	invest	VERB
ctmj-57	205	2	ophthalmol	ophthalmol	NOUN
ctmj-57	205	3	vis	vis	X
ctmj-57	205	4	sci	sci	PROPN
ctmj-57	205	5	2021	2021	NUM
ctmj-57	205	6	;	;	PUNCT
ctmj-57	205	7	62(1	62(1	NUM
ctmj-57	205	8	):	):	PUNCT
ctmj-57	205	9	25	25	NUM
ctmj-57	205	10	.	.	PUNCT
ctmj-57	205	11	doi	doi	NOUN
ctmj-57	205	12	:	:	PUNCT
ctmj-57	205	13	10.1167	10.1167	NUM
ctmj-57	205	14	/	/	SYM
ctmj-57	205	15	iovs.62.1.25	iovs.62.1.25	PROPN
ctmj-57	205	16	.	.	PROPN
ctmj-57	205	17	19	19	NUM
ctmj-57	205	18	.	.	PUNCT
ctmj-57	205	19	zhao	zhao	PROPN
ctmj-57	205	20	w	w	PROPN
ctmj-57	205	21	,	,	PUNCT
ctmj-57	205	22	l	l	PROPN
ctmj-57	205	23	l.	l.	PROPN
ctmj-57	205	24	strontium	strontium	PROPN
ctmj-57	205	25	ranelate	ranelate	NOUN
ctmj-57	205	26	inhibits	inhibit	VERB
ctmj-57	205	27	alveolar	alveolar	ADJ
ctmj-57	205	28	bone	bone	NOUN
ctmj-57	205	29	resorption	resorption	NOUN
ctmj-57	205	30	in	in	ADP
ctmj-57	205	31	diabetic	diabetic	ADJ
ctmj-57	205	32	rats	rat	NOUN
ctmj-57	205	33	with	with	ADP
ctmj-57	205	34	periodontitis	periodontitis	NOUN
ctmj-57	205	35	by	by	ADP
ctmj-57	205	36	regulating	regulate	VERB
ctmj-57	205	37	jak2	jak2	PROPN
ctmj-57	205	38	/	/	SYM
ctmj-57	205	39	stat3	stat3	NOUN
ctmj-57	205	40	signaling	signal	VERB
ctmj-57	205	41	pathway	pathway	NOUN
ctmj-57	205	42	.	.	PUNCT
ctmj-57	206	1	trop	trop	X
ctmj-57	206	2	j	j	PROPN
ctmj-57	206	3	pharm	pharm	PROPN
ctmj-57	206	4	res	re	VERB
ctmj-57	206	5	2022	2022	NUM
ctmj-57	206	6	;	;	PUNCT
ctmj-57	206	7	21(12	21(12	NUM
ctmj-57	206	8	):	):	PUNCT
ctmj-57	206	9	25832589	25832589	NUM
ctmj-57	206	10	.	.	PUNCT
ctmj-57	207	1	20	20	NUM
ctmj-57	207	2	.	.	PUNCT
ctmj-57	208	1	shen	shen	PROPN
ctmj-57	208	2	m	m	PROPN
ctmj-57	208	3	,	,	PUNCT
ctmj-57	208	4	lin	lin	PROPN
ctmj-57	208	5	b	b	PROPN
ctmj-57	208	6	,	,	PUNCT
ctmj-57	208	7	qian	qian	PROPN
ctmj-57	208	8	f	f	X
ctmj-57	208	9	,	,	PUNCT
ctmj-57	208	10	zhao	zhao	PROPN
ctmj-57	208	11	l	l	PROPN
ctmj-57	208	12	,	,	PUNCT
ctmj-57	208	13	xi	xi	PROPN
ctmj-57	208	14	y	y	PROPN
ctmj-57	208	15	,	,	PUNCT
ctmj-57	208	16	qian	qian	PROPN
ctmj-57	208	17	y.	y.	PROPN
ctmj-57	208	18	taxifolin	taxifolin	PROPN
ctmj-57	208	19	ameliorates	ameliorate	VERB
ctmj-57	208	20	sepsis	sepsis	NOUN
ctmj-57	208	21	-	-	PUNCT
ctmj-57	208	22	induced	induce	VERB
ctmj-57	208	23	lung	lung	NOUN
ctmj-57	208	24	capillary	capillary	ADJ
ctmj-57	208	25	leak	leak	NOUN
ctmj-57	208	26	through	through	ADP
ctmj-57	208	27	inhibiting	inhibit	VERB
ctmj-57	208	28	the	the	DET
ctmj-57	208	29	jak	jak	PROPN
ctmj-57	208	30	/	/	SYM
ctmj-57	208	31	stat3	stat3	NOUN
ctmj-57	208	32	pathway	pathway	NOUN
ctmj-57	208	33	.	.	PUNCT
ctmj-57	209	1	allergol	allergol	PROPN
ctmj-57	209	2	immunopathol	immunopathol	PROPN
ctmj-57	209	3	(	(	PUNCT
ctmj-57	209	4	madr	madr	PROPN
ctmj-57	209	5	)	)	PUNCT
ctmj-57	209	6	2022	2022	NUM
ctmj-57	209	7	;	;	PUNCT
ctmj-57	209	8	50(2	50(2	NUM
ctmj-57	209	9	):	):	PUNCT
ctmj-57	209	10	7	7	NUM
ctmj-57	209	11	-	-	SYM
ctmj-57	209	12	15	15	NUM
ctmj-57	209	13	.	.	PUNCT
ctmj-57	210	1	21	21	NUM
ctmj-57	210	2	.	.	PUNCT
ctmj-57	211	1	you	you	PRON
ctmj-57	211	2	g	g	PROPN
ctmj-57	211	3	,	,	PUNCT
ctmj-57	211	4	cao	cao	PROPN
ctmj-57	211	5	h	h	PROPN
ctmj-57	211	6	,	,	PUNCT
ctmj-57	211	7	yan	yan	PROPN
ctmj-57	211	8	l	l	NOUN
ctmj-57	211	9	,	,	PUNCT
ctmj-57	211	10	he	he	PRON
ctmj-57	211	11	p	p	X
ctmj-57	211	12	,	,	PUNCT
ctmj-57	211	13	wang	wang	PROPN
ctmj-57	211	14	y	y	PROPN
ctmj-57	211	15	,	,	PUNCT
ctmj-57	211	16	liu	liu	PROPN
ctmj-57	211	17	b	b	PROPN
ctmj-57	211	18	,	,	PUNCT
ctmj-57	211	19	shao	shao	PROPN
ctmj-57	211	20	f.	f.	PROPN
ctmj-57	211	21	microrna-10a-3p	microrna-10a-3p	PROPN
ctmj-57	211	22	mediates	mediate	VERB
ctmj-57	211	23	th17	th17	NOUN
ctmj-57	211	24	/	/	SYM
ctmj-57	211	25	treg	treg	PROPN
ctmj-57	211	26	cell	cell	NOUN
ctmj-57	211	27	balance	balance	NOUN
ctmj-57	211	28	and	and	CCONJ
ctmj-57	211	29	improves	improve	VERB
ctmj-57	211	30	renal	renal	ADJ
ctmj-57	211	31	injury	injury	NOUN
ctmj-57	211	32	by	by	ADP
ctmj-57	211	33	inhibiting	inhibit	VERB
ctmj-57	211	34	reg3a	reg3a	NOUN
ctmj-57	211	35	in	in	ADP
ctmj-57	211	36	lupus	lupus	ADJ
ctmj-57	211	37	nephritis	nephritis	NOUN
ctmj-57	211	38	.	.	PUNCT
ctmj-57	212	1	int	int	PROPN
ctmj-57	212	2	immunopharmacol	immunopharmacol	PROPN
ctmj-57	212	3	2020	2020	NUM
ctmj-57	212	4	;	;	PUNCT
ctmj-57	212	5	88	88	NUM
ctmj-57	212	6	:	:	SYM
ctmj-57	212	7	106891	106891	NUM
ctmj-57	212	8	.	.	PUNCT
ctmj-57	213	1	doi	doi	NOUN
ctmj-57	213	2	:	:	PUNCT
ctmj-57	213	3	10.1016	10.1016	NUM
ctmj-57	213	4	/	/	SYM
ctmj-57	213	5	j.intimp.2020.106891	j.intimp.2020.106891	NOUN
ctmj-57	213	6	.	.	PUNCT
ctmj-57	214	1	22	22	NUM
ctmj-57	214	2	.	.	PUNCT
ctmj-57	214	3	qu	qu	PROPN
ctmj-57	214	4	m	m	PROPN
ctmj-57	214	5	,	,	PUNCT
ctmj-57	214	6	qi	qi	PROPN
ctmj-57	214	7	x	x	PROPN
ctmj-57	214	8	,	,	PUNCT
ctmj-57	214	9	wang	wang	PROPN
ctmj-57	214	10	q	q	PROPN
ctmj-57	214	11	,	,	PUNCT
ctmj-57	214	12	wan	wan	PROPN
ctmj-57	214	13	l	l	PROPN
ctmj-57	214	14	,	,	PUNCT
ctmj-57	214	15	li	li	PROPN
ctmj-57	214	16	j	j	PROPN
ctmj-57	214	17	,	,	PUNCT
ctmj-57	214	18	li	li	PROPN
ctmj-57	214	19	w	w	PROPN
ctmj-57	214	20	,	,	PUNCT
ctmj-57	214	21	li	li	PROPN
ctmj-57	214	22	y	y	PROPN
ctmj-57	214	23	,	,	PUNCT
ctmj-57	214	24	zhou	zhou	PROPN
ctmj-57	214	25	q.	q.	PROPN
ctmj-57	214	26	therapeutic	therapeutic	ADJ
ctmj-57	214	27	effects	effect	NOUN
ctmj-57	214	28	of	of	ADP
ctmj-57	214	29	stat3	stat3	NOUN
ctmj-57	214	30	inhibition	inhibition	NOUN
ctmj-57	214	31	on	on	ADP
ctmj-57	214	32	experimental	experimental	ADJ
ctmj-57	214	33	murine	murine	ADJ
ctmj-57	214	34	dry	dry	ADJ
ctmj-57	214	35	eye	eye	NOUN
ctmj-57	214	36	.	.	PUNCT
ctmj-57	214	37	invest	invest	VERB
ctmj-57	214	38	ophthalmol	ophthalmol	PROPN
ctmj-57	214	39	vis	vis	X
ctmj-57	214	40	sci	sci	PROPN
ctmj-57	214	41	2019	2019	NUM
ctmj-57	214	42	;	;	PUNCT
ctmj-57	214	43	60(12	60(12	NUM
ctmj-57	214	44	):	):	PUNCT
ctmj-57	214	45	3776	3776	NUM
ctmj-57	214	46	-	-	SYM
ctmj-57	214	47	3785	3785	NUM
ctmj-57	214	48	.	.	PUNCT
ctmj-57	215	1	23	23	NUM
ctmj-57	215	2	.	.	PUNCT
ctmj-57	215	3	hu	hu	PROPN
ctmj-57	216	1	j	j	PROPN
ctmj-57	216	2	,	,	PUNCT
ctmj-57	216	3	yao	yao	PROPN
ctmj-57	216	4	y	y	PROPN
ctmj-57	216	5	,	,	PUNCT
ctmj-57	216	6	huang	huang	PROPN
ctmj-57	216	7	j	j	PROPN
ctmj-57	216	8	,	,	PUNCT
ctmj-57	216	9	qian	qian	PROPN
ctmj-57	216	10	j	j	PROPN
ctmj-57	216	11	,	,	PUNCT
ctmj-57	216	12	xiong	xiong	PROPN
ctmj-57	216	13	y	y	PROPN
ctmj-57	216	14	,	,	PUNCT
ctmj-57	216	15	miao	miao	PROPN
ctmj-57	216	16	w.	w.	PROPN
ctmj-57	216	17	erxian	erxian	PROPN
ctmj-57	216	18	decoction	decoction	NOUN
ctmj-57	216	19	modulates	modulate	VERB
ctmj-57	216	20	th17	th17	NOUN
ctmj-57	216	21	/	/	SYM
ctmj-57	216	22	treg	treg	PROPN
ctmj-57	216	23	cells	cell	NOUN
ctmj-57	216	24	differentiation	differentiation	NOUN
ctmj-57	216	25	through	through	ADP
ctmj-57	216	26	lfa-1	lfa-1	NUM
ctmj-57	216	27	/	/	SYM
ctmj-57	216	28	icam-1	icam-1	NUM
ctmj-57	216	29	/	/	SYM
ctmj-57	216	30	stat3	stat3	NOUN
ctmj-57	216	31	pathway	pathway	NOUN
ctmj-57	216	32	in	in	ADP
ctmj-57	216	33	menopausal	menopausal	ADJ
ctmj-57	216	34	dry	dry	ADJ
ctmj-57	216	35	eye	eye	NOUN
ctmj-57	216	36	disease	disease	NOUN
ctmj-57	216	37	.	.	PUNCT
ctmj-57	217	1	exp	exp	NOUN
ctmj-57	217	2	eye	eye	NOUN
ctmj-57	217	3	res	re	NOUN
ctmj-57	217	4	2022	2022	NUM
ctmj-57	217	5	;	;	PUNCT
ctmj-57	217	6	215	215	NUM
ctmj-57	217	7	:	:	PUNCT
ctmj-57	217	8	108890	108890	NUM
ctmj-57	217	9	.	.	PUNCT